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Abstract 
 
The cellular redox environment is a complex milieu of reactive oxygen, nitrogen, sulfur, 
carbon, and lipid species (ROS, RNS, RSS, RCS, RLS respective; collectively, RxS) 
that all have functional group interplay. Nowhere is this more apparent than on cysteine, 
which is readily oxidized to a wide range of functional groups. One group, the sulfenic 
acid, is the first oxidative step forward into this web. It has been studied extensively with 
biochemical and proteomic tools based upon the active methylene compound 
dimedone, but study of the localization of sulfenic acids has been limited to fixed cells 
due to the use of constitutively active dyes and antibodies to image. Herein we propose 
a design for a chemical ‘switch’ that would change the photoelectronics of an attached 
dye upon conjugation to a sulfenic acid, which he have developed in Chapter 2. This is 
based upon the observation that only one of the two α-protons is necessary for the 
reaction. We have successfully synthesized an aminonaphthalene-based dye with a 
fluorodimedone, F-DiNap, that allows for ratiometric imaging of live cells on TIRF and 
confocal microscopy. We have demonstrated F-DiNaps utility as a live-cell probe by 
collecting images before and after stimulation, as well as distinguishing established 
models of cancer malignancy with the cell lines that have been transfected with the 
transcription factor Snail. Critically, we have shown that our probe both increases 
 xxix 
selectivity over aldehydes, which are post-translational modifications that are formed 
from the same oxidative stimuli as sulfenic acids; and that the rate of these probes is 
dramatically enhanced by over a thousand-fold by the addition of the fluorine. 
Serendipitously, 19F is a minimalist reporter group for nuclear-spin instrumentation such 
as NMR and MRI. In Chapter 3 we have leveraged this capacity to study sulfenic acids 
in NMR, synthesizing several probes based on minimalist fluorobarbituic acids, or F-
Barbs. We have made preliminary studies into profiling these probes rates of 
conjugation, selectivity over other functional groups, and reactivity with biological 
samples, including purified proteins and lysates. The probes will be a large step towards 
imaging and interrogating the biological role of sulfenic acids in vivo.  
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Chapter 1: An Introduction to Protein 
Cysteine Oxidation and their Sensors 
and Probes 
 
1.01. General Introduction 
For all aerobic organisms, cellular respiration via molecular oxygen plays a critical 
role in metabolism. However, O2 specifically, and oxidation in general, is a two-edged 
sword: too little, and cells become hypoxic and die; too much, and it not only fuels the 
intended metabolic fire, but it lays waste to genetic information, all the surrounding 
protein machinery, and lipid structure. This is one reason why relatively strong oxidants 
such as bleach and peroxides make effective disinfectants. Thus, a prime challenge of 
all aerobic organisms is to develop cellular infrastructure to modulate and moderate 
cellular reduction-oxidation (redox) and balance the high degree of oxygen’s 
constructive reactivity with its high degree of destructive reactivity into a tightly 
controlled, well-regulated system.  
The extracellular region of the cell is typically an oxidizing environment, as it is in 
constant contact with either atmospheric oxygen itself, or delivered through the body via 
oxygen-rich arterial blood in the vascular system. In contrast, the interior of the cell 
tends to be a reducing environment, possessing high concentrations of free thiols and 
redox sponges that protect the cell from oxidative damage.  
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Many of these regulatory, antioxidant proteins are highly conserved1, and likely 
harken back to the time of the Great Oxygenation Event when anaerobic species had to 
adapt to deal with the drastic atmospheric change.  
 
Figure 1-01. Select redox species inside the cell, sorted by their redox potential2.  
The red line indicates energetically favorable electron flow i.e. the conversion of lactate 
into pyruvate is sufficient to turn fumarate into succinate. 
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In addition to these macroscopic, environmental redox sources, there are a large 
number of redox active small molecules and molecules that act as either oxidizing or 
reducing equivalents (Figure 1-1). The cell produces other specific, extremely small-
molecule inorganic reactive redox species endogenously. These enzymatically-
produced molecules are typically highly reactive, and lead to localized, non-enzymatic 
changes to protein function and structure. Because of their high reactivity, their diffusion 
distances are limited before redox machinery degrades them. Before that point, 
gaseous or low-molecular weight molecules can react with metabolites and proteins, 
altering their function and structure in reversible or irreversible ways.  
 
1.02 Reactive species and gasotransmitters 
Though many of the pathways in the cell are modulated by protein-protein, protein-
metabolite, and protein-organelle interactions, extremely small molecules of two or less 
heavy atoms are also prevalent means of transmitting cellular information via 
modification of key residues. These molecules, being small, often rapidly diffuse across 
membranes and cells and many of them possess high enough vapor pressures to be 
considered gaseous, thus earning the name gasotransmitters. These are typically 
enzymatically produced or produced through side-reactions, though their reactivity with 
biomolecules tends to be dependent to the individual reactivity of a residue, or binding 
ability of the protein, metabolite, or cofactor.  
To this end, the cell produces a number of extremely small molecule reactive oxygen 
species (ROS), reactive nitrogen species (RNS), reactive sulfur species (RSS) and 
reactive carbon species (RCS), collectively referred to herein as RxS. Collectively they 
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make up some of the smallest molecules possible. We will review some of the most 
prominent species herein. 
 
Reactive Oxygen Species 
ROS exist in the cell both as metabolic byproducts, and specifically through enzyme-
mediated processes. The vast majority of aerobic organisms derive the primary 
oxidation source from molecular oxygen, which makes up roughly 20.8% v/v of the 
atmosphere currently, up to the geological historical maximum of approximately of 
35%3. At concentrations as low as 28%, O2 can cause hyperoxia4. It is produced 
historically first by cyanobacteria and then by photosynthesis by plants as a way to fix 
gaseous carbon dioxide from the atmosphere5. Diatomic molecular oxygen has a 
standard reduction potential of: 
 
O2(g) + 4H+ +4e- ! 2H2O(l)    ξ0’ = +0.815 V6 
O2(g) + 2H+ +2e- ! H2O2(aq)    ξ0’ = +0.281 V6 
 
 This makes it a strong common oxidant, the one that is highest in concentration, 
and thus the primary electron sink in respiration. It has a high atmospheric partial 
pressure, and it is pervasive throughout the physiology of higher-order species due to 
it’s efficient distribution by the vascular system. After travelling through the blood stream 
by hemoglobin, it is readily able to cross cellular membranes at 96% of the rate if would 
diffuse through pure water7. It is sometimes transferred to myoglobin, which has a 
higher affinity for and acts like a cellular oxygen store8. Therefore, when dealing with 
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biological samples, molecular oxygen always has to be considered in oxidative 
biochemical reactions.  
Several secondary oxidants are also produced. A metabolic side product, the 
superoxide radical, O2˚-, is produced when the electrons from the mitochondrial electron 
transport chain in eukaryotes (and from the electron transport chain in the chloroplasts 
of plants) do not complete the journey along the pathway from complex I to IV and 
instead find other side reactions9. Such ‘leaky electrons’ combine with molecular 
oxygen, forming the highly reactive superoxide9.  
 
   O2(g) + e- ! O2˚-     ξ0’ = -0.33 V6 
   O2˚- + e- + 2H+! H2O2   ξ0’ = +0.89 V6 
 
Superoxide is also enzymatically generated by NADPH oxidase (NOx)10. 
 
2O2(g) + NADPH + [2e-] ! NADP+ H+ + 2O2˚- + [2e-]    
 
O2˚- can react in a number of ways, both as a nucleophile, and in radical reactions.  
Superoxide O2˚-, rapidly dismutates into H2O2, by the following pH-dependent process11: 
 
2HO2˚ ! H2O2 + O2    k1 = 7.61 x 105 M-1 s-1 
HO2˚ + O2˚- H2O ! H2O2 + O2 + OH- k2 = 8.86 x 107 M-1 s-1 
O2˚- 2H2O ! H2O2 + O2 + 2OH-  k3 = < 0.3 M-1 s-1 
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The hydroperoxy radical may have different roles in cellular oxidation than 
superoxide, but it is not yet understood. Regardless, it will exist in the mostly anionic 
state at physiological pH: 
 
O2˚- + H+ ! HO2˚    pKa: 4.8512 
 
Due to the short lifetime of the superoxide radical, hydrogen peroxide is the more 
prevalent small molecule oxidant. It has the following reduction half-reaction: 
 
H2O2(aq) + 2H+ +2e- ! 2H2O(aq)    ξ0’ = +1.34 V6 
H2O2(aq) + H+ +e- ! H2O(aq) + OH˚   ξ0’ = +0.38 V6 
 
Outside the cell, strong solutions of hydrogen peroxide (30-40% v/v) can be stored 
indefinitely in aqueous solutions in cool, dark locations.  
Hydroxyl radicals are among the most reactive species present in a cell. They are 
produced from a process akin to the Fenton Reaction shown in Figure 1-0213, which 
involves the use of a CuI/CuII or FeII/FeIII pair, along with hydrogen peroxide and a 
reductant: 
          
H2O2
•OH + HO-Fe+3
Fe+2
O2•-
or
Cu+/ Cu+2
or
AscH- / AscH
O2
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Figure 1-02. The Fenton reaction.  
In an electron cascade originating with an electron from the superoxide anion or from 
ascorbate, reduces CuII or FeIII  to CuI or FeII. This in turn, reduces hydrogen peroxide 
in a single-electron cleavage, producing highly reactive hydroxyl radicals and hydroxide. 
 
The radical has the large standard reduction potential: 
 
OH˚ + H+ +e- ! H2O(aq)    ξ0’ = +2.32 V6 
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Figure 1-03. Conversion of lysine, arginine, proline, and the peptide back bond into 
their corresponding carbonyls by hydroxyl radical. 
 
 
A particular feature of the high reactivity of hydroxyl radicals is the ability to oxidize 
C-H bonds proximal to amines at diffusion-limited rates, which converts it to the imine 
with subsequent hydrolysis to the aldehyde. Of interest is the ability to convert the sp3-
carbon attached to the nitrogen of lysine, arginine, proline, and the amide backbone into 
their corresponding aldehyde or ketone14, with lysine being the most reactive15. This 
process is referred to in the literature as metal-centered oxidation (MCO), or primary 
carbonylation. This is of importance because aldehydes are highly reactive groups on 
their own, and interact with a wide number of functional groups in reversible and 
irreversible ways. 
Myeloperoxidase (MPO) combines cellular H2O2 and Cl- to make ClO-16. MPO is 
primarily expressed in white blood cells, which breaks apart peroxide into hypochlorous  
acid and water. This heme-based enzyme is active during the respiratory burst of white 
blood cells and is responsible for some of the antimicrobial of neutrophil granulocytes17-
19.  
HClO(aq) + H+ +2e- ! Cl-(aq) + H2O(l)  ξ0’ = +1.49 V20 
 
Reactive Nitrogen Species 
The primary biological reactive nitrogen species is the gaseous radical nitric oxide, 
and it is an of itself an important biological signaling molecule. When released outside of 
the body, it rapidly oxidizes to nitrogen dioxide in air. Biologically, it is produced from 
nitric oxide synthase via the following reaction:  
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L-Arginine + 2 O2 + 3/2 NADPH + ½ H+ ! 
     citrulline + NO˚ + 2 H2O + 3/2 NADP+21 
 
There are several important isoforms of NOS, which are complex, multi-cofactor 
enzymes, including inducible iNOS22, neuronal nNOS23-25 and endothelial eNOS26-28. 
Like MPO, iNOS is also involved in immune response, as NO is highly reactive and as a 
small neutral nonpolar molecule it is able to diffuse through bacterial, fungal, and viral 
membranes, and at high concentrations it is toxic29. Interestingly, NO˚ is the only one of 
the family of small molecule & gasotransmitters that is also a radical, since superoxide 
dismutates too rapidly to be considered a signal transducer.  
            
Figure 1-04. The complex interplay of primary ROS, RNS and their secondary species. 
 RSS, RCS, and RLS are not included in this diagram. 
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When neutrophils sense an antigen, iNOS is activated by cytokines induced by 
interferon-γ30This produces a respiratory ‘burst’ of activity, which can damage or kill the 
intruder, and is one of the primary mechanisms for antibiolic defense. Other biological 
functions of nitric oxide is involved in vascular relaxation and vasodilalation by way of 
activating guanadyl cyclase (sGC)28, sexual stimulation by way of activating sGC31, and 
neutrotransmission32.  
However, due to the interplay between various RNS and ROS species, many 
additional species are possible, including peroxynitrite (ONOO-) (Figure 1-04)33, 
nitrogen dioxide (NO2˚)34, nitrate (NO3-)35, carbonate radical (CO3˚-)34 and more. Each of 
these species has their own individual, but at times overlapping reactivity, making their 
specific contributions to protein modification in the cellular context difficult to determine. 
Each species may potentially react in a nucleophilic, electrophilic, or radical fashion. It is 
well beyond the scope of this document to describe the role of all of these species, 
except to note that all of these highly reactive molecules and ions may play their own 
unique role in the redox environment and signaling processes by virtue of their 
concentration, charge, diffusion, membrane permeability, rates, and individual reactivity 
and rates of reactivity with various functional groups which may also be affected by the 
local chemical environment.  
 
Reactive Sulfur Species  
Hydrogen sulfide (H2S) is another gaseous transmitter. H2S is highly toxic on its 
own, with doses of 320-530 ppm able to kill a human36. However, when produced 
endogenously by cystathionine γ-lysase37 (CγL), cystathionine β-synthase38 (CβS), and 
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several other enzymes, at physiological levels of ~14 nM39, it plays a similar role to NO: 
it acts as an endothelium-derived relaxing factor40, as well as relaxing the smooth 
muscles and acting as a vasodilator41. In this vein, H2S has also been shown to play a 
role in sexual stimulation in males42. It in the central nervous system, it appears to have 
a extremely wide range of functions, including activating Ca+2-, K+-, and Cl—ion 
channels; activating protein kinase A; and acting upon γ-amino butyric acid (GABA), 
glutamate, and cachetolamine receptors43. It is a potent neuroprotectant, helping to 
diminish damage during repeated seizures44 and is produced endogenously upon 
hypoxia45, where carbon monoxide produced by heme oxygenase ceases, increasing 
H2S production and stimulating cerebral circulation46. It seems to mitigate stroke 
damage47,48 though this effect may be disputed50. In extreme examples, H2S has been 
shown to and induce suspended animation in which metabolism decreased to 10% and 
core body temperature decreased to 2˚C above ambient with no apparent long-term 
damage49, and increasing wound and blood-loss survivability50. 
 
Reactive Carbon Species 
Reactive carbon species include a pair of isoelectronic molecules: carbon monoxide 
(CO) and hydrogen cyanide (HCN or -CN). They are each highly toxic exogenously, with 
death occurring at 3200 ppm after 30 min for carbon monoxide51,52 and death occurring 
in 10-60 min with 320 ppm hydrogen cyanide. Their toxicity is due to their high affinity 
for iron-based porphyrin (heme). The lone pair of each carbon has strong Lewis-basic 
electron-donating properties that are supplemented by strong π backbonding into the -
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CX. Both CO and -CN competes for binding at a higher affinity than oxygen53, 
preventing oxygenation of the blood, and, more critically, poisoning cellular respiration.54 
Carbon monoxide is produced endogenously from a family of proteins known as 
heme oxygenase (HO-x)54. This is a heme degradation pathway that oxidizes heme with 
molecular oxygen and NADPH to release CO(g), iron+3, biliverdin, and H2O and NADP+. 
Carbon monoxide is derived from one of the bridging methyne unites of heme, 
producing biliverdin as a linearized chain of pyrroles54. Heme plays a central role in 
cellular redox processes due to its ability to bind and transport oxygen, as well as the 
ability of the iron to go from Fe+2 to Fe+3 and back again. Cytochromes, oxidating 
enzymes that are conserved all the way down to viruses55 also use heme as a cofactor 
to oxidize and metabolize drugs. Thus heme degradation plays its own role in regulating 
these processes. The production of CO has effects on its own, with it binding and 
deactivating catalase56, cytochrome p45057, hemoglobin58, NADPH oxidase59, nitric 
oxide synthases60,61, and myoglobin62. Interestingly CO activates some enzymes too, 
guanylyl cyclase63 and cyclooxygenase64. Exogenous CO has been shown to be a, 
paradoxically, vasorelaxant65 and as a vasoconstrictant65, as well as involved in platelet 
aggregation66 by inducing the release of NO˚ stores, and plays roles in 
neurotransmission67 and long-term memory68, and binds hemoglobin 200-250 times 
higher than oxygen,69 amongst other roles54. 
The last small-molecule transmitter that will be discussed is hydrogen cyanide, or its 
deprotonated anion, cyanide. Cyanide has a pKa of 9.2, so all but ~1.5% will be in the 
less nucleophilic, less coordinating, but more diffusible HCN form. It is a potent 
nucleophile an even more potent binder of heme than CO due to increased Lewis 
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basicity. In macrophages, cyanide is produced by an MPO-mediated N-terminal 
oxidation of glycine or N-terminal glycyl peptide for phagocytosis70. In this process, N-
chloroamino product degrades to cyanide. Other routes include the oxidation of 
thiocyanate71. CN- also decreases cellular metabolism72 and initiates hypoxic-stress 
related proteins such as protein kinase C73. Cyanide is generated by µ-opiate receptor 
and evidence suggests that it modulates NMDA receptor response74. Likewise, 
stimulating muscarinic cholinergic receptors in cultured cells increases HCN production, 
while in vivo the same action decreases HCN production75. 
 
Reactive Lipid Species 
Another class of RCS are reactive species that derive from the perodixation of 
polyunsaturated fatty acids (PUFA) such as arachidonic acid (20:4), eicosepentenoic 
acid (20:5), or docosahexaenoic acid (DHA)  that are present in the lipid membrane. 
These PUFAs help maintain membrane fluidity, are precursors to prostaglandins76 and 
other signaling molecules such as anadamide77, and aid in memory78.   
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Figure 1-05. Reactive lipid species producted from the peroxidation of PUFAs. 
 
 
Due to their high degree of unsaturation, they are also prone to oxidation by 
peroxides, and are cleaved by the Hock reaction (Figure 1-05)79. This causes their 
breakdown into a wide number of products, including acrolein, 4-hydroxynonenal (HNE), 
and 4-oxononenal (ONE). These ene-als are bifunctional, able to undergo 1,4 (Michael) 
addition and aldehyde chemistry. They react in a 1,4 fashion with the following order: 
cysteine >> lysine > histidine. Though usually a sign of oxidative stress80 and are 
implicated in neurodegeneration81, RLS can act as signaling molecules82, as shown by 
its modification of NF-κβ83,84, and at low concentrations, inducing activation of Nrf285 
and acting as a neuroprotective agent in response to oxidative insult.  
 
In summary, these molecules are extremely toxic when administered at any 
meaningful concentration exogenously, much of which is explained by their bioactivity86. 
However, they all play biological roles at endogenously low levels produced by well-
regulated enzymes and buffered by high redox concentrations of GSH.  
 
1.03. Small-molecule antioxidant species 
The highly reactive nature of all of the RxS species means that their regulation is 
highly necessary. Each of these plays a role in maintaining the overall redox state, 
though their small diffusible, but highly reactive nature shows that they have increasing 
roles in localized small molecule signaling, inflammation, immune response, and 
response to disease and redox stress.  Their degradation-limited localization and ability 
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to affect proteins either on the short or long-distance is dependent on their reaction with 
GSH (Table 1-1)87.  
     
Table 1-01. Rate constants and average diffusion distances of ROS and RNS in the 
cell. Superoxide diffusion is rate-limited by its own disproportionation87. 
 
Glutathione (GSH) is a secondary reductive metabolite and the primary small 
molecule reducing cofactor for most for antioxidant proteins. Due to its high cellular 
concentration, we will also include glutathione (GSH) as a RSS. Though it varies tissue 
to tissue, most sources put intracelluar glutathione concentrations in the low single-digit 
mM range88. This high concentration allows it to act as an effective and electron source, 
forming oxidized glutathione, GSSG (Figure 1-06). Glutathione reductase (Grx) is 
responsible for turning over GSSG back to GSH using NADPH. It can react on its own 
at physiological pH; however, the pKa of GSH is high for a thiol at 9.6589, compared to 
8.2 for typical cysteine residues, likely due to the molecule’s net negative charge thanks 
to the two carboxylates. We speculate that the fact that <1% of GSH exists as GS- may 
in fact be favorable for the cell, so that there is a large cellular reservoir of neutralized 
and/or acid-passivated reductant that can converted to a much more reactive anionic 
form in the microenvironment of a protein, but oxidative and nitrosative species such as 
ROS and RNS can diffuse relatively freely and their products can persist for as longer. 
This gives the cell more opportunities for oxidative regulation and signaling, but allows 
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the cell regulate the production and activity of antioxidant proteins that convert GSH into 
the more reactive GS- in order to deal with the oxidative stress. By tightly controlling the 
concentration and limiting range of the redox modulators, the cell can benefit from the 
signaling capabilities of these species while abrogating the potential damage and 
negative effects.  
 
Figure 1-06. Glutathione reduction cycle.  
Glutathione (GSH) is a tripeptide that has an oxidizable thiol derived from cysteine. It 
gets oxidized to a disulfide GSSG dimer, which subsequently gets reduced by 
glutathione reductase (Grx) using NADPH as a cofactor. 
 
Other small-molecule electron sources are nicotinamide adenine dinucleotide 
phosphate (NADPH) and nicotinamide adenine dinucleotide (NADH). NADPH is 
produced from pentose phosphate pathway90 as well as phosphorylation from 
NAD+/NADH. Due to its direct production from exogenous energy sources (i.e. nutrients 
and food) it is the progenitor reducing species. These are cofactors in protein reactions 
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and rarely react with anything on their own. When GSH gets oxidized to GSSG, it 
provides the electron pairs to re-reduce it.  
 
1.04. Proteins contributing to the antioxidant biology  
The diversity of oxidant species and the necessity for careful regulation in 
maintaining a redox balance results in numerous pathways that cell can regulated the 
intracellular redox state. This leads to two classes of regulation: powerful antioxidant 
species that rapidly turn over to decrease the concentration and prevent the buildup of 
ROS and mitigate the ever-present threat of environmental and endogenous oxidants, 
and less active, regulatory proteins that chemically, structurally, and/or transrelocate 
and react to oxidative stress which induces downstream antioxidant response.  
In the first, highly active antioxidant proteins are the front line of defense against 
high levels of ROS and regulate and limit the concentration of these oxidants. These 
include peroxyredoxin (Prx)91, which reduces H2O2 into H2O in combination with GSH 
via a pair of proximal thiols (Figure 1-7a and 1-7c); superoxide dismutase (SOD)92, 
which converts O2˚- into either H2O2 or O2; and catalase93, which converts H2O2 into 
H2O and O2, which dramatically increase the rate of the degradation of these ROS. 
Some of these enzymes, such as catalase, are amongst the most active enzymes 
known, with catalytic efficiencies approaching the diffusion limits. These proteins put 
concentration limits on ROS under basal levels, apply stringent diffusion limits to ROS in 
the time of oxidative signaling and respiratory bursts, and protect the cell from high 
levels of primary oxidants during times of oxidative stress. AhpC C165S or C166S, in 
which the resolving cysteine is mutate out, lacks this catalytic ability.  
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Glutathione is a the primary small-molecule re-reducing agent for peroxyredoxins, 
when it gets oxidized, a second equivalent of GSH forms disulfide-linked dimers 
(GSSG), which are ultimately reduced by glutathione reductase (Grx) utilizing NADPH 
as an electron source (Figure 1-7d).  
 
Figure 1-07. Redox management in the cell.  
a) Peroxyredoxin, in this case AhpC, often has dimers and higher-ordered ring 
structures. b) Thioredoxin mechanism. The molecule has a two-cysteine CXXC motif. 
Two reduced thiols encounter an oxidized species. One thiol attacks, forming a transient 
disulfide, which the second cysteine resolves into a disulfide, freeing the now-reduced 
substrate. c) Like Trx, the structure of monomeric Prx has two proximal thiols, either 
intermolecularly or inter-subunit . The first is the peroxidase thiol, which is more 
reactive, and forms a transient sulfenic acid. The resolving thiol then attacks the sulfenic 
acid to form an intramolecular disulfide bond. It is regenerated by GSH/Grx. d) The 
mechanism of glutathione turnover. Grxred reduces GSSG to GSH, forming oxidized 
Grx. Grxox is then reduced to active form by NADPH. e) An overview of the fate of 
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oxidative species in the cell. Molecular oxygen is the progenitor oxidant of the cell. The 
majority of it goes to metabolism, where it catabolizes carbohydrates, lipids, and 
proteins. However, some gets reduced to O2˚-, either accidentally through the ETC of 
the mitochondria, or through the enzymatic production by NOX. O2˚- either gets 
reoxidized to O2 by SOD, or further reduced to H2O2 by SOD or rapid disproportionation. 
From there, Prx reduces it into water, forming a disulfide. Prx can be regenerated by 
converting GSH into GSSG, which gets reduced by Grx and NADPH. Alternatively, Trx 
can reduce Prx. The oxidized Trx is converted back to the reduced Trx by Trxrx and 
NADPH. 
 
Thioredoxins (Trx) are small proteins with CXXC motif. When they encounter disulfides 
in proteins, thioredoxin undergoes and oxidative thiol-disulfide exchange, transferring 
the reducing equivalent onto the substrate, and leaving the substrate protein with 
reduced thiols (Figure 1-7b)94. The close proximity of the Trx cysteines make this 
possible, much like the small-molecule biochemical reducing agent dithiothreitol (DTT). 
Trx is then re-reduced by thioredoxin reductase (Trxrx), a flavin protein that uses an 
NADPH cofactor95. 
This first class of antioxidant proteins combines stray byproducts of molecular 
oxygen ultimately with NADPH through a series of thiol-disulfide exchange and cofactor-
enabled reactions, an overview of which can be seen in Figure 1-7e.  
The second class of antioxidant response proteins acts as upfield sensors of 
oxidative stress. Such proteins often have a redox-sensitive residue or cofactor, 
typically a cysteine, and help to maintain the balance of a cell or compartment. These 
are not directly related to this research, but they are critical to maintaining the redox 
balance of the cell. Descriptions of some of the important species can be found in 
Appendix C. 
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1.05. The post-translational modifications of cysteine and sulfenic acids 
Like the thiol moiety of glutathione, protein cysteine residues present a reductive 
sink and an electron source for these reactive species, albeit at much lower 
concentrations in the cell. Though other amino acids, such as tyrosine, tryptophan, 
lysine, and methionine are also at times oxidized, the free thiol of cysteine is in 
particular susceptible to these numerous changes and diverse chemistries (Figure 1-
08). Because sulfur is the only third-row element that natively exists with multiple 
oxidation states within the cellular context, it adopts a diverse array of post-translational 
modifications (PTMs). Each of these PTMs can be reversible or irreversible, and play a 
different functional role for the protein.  
 
Figure 1-08. A simplified view of the post-translational modifications of cysteine. 
Cysteine can occupy a number of different oxidation states. Starting from its thiol form, it 
may be oxidized with nitric oxide to a nitrosothiol or transnitrosylated from another 
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nitrosothiol, or in the presence of ROS, can be oxidized to a sulfenic, sulfinic, or sulfonic 
acids.96  Sulfenic acids themselves can be reduced to sulfyhydrylated polysulfides of 
cysteine with inorganic H2S97,98, or to a disulfide with an organothiol, as was seen with 
the redoxins. Furthermore, it has been shown that a sulfenic acid can degrade to an 
aldehyde. Other important modifications are lipidation through thioester formation, which 
includes palmitoylation, and alkylation e.g. prenylation. 
 
Indeed, this is small list, for thiosulfinates, thiosulfonates, sulfinamides, sulfonothioic 
S-acid, disulfur trioxides, disulfone, alkylated-sulfoxides, alkylated sulfones, conversion 
to dehydroalanine, serine99, and carbonylglycine100 have been observed in HRMS 
(Figure 1-09). 
 
Figure 1-09. Other less common PTMs of cysteine, as detected in vitro with HRMS99100. 
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1.06.  Factors influencing the post translational modification of cysteine by RxS 
The small molecule ROS, RNS, RSS, and RCS species are enzymatically produced, 
and ROS leads to the production of RLS from PUFAs. Then these species may be 
rapidly enzymatically and/or non-enzymatically degraded, and are typically non-
enzymatically appended to the proteins, several factors play into this whether a certain 
cysteine residue will be modified:  
1. The protein must be sufficiently colocalized near the point of generation of the 
RxS for the molecule to reach the protein.  
2. The reactivity of the cysteine residue must be sufficiently high so as to compete 
with the intracellular redox machinery that is working to degrade the ROS, RNS, 
and RSS. Without competitive rates with this system, the protein will not be 
modified. 
3. These reactions tend to either be nucleophilic or radical-driven, so catalytic 
cysteine residues and those with favorable microenvironments are decisively 
more reactive towards ROS, RNS, and RSS, because their thiols tend to be in 
the much more reactive and electron-rich and more easily oxidized thiolate form.  
4. The most prevalent RSS, glutathione, tends to be the sink for ROS, RNS, and 
RLS species and modifications.  
 
1.07. Early study of sulfenic acids  
Some of the first references to sulfur in the sulfenyl oxidation state, which includes 
sulfenyl halides (R-SX), sulfenic acids, and sulfenamides, occurs in 1911 for a sulfenyl 
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chloride (R-SCl). The first evidence of a sulfenyl group forming on a protein was 
uncovered by Heinz Fraenkel-Conrat in 1955, then at UC Berkeley. A single thiol on the 
coat protein of the Tobacco Mosaic Virus was converted into a sulfenyl iodide with 
triiodide (I3-), and in studies with radioactive 131I, the stoichiometry was subsequently 
shown to consume twice the the amount of isolated thiols, indicating no disulfide was 
formed101. and early biological research focused on the application of exogenous 
sulfenyl halide species to proteins, noting that they formed disulfides102, the modification 
of tryptophan by sulfenyl chlorides103. It became clear that sulfenyl species were 
involved in the antioxidant properties of certain enzymes such as peroxidases104. By 
1969, the mechanism of inactivation of GAPDH as a dehydrogenase via a sulfenic acid 
intermediate was elucidated by William Allison, using tetrathionate, iodosobenzoate and 
iodine monochloride105; in the same year it was determined that the activity of GAPDH 
could be switched to an acyl phosphatase by Ehring et al.106. In 1973, it was already 
known that cyanide, thiosulfate, bisulfite, hydrazine, and dimedone were reactive.107 
Other proteins, along with wide range of oxidants and reactants with sound mechanistic 
insight were found108. Of these initial studies on GAPDH, dimedone emerged from the 
pack as the scaffold of choice, both for its relatively high degree of activity against 
GAPDH-SOH, its selectivity against other residues and disulfides, and because it forms 
a stable CysS-dimedone thioether bond with the protein.  
 
1.08. Isolated stability of sulfenic acids 
Small molecule sulfenic acids can be extremely unstable. The half-life of 
methanesulfonic acid in the gas-phase at low pressure (0.1 torr or 0.00013 atm) is 
 24 
approximately 1 min at 25˚C109. The rapid disproportionation of the sulfenic acid to the 
thiosulfinate prevents facile study of simple unhindered derivatives such as cysteine 
sulfenic acid (Figure 1-10a). When this disproportionation is prevented via steric 
occlusion, species such as triptycenesulfenic acid can be long-lived (Figure 1-10b)110. It 
is from such hindered molecules that we know that the structure of the sulfenic acid is 
predominantly R-SOH and not its tautomer RS(=O)H; the pKa of the oxo-acid is 12.5110, 
closer to the pKa of a hydroxyl than a thiol. Like their hindered small-molecule cousins, 
cysteinyl sulfenyic acids on proteins may be sterically occluded from interaction with 
either other sulfenic acids (putatively present in a low concentration in the cell) or from 
the high concentrations of cellular thiols such as GSH or other proteins that would 
reduce the sulfenic to a disulfide (Figure 1-10c). Such proteinacious sulfenic acids may 
be stable for extended times. For instance the PTP1b sulfenic acid decays in the course 
of one to five minutes, while the GAPDH-SOH appears to be stable for thirty minutes or 
longer111. Our own research supports the hypothesis that the sulfenic acid in AhpC 
C166S, there the resolving cysteine has been mutated out, is stable essentially 
indefinitely as a bacterial lysate. Furthermore, their local microenvironment may prevent 
further oxidation to sulfinic and/or sulfonic acids.  
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Figure 1-10. Sulfenic acid lifetime and stability.  
a) Small, unhindered sulfenic acids disproportionate to thiosulfinates extremely rapidly, 
with lifetimes on in seconds. These undergo additional complex degradation pathways. 
b) Stable, sterically hindered sulfenic acids can be made, with features such as 
intramolecular hydrogen bonds providing additional stability. c) Proteins that have 
cysteine residues that are sterically occluded from either glutathione (top path) or other 
proteins (bottom path) can have very long-lived sulfenyl species. 
 
1.09. Oxidant proteins and the formation of sulfenic acids  
Our studies focus on the biological role of sulfenic acids within the cellular context. It 
is the first oxidative step a thiol may take within a cell, and it stands at the crossroads in 
between all other ROS-induced functional groups, including irreversible sulfinic acids, 
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aldehydes (Figure 1.08 and 1.09). As a highly reversible modification, it is capable of 
turning on and turning off signaling based on the redox environment, and thus may play 
an important regulatory role. The transition from thiol to sulfenic acid requires one 
equivalent of oxidant, and has the highest reduction potential, so it is fundamentally the 
most accessible.  
Sulfenic acids are labile, reversible functional groups that are non-enzymatically 
appended to the sites of intracellular cysteine residues, which tend to reduced in the 
basal state of the cell due to the high glutathione concentration and action of efficient 
antioxidant enzymes. A reactive cysteine comes into contact with peroxide, liberating 
water and forming the sulfenic acid. There are two main sources of hydrogen peroxide 
in cells. The first is enzymatically produced by the inducible NADPH Oxidase 
(NOX)10,112. Upon stimulation, NOX produces extracellular sources of superoxide radical 
(O2˚-), which rapidly disproportionates into H2O2 and diffuses into the cell, either through 
the membrane or through aquaporin channels, where it modifies thiols proximal to the 
plasma membrane. A second route comes from so-called ‘leaky electrons’ from the 
mitochondrial electron transport chain, which get taken in by elemental oxygen, again 
forming O2˚- leading to disproportionation to H2O2 (Figure 1-11)9. Once formed, the 
sulfenic acid has several fates. Most often it is reduced by cellular thiols, either forming 
protein-protein disulfide bonds or is fully reduced by two equivalents of glutathione, 
regenerating the original thiol in two-step process, producing GSSG as a byproduct. 
However, sulfenic acids are intersectional biological functional groups, and depending 
on the particular redox environment and presence of other ROS, RNS, and RSS 
species, can be further converted in to some of the species mentioned above. 
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Futhermore, with a proximal thiol, an intramolecular disulfide bond can form. And given 
the appropriate local microenvironment, a sulfenic acid can convert to a sulfonamide by 
cyclizing with the backbone amide by dehydration113. It can reversibly hydrolyze to the 
sulfenic acid. 
It has been shown on small molecule peptidyl analogues that this cyclization into a 
sulfenamide can protect a cysteine thiol from irreversible overoxidation when it further 
oxidizes into the sulfinamide114. Its analogue, the sulfinic acid, is irreversible in by 
glutathione. However, the sulfinamide is fully, non-enzymatically reducible to the thiol by 
four equivalents of glutathione. This is also the case for thiosulfinates, though they are 
more labile. Because of their dynamic nature is unknown the full extent of the biological 
roles of either the sulfenic acid or sulfenamide in biological systems, what their relative 
population and reactivity is. An oxidized version of the protein tyrosine phosphatase 1b 
(PTP1b) was crystalized with a sulfenic acid in the active site115.  
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Figure 1-11. Overview of biological sulfenylation.  
Hydrogen peroxide is originally derived from the rapid disproportionation of the 
superoxide radical, produced primarily at the mitochondria and from NADPA oxidase 
(NOX). These react with protein cysteine thiols, oxidizing them to sulfenic acids. 
Sometimes these form protein-protein disulfide bonds, but most often, sulfenic acids are 
reduced by the high concentration of intracellular glutathione back to the original thiol. 
However, depending on the protein, and the concentrations of RNS, ROS, and RSS, 
these can be taken on to other PTMs. Among their roles, sulfenic acids can change the 
function, structure, and aggregation state of proteins.  
 
A well-studied system for peroxide regulation is the signal transduction of epidermal 
growth factor (EGF) by the EGF receptor (EGFR)116. In this model, upon binding of EGF 
to EGFR, EGFR colocalizes on the plasma membrane with NOX by an unknown 
mechanisms, which induces NOX to produce H2O2, which has several effects. In the 
first, EGFR is itself directly sulfenylated by NOX at Cys797. This is proximal to the ATP 
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binding site of the kinase. At low concentrations of 0.05 – 0.5 µM peroxide, kinase 
activity is enhanced; above 0.5 µM was inhibited117. In the second, the catalytic cysteine 
of protein tyrosine phosphatase (PTP) is sulfenylated118. PTP redox regulation has been 
extensively studied119. In the crystalized form of PTP1b, this emerges as a 
sulfenamide115, calling into question both what the predominant sulfenyl species is, and 
which is most reactive, and if there are different structural and regulatory roles for a 
sulfenic acid vs. sulfenamide. Regardless of form, this prevents the phosphatase activity 
of PTP, leading to increased levels of growth factor receptor phosphorylation, which 
leads to downstream RAS-to-ERK signaling. In healthy cells, this leads to normal 
growth. In cells where the oxidative balance has been disrupted, this can lead to cell 
death or abnormal cell proliferation.  
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Figure 1-12. The redox regulation of EGF signaling.  
Activation of EGFR by EGF, sulfenylation at Cys797, and by inhibition of 
dephosphorylation by PTP1b increases the growth response through the RAS pathway.  
 
1.10. Functional group interplay between other oxidative, acylating, and alkylating 
modifications. 
Cysteine has, arguably, the largest number of unique post-translational modifications 
(in possible contention with lysine) that can be induced by ROS, RNS, and RSS, in 
addition to acylating and alkylating modifications, such as palmotylation, prenylation, 
and lipidation via RLS. It is clear that no more than one PTM can exist on a particular 
cysteine residue at a particular time (i.e. two sulfenic acids on a cysteine make a sulfinic 
acid). Therefore, competition and interaction must exist on residues that are capable of 
multiple modifications.  
Recently, it has been shown that cysteine modifications have reciprocally regulated 
each other. Most prominently, it was shown that palmoylated PSD-95 in complex with 
nNOS can be released from the membrane by Ca+2-induced stimulation of the NMDA 
receptor120. This activates nNOS, which produces NO˚, with then goes on to nitrosylate 
the same residues that were palmitoylated. This prevents palmitoyl acyl transferases 
(PATs), sometimes called aspartate-histidine-histidine-cysteine (DHHC), enzymes from 
repalmitoylating PSD-95.  
Given that multiple modifications are present in a cell, it is unsurprising that they 
interact with each other. Recent work by Madjumar et al. has shown that nitrosocysteine 
and sulfinic acids can react form a thiosulfinate, a highly reactive thiosulfonate that, 
unlike typical disulfides, are rapidly reduced by cellular thiols121. It is hypothesized that 
the denitrosative and antioxidant properties of DJ-1 is due to its stable sulfenic acid. 
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Though the exact role of sulfenic acids in reciprocal modification and regulation is 
unclear, its intersectional role in nearly every other ROS- and RSS-governed process 
seems to be of great importance. Furthermore, sulfenylated cysteine residues cannot be 
nitrosylated, demonstrating their inhibitory effect on RNS. Sulfenylation, namely the 
residue-specific ease of sulfenylation by ROS and the residue-specific susceptibility of 
sulfenylation to conversion to other functional groups, including GSH reduction, 
dehydration to sulfenamides, and further oxidation to sulfinic and sulfonic acids, and the 
regulatory functionality of this complex interplay of oxidative, nitrosative, and acylative 
functional groups remains a prime question in the cellular context.  
 
1.11 Fluorescent redox sensors 
Fluorescent probes are central tools in chemical biology122. Since the discovery of 
the first fluorescent molecule, the antimalarial quinine, fluorescent dyes have have 
captured the attention of chemists and biologists alike. Visible-light stains were 
previously used to stain various organelles, and in modern biochemistry fluorescent 
dyes have largely taken over this role. Fluorescence in certain molecules is induced by 
the excitation of an electron through one frequency of light, the excitation. There is then 
a fast relaxation of the electron, followed by a relatively slow decay back to ground state 
(Figure 1-13a). Because of that fast intermediate relaxation, the frequency of light that 
is used to elevate the electron to the higher frequency (excitation frequency) is lower 
than the frequency of light that is released from its fall (emission frequency). This allows 
fluorescent to be a large step forward from visible-light stains by the increased of signal-
to-noise by separating the excitation-emission frequencies and monitoring only at the 
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emission. Typically the λmax of the excitation is separated from the λmax of emission by 
10-50 nm (Figure 1-13b). This is called the Stokes shift. Because of this shift, the 
excitation light can be filtered from the signal, thus resulting in a much higher S/N over 
conventional dyes. A brief review of these principles can be found here123. An estimated 
>80% of images published are with fluorescent probes due to their generally excellent 
sensitivity and resolution, with new super-resolution techniques being developed to 
break the theoretical resolution barrier124. Though the classes of dyes are fairly well-
established (xanthene, coumarin, porphyrin, cyanine etc.), the properties of each dye 
can be tailored by the pendant groups connected directly and indirectly to the 
fluorophore. Sometimes, large improvements can be made to the photophysics across 
entire classes of dyes, as is the case of substituting an amine (-NH2) for the four 
member nitrogen-containing heterocycle azetidine (-N(CH2)2CH2)125.  
 
Figure 1-13. Fundamentals of fluorescence.  
a) Jablonski diagram. A molecule absorbs light (blue squiggly arrow), exciting an 
electron to a higher energy level. The electron undergoes fast vibrational non-radiative 
decay (dashed arrow), resulting in a lower-energy photon emission (green squiggly 
arrow). b) Typical excitation/emission spectra for fluorescent dyes. The separatation 
between the λmax of the excitation and the λmax of the emission is called the Stokes shift. 
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Redox sensors and probes play a critical role in evaluating and comparing redox 
states.  For the sake of this document, we will define fluorescent sensors as small-
molecules that are either non-fluorescent, weakly fluorescent, or experience a spectral 
shift in either the excitation or emission or both (Figure 1-14). These proto-fluorophores 
activate upon exposure to a particular input (H2O2, H2S, etc.). These sensors are 
chemically changed, but remain as small molecules unattached to larger biomolecules. 
Therefore, in the absence of targeting moieties or biological traps, they may be able to 
freely diffuse throughout their organelle, into different compartments, or out of the cell. 
In order to overcome the background of unreacted probe, sensors must always change 
their photophysical properties, either altering their excitation or emission properties, or 
both. The mechanisms of some such mechanisms will be discussed below. Samples 
visualized with sensors are not amiable to preparation by cell fixation, because the 
small molecule dyes are easily washed away.
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Figure 1-14. Methods to detect cellular oxidation.  
Small molecule primary, secondary and tertiary oxidants can be detected with redox 
sensors. These molecules are modified selectively or non-selectively by the oxidant, 
and change their spectral properties to allow detection. However, they remain 
as,diffusible small molecules. Probes react at the protein level with a specific post 
translational modification X (PTM) and remain attached. The probe can either be used 
as an affinity capture (black sphere) or as a fluorescent tag (pink sphere).  
 
Both sensors and probes can be used to evaluate the redox state of the cell, but 
they interrogate different aspects of the process. Sensors typically react to the small-
molecule primary and secondary oxidants such as peroxide, hydrogen sulfide, and nitric 
oxide. As we saw in Figure 1-04, this interplay can be quite complex, with many 
similarly reacting species complicating specificity.  
An example of this lack of specificity is the in the commonly used redox-activated 
dihydrodichlorofluorescein (DCFH2)126. In the hydrogenated form, the probe is non-
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fluorescent (Figure 1-15a). It is activated to dihydrofluorescein (DFC) by reactive 
oxygen species, and is often billed as a selective probe for peroxide. However, as one 
can see from Figure 1-15b, the activation chemistry is complex and non-specific, where 
nitrogen dioxide radical, carbonate radical, even glutathione radical can activate it. 
Critically, molecular oxygen can play a role in its activation, taking the monoradical 
species to the activated DCF, and generating O2˚-. It is generally preferable that 
molecular oxygen not be involved in the activation because it is both prevalent and its 
concentration varied in tissues. It is generally also not preferred for a redox-sensing dye 
to generate redox-active species. So while DFCH2 is sometimes used as a sensor for a 
specific ROS, it should much more correctly be applied as a general sensor for  the 
oxidation state of a cell as a whole.  
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Figure 1-15. Dichlorofluorescein.  
a) Reduced dichlorofluorescein (DCFH2) is a widely used sensor for the visualization of 
reactive oxygen species. b) However, the pathways for non-fluorescent DCFH2 to 
fluorescent dichlorofluorescein are highly non-specific, with multiple reactive oxygen 
species, reactive nitrogen species, and reactive sulfur species involved in the activation, 
degradation, and reactivation in the complex network. 
 
Below we shall discuss some of the mechanisms of more specific probes. These 
generally go by one of two mechanisms. In the first, the electronics directly attached or 
part of the fluorophore core is directly modified and an active form is generated from an 
inactive form. The DCFH2-to-DFC transformation is an example of this, where the 
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central meso carbon of DCFH2 is sp3-hybridized, rendering the dye completely non-
fluorescent. The esters of fluorescein, resorufin, and coumarin are popular to measure 
the properties of esterase, while the amides of rhodamine, aminonaphthalene and 
aminocoumarin can measure protease activitycaspase127. The acyl groups attached to 
the electron-donating portions of the dyes prevent the necessary electronics.  
The second mechanism alters the chemical properties of pendant groups that do not 
directly contribute to the fluorophore core. In order to affect the fluorescence of the dye, 
these pendant groups quench fluorescence by a process known as photoinduced 
electron transfer (PET, or simply photoelectron transfer). In this, the excited electron of 
the fluorophore, which normally decays from the excited state to the ground state with 
the release of an electron, has favorable electronics to be transferred to the slightly 
lower energy of the LUMO of the acceptor. From there, it undergoes non-radiative 
decay and collapses non-productively (i.e. non-fluorescently) to the ground state 
(Figure 1-16a). Alternatively, the HOMO of the pendant group can be higher than the 
HOMO of the dye, and so when the electron of the dye is excited, the donor electron 
transfers to fill the molecular orbital. The excited electron then, like the first case, 
collapses non-productively (Figure 1-16a).  
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Figure 1-16. Mechanism of fluorescence quenching by photoinduced electron transfer 
(PET).  
a) Upon exposure to an appropriate wavelength of light, an electron of donor D, typically 
a dye is excited. It relaxes through transfer to a lower acceptor energy level through 
PET, where it further relaxes to the ground state by non-radiative decay (NRD). b) 
Alternatively, in the case where the pendant group has a higher HOMO, the donor 
electron fills the hole left by the excited electron of the fluorophore, which then 
undergoes non-radiative decay.  
 
To demonstrate some of the sensors that have been developed for RxS, Figure 1-
17 and Figure 1-18 shows some examples of the mechanisms used to detect H2S, 
H2O2, NO˚, and O2˚-. Of these, H2S has the greatest variety of mechanisms, from 
reductions of masked amines (-NHOH128, -N3129, -NO2129) or oxide (from –O-R130), 
reactions with disulfides131, Michael acceptors132, aryl substitutions133, and other 
cleavage mechanisms. In contrast, detection of peroxide almost universally relies on 
direct peroxolysis of aryl boronic esters on the fluorophore core134, installing a hydroxyl 
group and generating the active fluorophore. Detection of nitric oxide involves 
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condensation with an ortho-diaminobenzene ring to a benzotriazole135-137. The electron-
rich diaminobenzene acts as a PET quencher, and transformation of the group into the 
much more electron-poor benzotriazole sensors. And the superoxide sensor relies on 
simple nucleophilic cleavage of the triflate group to release the fluorophore138.  
In this brief overview, is becomes clear that despite the diversity of dye scaffolds, 
which include aminonapthalenes, xanthene (fluorescein and rhodamine), cyanines, and 
BODIPY structures, there are only a small number of mechanisms by with RxS sensors 
work. While these sensors have each demonstrated to be sufficient to measure RxS in 
simple and complex mixtures, they are limited to fluorescence microscopy of small 
molecules. Because of their diffusion, they will only be able to tell gross locational 
information: cytoplasm, nucleus, Golgi. Therefore, we will now discuss chemical probes 
for oxidation.  
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Figure 1-17. Mechanisms of H2S sensor detection.   
a) Hydrogen sulfide can easily reduce many functional groups. These turn electron-
withdrawing groups into electron-donating groups, enhancing fluorescence. b) Many 
different scaffolds use the azide-reduction approach. c) The nucleophilic properties of 
H2S can be exploited to regioselectively cleave disulfides and form a reactive thiosulfide 
that can cleave the ester and release the latent fluorophore131. d) This soft 
nucleophilicity of H2S can also disrupt conjugation to quenching moieties139. e, f) H2S 
can participate in SnAr to either remove a quenching group133 or establish favorable 
electronics140. g) Activated sulfonamides can also be cleaved141. H) Other sensors 
utilize the bifunctional nature of H2S for a two-step nucleophilic addition to negate a 
quenching group132.  
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Figure 1-18. Other small-molecule redox sensors.  
a) Peroxide sensors utilize boronic acid peroxolysis to release a latent 
fluorophore137,142,143. b) nitric oxide sensors use 1,2-diamino phenols as PET 
quenchers. Upon conjugation to NO˚ the resulting triazole no longer quenches the 
florophore135-137. c) A superoxide probe uses the nucleophilic aspect of the O2˚- to 
release fluorescein.  
 
There is some controversy as to whether or not the activity of sensors that typically 
have been attributed to ROS are actually RSS144.  
 
1.12. Genetically encoded redox sensors 
Since the discovery of green fluorescent protein (GFP)145 and development of the 
host of fluorescent protein (FP)146, the ability to genetically encode, and express a 
fluorescent dye has played a central role in biochemistry. GFP (Figure 1-19a) is an 
eleven-sheet barrel than encases an internal fluorophore composed of inward-facing 
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amino acids. These are routinely joined to proteins of interest to track expression and 
cellular localization. Many excitation-emission pairs have been developed across the 
visible light spectrum, and while the chromaphore for GFP is displayed below, in 
actuality these are built off of several colors of fluorescent protein.  
 
Figure 1-19. Genetically encoded redox sensors.  
a) The chromaphore of GFP is tucked inside the β-sheets that are critical for 
fluorescence. b) Simple redox sensor in which a disulfide bond formed from two 
proximal cysteines increases the fluorescence of the dye. c) General model for protein 
co-sensor. d) NAD+ sensor incorporates a Rossman fold to bind NAD+. The 
NAD+/NADH balance is one indication of the redox state of the cell. e) FRET-based 
redox sensor 
 
The simplest of the redox-FP’s is one in which two thiols are proximal on the 
external face (Figure 1-19b). Like Prx or Trx, upon exposure to an oxidant, these form 
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an intramolecular disulfide bond, which activates the dye147. In practice, this exchange 
happens quite slowly. Thus as a general feature of genetically encoded sensors, 
additional biomolecules can be express onto this to either improve the biochemical 
properties or fluorescent sensing (Figure 1-19c). The simple co-expression of some 
proteins, like glutathione reductase (Grx) to the media greatly increases the rate of 
sensing for the sensors in Figure 1-19b148. Others have fused peroxidases, such as 
Orp1, to the fluorescent protein with the theory that hydrogen peroxide-derived oxidation 
of thiols to disulfides is in fact mediated in a stepwise fashion by the much more rapid 
peroxidases, which appears to be the case149. Sensing other aspects of the redox 
balance of cells, Rex domains contain a Rossmann fold, a nucleotide binding domain, 
whose specificity can be selectively tuned to bind to NAD+ (Figure 1-19d)150. The 
NAD+/NADH balance is one indicator of redox balance. Finally, fluorescence resonance 
energy transfer (FRET) probes operate in a similar manner to the monomeric disulfide-
forming fluorescent proteins, but with the added bonus of having lower intrinsic 
background due to the excitation of FP-1 being further from the excitation of FP-2 
(Figure 1-19e)151. Like many of these probes, they are often ratiometric, with one 
conformation and spectral peak going up with another conformation and spectral peak 
going down. It should be noted that all genetically encoded fluorescent molecules are 
sensors, as no endogenous protein functional groups react with irreversible covalent 
bonds with oxidized cysteine species. 
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1.13. Covalent sulfenic acid probes 
As opposed to fluorescent sensors, fluorescent probes remain covalently or pseudo-
covalently attached to the biomolecule. They are not free to diffuse around the cell 
without the movement of the appended protein. Therefore the samples can be prepared 
by cell fixation, in which proteins are crosslinked with formaldehyde or denatured with a 
methanol or acetone solution and rendered insoluble while the background of remaining 
small molecules are washed away. Therefore, due their compatibility with cell fixation, 
probes do not necessitate activation, or to be ‘turned on’.  
Because chemical probes are covalently bound to the protein of interest, they are 
also amiable to other sorts of study besides fluorescence microscopy, such as SDS-
PAGE analysis or proteomic analysis by LC-MS.  
The diversity of chemical probes for all sorts of post-translational modifications is 
large, so we will focus simply on the reactive probes for sulfenic acid. The primary 
molecule that has been used to study sulfenic acids is dimedone (Figure 1-20a)108. 
Dimedone is an active methylene compound (AMC) that can readily enolize into a soft 
nucleophile that can then attack sulfenic acids.  
However, the published reaction in Figure 1-20a is unlikely to be the true reaction 
mechanism, because the pKa of dimedone is 4.3, meaning that only 0.1% of the 
reacted probe is going to be in the neutral protonated form152. Thus the enolate is more 
likely to be the reactive nucleophile, which makes a great deal of chemical sense 
(Figure 1-20b). This is supported by the observation that reaction rates drop drastically 
when the pH is dropped, from 1.7 M-1 s-1 at 37 ˚C153 and pH 7.0 to 0.008 M-1 s-1 at 25 ˚C 
pH 5.5152. The substrate in both cases was AhpC C166S.   
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Once the probe reacts and forms the stable thioether, it has a second remaining α-
proton that likely has a pKa not substantially far from the pKa of the unreacted probe, 
thus we hypothesize that the probe undergoes a second deprotonation, returning to the 
anionic form.  
Dimedone-based probes may be as simple as DYne-2154, a ‘click’able version of the 
AMC. The ‘click’ reaction is a copper-catalyzed terminal alkyne-azide cycloaddition, 
resulting in a highly thermo- and chemostable 1,4-triazole155. This allows the attachment 
of a wide array of probes, from fluorescent dyes to affinity probes like biotin for pull-
down procedures and proteomic analysis. Alternatively, these probes can come with the 
reporter group pre-conjugated, such as dimedone-FL153, and α-dimedone antibodies 
have been developed for enrichment of labeled samples (Figure 1-20b)156. Finally 
sotopically labeled d6-dimedone/iododimedone pairs for ratiometric profiling of thiols and 
sulfenic acids by mass spectrometry154.   
 46 
 
Figure 1-20. Dimedone as a sulfenic acid probe.  
a) Published mechanism of sulfenic acid condensation with dimedone. The enol form of 
dimedone reacts with the sulfenic acid, forming a stable thioether. b) However, this is 
unlikely to be the correct mechanism, due to the pKa of the α-proton that is far below 
physiological. Furthermore, a second deprotonation is likely, leaving an anionic product. 
c) Several different types of probes have been developed, for either secondary 
conjugation (DYn-2), direct fluorescent detection (Dimedone-FL) or α-dimedone affinity.  
 
Though sulfenic acids are not stable on their own, sulfenamides are isolable and by 
traditional chemistry157. The dipeptide sulfenamide MeOVal-CysSA-Cbz is stable in 
DMSO solution, but when put into water, hydrolyzes to the sulfenic acid (Figure 1-
21a)158. As stated previously, it is unknown which species contributes to the reactivity 
more. The sulfenic acid eventually disproportionates and degrades to a complex 
mixture. However, MeOVal-CysSA-Cbz can be used to test the rate of addition of 
various probes (Figure 1-21b)158.  
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Because the slow kinetics other biochemical properties of dimedone leave 
something to be desired, effort has been made to search for other reactive AMCs 
(Figure 1-21c). Leslie Poole’s lab introduced linear probes based on alkyl 
acetoacetates159. These probes have the apparent advantage of low cellular toxicity and 
facile cleavage; once bound and enriched, the AMC can be separated from the 
alkyne/triazole by hydroxylamine. The Carroll Lab conducted mass-spectrometry based 
rate profiling of a truly astounding number of AMCs, some of which are highlighted here. 
Their maximum rate was 3.175 M-1 s-1, an increase of approximately 450 times faster 
than dimedone158. This remarkable rate increase speaks to the high degree that the 
electronics of the electron withdrawing groups surrounding the α-carbon of the probe 
can influence the reaction.  
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Figure 1-21. Model sulfenic acids and rates.  
a) The small molecule sulfonamide MeOVal-CysSA-Cbz is a stable, isolable peptide, 
which b) reacts with AMC probes. c) a selection some of the probes, and their rates, 
that have been developed recently.  
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1.14. Electrophilic and electrocyclic reagents 
The sulfur of the sulfenic acid is a potential nucleophile. Though the reactivity of it as 
a nucleophile is dampened somewhat by the electron-withdrawing effect of the oxygen, 
alkylating agents such as methyl iodide are sometimes used to trap the sulfenic acid as 
a sulfoxide. The pKa of the sulfenic acid (12.5) renders it too weakly acidic to be largely 
deprotonated at physiological pH, and so it will largely be in its less reactive neutral 
form. The nucleophilic anionic form will also be present in much smaller amounts 
(0.0001%) than its cysteine counterpart (~8%) at physiological pH. Furthermore, a 
widespread issue of electrophilic reagents is that all the native reactive residues of 
proteins are nucleophilic, so competition and selectivity is a general problem.  
4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) is an electrophilic trapping reagent 
that reacts via nucleophilic aromatic substation to covalently bind to sulfenic acids and 
change absorbtion maxima to 347 nm160. However, because many nucleophilic residues 
exist (thiols, lysines, serines) this is not selective, or considered a favorable probe for 
imaging or quantitation. However, it does highlight one way that photophysical changes 
can be induced by sulfenic acid binding to the probe. 
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Figure 1-22. Electrophilic and electrocyclic reagents.  
a) Sulfenic acids react with the pro-dye NBD-Cl to form a colored sulfoxide product with 
an absorbance maximum at 347 nm. b) However, because of the prevalence of other 
nucleophilic groups in the cell, other colored products are formed with thiols, alcohols, 
and amines. These functional groups are like present in vastly higher amounts than 
cysteines in the specific oxidation state of sulfenic acids. c) Cyclooctynes undergo a 
putative electocyclization with suldenic acides, forming ene-sulfoxides. 
 
For the sake of completeness, some other probes should be mentioned. 
Cyclooctynes have achieved some level of popularity as ‘copper free’ click reagents, 
N
O
N
NO2
Cl
N
O
N
NO2
S+
R
R SOH
O-
N
O
N
NO2
S
R
N
O
N
NO2
O
R
N
O
N
NO2
NH
R
N
O
N
NO2
Cl
R SH
R OH
R NH2
R R
S+
R
O-
R SOH
R
H
O
S
R
+
a
b
c
 51 
allowing the reagent to form a triazole without a catalyst or the requirement of being a 
terminal alkyne. However, the strained nature of the bond also makes it susceptible the 
addition reactions. Alkynes are known to undergo the thiol-yne reaction and alkenes the 
thiol-ene reaction. Cyclooctynes have been shown to undergo an addition reaction with 
sulfenic acids; however, forming sulfoxides-enes161. It is highly unlikely that this is 
selective for sulfenic acids, and in fact has been shown to be also is attacked by thiols.  
 
1.15. Conclusions. 
Cellular redox homeostasis exists in a complex milieu of highly reactive small-
molecules species that straddles the narrow divide between enough oxidative power to 
support respiratory metabolism but not enough to tear apart the genetic memory and 
protein machinery of the cell. An interconnected network of antioxidant proteins, redox-
sensing proteins, transcription factors, and redox chaperones maintains the 
macroscopic redox homeostasis, while at a microscopic level, NOX, xNOS, and CγL 
and CβS, HO-x produce small-molecule ROS, RNS, RSS, and RCS respectively and 
lead to RLS. While the macroscopic regulation keeps the background redox 
environment of the cell fairly constant, these RxS protein produce bursts of redox 
species that are quickly consumed and diluted in the cell, but can dramatically influence 
the local environment. Because structure informs function and location informs function, 
the spacial constraint is a critical regulatory mechanism of the cell. 
Sulfenylation is an intersectional modification. Dimedone, and derivatives of 1,3-
cyclohexanedione remain the primary probes to study this. However, in the current state 
of the art, such probes have only been used with fixed cells, and are incompatible with 
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live-cell imaging. Live cell imaging represents a more accurate state of the cell, does not 
wash away small organelles or features, and allows for before-and-after measurements 
and stimulation.  
In order to overcome the high background of unbound probe, the challenge of 
developing a live-cell probe is that it must be designed to leverage its covalent 
attachment to induce a sensor-like spectral shift. Therefore, some sort of chemical 
change must occur upon binding, rendering a measurable spectroscopic shift. 
Furthermore, being able to find a way to study them in live cells is a necessary step to 
advance to working in vivo. While live-cell imaging is an improvement over fixed-cells as 
a more representative way to examine the biology, in vivo analysis is an improvement 
over plate-grown cultured cancer cell lines.   
Therefore the questions that will attempt to be answered herein are:  
• How can we utilize rationale organic chemistry to develop probes to examine 
the biochemistry of and visualize sulfenic acid formation in live cells? Can we 
use these probes to visualize cellular stimulation? Can we distinguish 
between different cancer cell lines?  
• Further questions are: how can we translate what we have learned in via 
rationale organic chemistry to image sulfenic acids in vivo, where organs and 
structures are as they are in living creatures, as opposed to various cancer 
cell lines grown in an extracorporeal setting in vitro?  
• Ultimately, what is the role of sulfenic acids in normal biology, and in disease 
states? 
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This thesis contains work that has attempted to develop and describe tools that can 
interrogate these questions.   
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Chapter 2: Rapid bioorthogonal 
ratiometric live-cell imaging of protein S-
sulfenylation 
 
Abstract. Protein S-sulfenylation describes the dynamic post-translational oxidation of 
cysteine residues, which is integral to redox regulation and cellular signaling. Here we 
report an α-fluoro-substituted aminonaphthalene-dimedone (F-DiNap) probe, which 
displays a dramatic excitation ratio change after sulfenic acid conjugation. DiNap α-
fluorine substitution accelerates sulfenic acid condensation by 103- to 105-fold and 
blocks nonspecific condensation with biological aldehydes. Overall, F-DiNap provides a 
selective ratiometric tool for live-cell imaging of protein S-sulfenylation. 
 
Individual contributions 
Christopher T.M.B. Tom designed and carried out all chemical synthesis, 
characterization, and biochemical analysis of the DiNap probes. Lyanne Gomez-
Rodriguez performed spectroscopic measurements. Kristin J. Labby cloned, expressed, 
and purified recombinant proteins. Prof. Paul M. Zimmerman performed computational 
modelling. Jeannie L. Hernandez prepared MCF10A-Snail cells. Yu-Hsuan Kuo 
performed MCF10A-Snail DiNap labelling and gel-based analysis. Matthew B. Stone 
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and Prof. Sarah L. Veatch performed TIRF microscopy and analysis. Prof. Paul M. 
Jenkins performed confocal imaging and analysis. Christopher T.M.B. Tom and Prof. 
Brent R. Martin designed the experiments and wrote the manuscript. Prof. Brent R. 
Martin was gracious enough to provide funding for this over the last four years.  
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2.01. Introduction 
     The cysteine sulfhydryl group is a key target of oxidative stress and is readily 
modified by redox-active species to induce temporary and sometimes permanent 
protein damage. When exposed to hydrogen peroxide or other select redox active 
agents, cysteine thiols are oxidized to sulfenic acids, which are quickly resolved by a 
second thiol to form disulfides162,163. In the absence or steric occlusion of a resolving 
thiol, the sulfenic acid can be long-lived, establishing S-sulfenylation a reversible protein 
post-translational modification164. In several examples, S-sulfenylation has emerged as 
a redox regulatory switch, coordinating complex cellular cues116,163-165 by chemically 
modifying proteins as part of conserved redox-dependent signaling cascades116,163.  
     The active methylene compound dimedone is the primary method for detecting 
sulfenic acids in biological systems159,166-170. When added to cells, the dimedone 
nucleophilic enolate reacts with sulfenic acids to form a stable thioether, linking the 
probe to sites of S-sulfenylation. This covalent adduct can then be detected either by 
anti-dimedone antibodies156 or by conjugation to a reporter group159,166,167,169,171. 
Strained cyclooctynes, benzoxaborazoles, and boronic acids have also been explored 
as sulfenic acid labeling reagents161,171, opening new directions for improved analysis. 
Nonetheless, in order to monitor protein oxidation in living cells, new fluorophores are 
needed that change their fluorescent properties after sulfenic acid conjugation.  
 
2.02 Results and Discussion 
     In order to engineer such a fluorescence probe for S-sulfenylation, we began by 
examining the reaction mechanism of dimedone. Dimedone possesses two acidic α-
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hydrogens (pKa = 4.3)172, which promotes deprotonation and enolate formation at 
physiological pH. When in proximity to a sulfenic acid, the enolate reacts with the 
sulfenic acid to form a transient diketone, which is followed by a second deprotonation 
to form the product enolate (Scheme A-01). Based on this scheme, we hypothesize that 
only one α-hydrogen is required to react with a sulfenic acid, and substitution of a single 
α-hydrogen with a small blocking group would prevent the second deprotonation and 
trap the product diketone. Thus, the enolate-to-diketone transition could switch the 
chemical and electronic properties of a conjugated dye after reaction with a sulfenic 
acid, providing a direct approach for live-cell imaging of this emerging post-translational 
modification. 
 
2.03. DiNap design and testing 
     Aminonaphthalene fluorophores, such as Lucifer Yellow, are typically attached to 
biomolecules at the imide nitrogen for use in biological imaging173. We hypothesized 
that replacement of the imide nitrogen with a carbon would create a sulfenic acid 
reactive fluorophore. Dimedone-naphthalene (DiNap) probes were synthesized at gram 
scale in two steps as dark red powders (Scheme A-02 and A-03). In the enolate form, 
H-DiNap (3a) has a single α-hydrogen, while the substituted Me-DiNap (3b) and F-
DiNap (3c) have none (Figure 2-01a). Next, each DiNap probe was evaluated for 
labeling efficiency using the mutant E.coli peroxiredoxin AhpC (C166S), which lacks the 
resolving thiol and forms a stable sulfenic acid162. F-DiNap showed surprisingly more 
intense labeling of AhpC (C166S) than H-DiNap (Figure 2-01b), but little labeling by 
Me-DiNap. Importantly, F-DiNap yields a similar profile of labeled proteins as the 
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alkyne-linked dimedone derivative Dyn-2 (Figure A-01)116, labels AhpC (C166S) in an 
oxidation-dependent manner (Figure A-02) while also being subject to overoxidation to 
sulfinic (RSO2-) and/or sulfonic (RSO3-) acids at higher concentrations of peroxide 
(Figure A-03). F-DiNap labeling can be removed by dimedone (Figure A-04) albeit at 
concentrations exceeding the concentration of F-DiNap itself. F-DiNap reacts to 
completion with a sulfenamide standard (Figure A-05), and furthermore, sulfenic acid 
conjugation yielded a >50 ppm 19F-NMR shift (Figure A-06), potentially offering an 
expanded toolkit for sulfenic acid detection that will be discussed in Chapter 3.  
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Figure 2-01. DiNap probes react with S-sulfenylated proteins.  
a) Unsubstituted active methylenes, such as DiNap 3a, react with sulfenic acids in their 
enolate form. After sulfenic acid conjugation, the probe undergoes a second 
deprotonation to return to the enolate form. However, α-substituted Me- and F-DiNap 
probes are locked as a diketone after conjugation. b) Comparison of reactivity between 
3a-c in AhpC (C166S) over-expressing bacterial lysates by in-gel fluorescence (Ex. 488 
nm, Em: 555/20 nm). c) F-DiNap fluorescent excitation and emission spectra before and 
after conjugation. d) Comparison of the rates of reaction between H-DiNap and F-DiNap 
with AhpC (C166S). e) Simulated substituent geometries demonstrate that F-DiNap 
distorts significantly from sp2 planarity to increase the reaction rate. 
 
     We then synthesized small-molecule standards to determine the spectral properties 
of the dyes-conjugate pairs for their potential in cell imaging. Since small-molecule 
sulfenic acids are unstable (t1/2 <1 min)174, we found that methylmethane thiosulfonate 
(MMTS) can act as simple one-step surrogate to provide a direct route to the reacted 
standards 4a and 4c (Scheme A-04). In aqueous buffer, MMTS reacts quickly with 
dimedone, but F-DiNap reacts only with MMTS in organic solvent with base (Figure A-
07). Both H-DiNap (3a) and F-DiNap (3c) have similar spectral properties (Table A-01), 
although 3a is nearly three times brighter than 3c. Both DiNap probes are maximally 
excited at 460 nm and to a lesser degree near 400 nm. After conjugation with MMTS, 
the 400 nm excitation peak in is reduced in 4a and completely absent in 4c (Figure 2-
01c and Figure A-08). In acidic buffers, the protonated enol tautomer lowers the violet 
excitation peak (Figure A-09), confirming the enolate as the predominant physiological 
species and established a spectroscopic method to measure the pKa of each DiNap 
probe (Figure A-10). In addition, 3a is 6.8 times brighter than 4a, which largely cancels 
out any effective ratio change (Table A-01). Conversely, 3c and 4c are nearly the same 
effective brightness, presenting an effective ratiometric sensor for imaging protein S-
sulfenylation. 
 60 
 
 
2.04 Rate determination and quantum simulation 
     In an effort to understand why F-DiNap labels more efficiently, we examined the 
reaction rates for 3a and 3c. S-sulfenylated human serum albumin is reported to slowly 
react with dimedone (0.027 M-1 s-1), but reacts with glutathione 100-fold faster (2.9 M-1 
s-1)160 to form a disulfide. Accordingly, when added to living cells dimedone must 
compete with cellular thiols to efficiently label S-sulfenylated proteins, hence new 
probes with faster reaction rates are highly desirable. As measured by in-gel 
fluorescence, H-DiNap labeled AhpC (C166S) at roughly the reported rate of dimedone 
(3.24 M-1 s-1 and 1.7 M-1 s-1, respectively)96. Surprisingly, F-DiNap reacted with AhpC 
(C166S) >900-fold faster than H-DiNap (3020 M-1 s-1) (Figure 2-01d), and on average 
3500-fold faster across a panel of E.coli proteins (Figure A-11 and Table A-02). 
     In order to shed light on the mechanism of rate enhancement, we carried out 
quantum chemical simulations on both H- and F-DiNap probes. H- and F-DiNap can 
only react with methyl sulfenic acid when the sulfenic acid hydroxyl group and an 
available proton leave to form water, and the calculated free energy change for the rate-
determining step of F-DiNap is 5.4 kcal / mol lower than H-DiNap. The simulated 
transition state barrier for methyl sulfenic acid to react with H-DiNap is 28.4 kcal / mol, 
but only 18.3 kcal / mol when simulated with F-DiNap. This 10.1 kcal / mol difference 
between the H- to F-DiNap transition energies translates to a maximal 107-rate 
acceleration, supporting the 103- to 105-fold rate acceleration observed on AhpC 
(C166S) and other proteins. The fluorine on F-DiNap contributes a strong electron 
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withdrawing effect, dropping the pz orbital energy at the α-carbon. However, as 
compared to the planar H-DiNap, the quantum chemical simulation also revealed the 
fluorine is 5.4 degrees out of plane (Figure 2-01e), suggesting a primed electronic 
configuration for subsequent sp3 hybridization following sulfenic acid conjugation is the 
determining factor for this remarkable rate enhancement (Figure A-12 and Table A-03).  
 
2.05 Selectivity against in vitro and biologically-generated aldehydes 
     Active methylene compounds are known to undergo Knoevanegal condensation 
reactions with aldehydes in both organic and aqueous solvents (Figure 2-02a)175,176. 
After a brief incubation with pyridoxal or glyceraldehyde in phosphate-buffered saline 
(PBS), we observed complete conversion to the predicted condensation products, as 
well as secondary Michael addition to the resulting electrophilic unsaturated ketone 
(Figure A-13 and A-14). We find that dimedone reacts with glyceraldehyde at a rate of 
0.059 M-1 s-1 (Figure A-15), which is similar to the rate of reaction with S-sulfenylated 
albumin (ref). In light of these studies, it is important to note that F-DiNap is 
mechanistically blocked from reacting with aldehydes, since the Knoevanegal 
condensation requires two α-hydrogens (Figure 2-02a).  
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Figure 2-02. F-DiNap is bioorthogonal to aldehydes.  
a) DiNap α -fluorine substitution prevents aldehyde condensation. b) Oxidized GAPDH 
reacts with H-DiNap, but not F-DiNap (Ex. 488 nm, Em: 555/20 nm). c) Addition of 
acrolein or 4-hydroxynonenal (HNE) to AhpC (C166S) increases labeling by H-DiNap, 
but not F-DiNap. d) Pre-treatment with TCEP reduces all sulfenic acids and removes all 
non-aldehyde labeling.  
 
     While proteins are proteins are generally not modified with aldehydes under basal 
conditions, they can be heavily modified under conditions of redox stress. In a process 
analogous to the Fenton reaction, Cu+1/Cu+2 or Fe+2/Fe+3, ascorbate, and hydrogen 
peroxide react to release hydroxyl radicals, which modify nearby proteins by direct 
oxidation of arginine, lysine, proline, and the peptide backbone to form protein-linked 
aldehydes at diffusion-limited rates (Scheme A-05a)177. To examine the reactivity of 
DiNap derivatives under these conditions, recombinant glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was incubated with CuSO4, ascorbate, and peroxide. These 
conditions mimic the common ‘click’ chemistry conditions used for dimedone labeling of 
peroxide treated samples. Next, TCEP was added to reduce any sulfenic acids, leaving 
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aldehydes as the sole electrophiles. Under these Fenton conditions, GAPDH was 
efficiently labeled with H-DiNap, but there was no detectable labeling by F-DiNap 
(Figure 2-02b).  
     Protein-linked aldehydes are also formed following peroxidation of long-chain 
polyunsaturated fatty acids, releasing a diverse array of α,β-unsaturated aldehydes 
including acrolein and 4-hydroxynonenal (4-HNE). These ene-als react by 1,4-addition 
primarily with cysteine, tethering a reactive aldehyde to proteins (Scheme A-05b). To 
explore any cross-reactivity, dimedone, acrolein and N-acetyl cysteine were mixed 
together and produced a series of aldehyde condensation products. Importantly, F-
DiNap is completely unreactive under these conditions (Figure A-16 and A-17). Next, 
the biological ene-als acrolein and 4-HNE were added to AhpC (C166S) or GAPDH-
overexpressing bacterial lysates. H-DiNap labeling of AhpC (C166S) was greatly 
enhanced by each ene-al, while F-DiNap labeling remained constant (Figure 2-02c). 
Similarly, pre-treatment with TCEP eliminated all F-DiNap labeling of ene-al conjugated 
GAPDH (Figure 2-02d), confirming that α-fluoro substitution of active methylene 
compounds prevents condensation with peroxide-catalyzed aldehyde byproducts on 
proteins. Because both sulfenylation and aldehyde elaboration are initiated by hydrogen 
peroxide input, this is a relevant level of selectivity that is offered by fluorination.  
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Figure 2-03. Live cell ratiometric imaging of sulfenic acids in CH27 B-cells with DiNap 
probes.  
a) Images were acquired by TIRF microscopy 15 minutes after probe addition, showing 
spatially resolved ratio changes with F-DiNap. b) Hydrogen peroxide (1 mM) induces 
rapid F-DiNap ratio changes within a few seconds. Data is normalized to ratios 
measured after 9 minutes of F-DiNap labeling. Scale bar = 20 µm. c) Snail expression 
attenuates F-DiNap labeling in MCF10A cells. d) Confocal ratiometric imaging of F-
DiNap between MCF10A and MCF10A-Snail cells. MCF10a shows clearly higher levels 
of sulfenylation, and this appears to be localized in the secretory pathway and along the 
cellular membranes, with lower levels appearing in the nucleus. 
 
2.06 TIRF and confocal microscopy with stimulation and comparing cell lines 
     When added to cultured mammalian cells, F-DiNap is highly cell permeant, allowing 
live cell labeling and gel-based fluorescence profiling of S-sulfenylation in different 
cancer cell lines, corroborating high levels of protein S-sulfenylation in MDA-MD-231 
cells (Figure A-18)156. Next, CH27 B-cells were incubated with H- or F-DiNap probes 
and imaged by total internal reflection microscopy, alternating excitation between 405 
and 488 nm lasers. Over the time course of 15 minutes, H-DiNap labeled cells showed 
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no change in excitation ratio. In contrast, F-DiNap labeled cells demonstrated a robust 
excitation ratio change, revealing distinct hotspots at the cell membrane (Figure 1-03a 
and Figure A-19). In some F-DiNap labeled cells, the rapid F-DiNap reaction rates 
enabled detection of spatially restricted ratio changes within 6 seconds of hydrogen 
peroxide stimulation, revealing sites of rapid membrane-localized redox stress (Figure 
1-03b and Figure A-20).  
     Reactive oxygen species are reported to both promote and suppress cancer, 
suggesting a complicated network of redox regulation178. The transcription factor Snail 
is elevated in metastatic cancers, and plays a key role in reprogramming cells to 
undergo epithelial-to-mesenchymal transition179. Upon Snail overexpression, we 
observed a significant reduction in F-DiNap labeling in MCF10A breast cancer cells 
(Figure 1-03c). Confocal ratiometric F-DiNap imaging in live cells confirmed reduced 
sulfenylation (Figure 1-03d), particularly outside of the nucleus. Accordingly, Snail both 
represses cell adhesion proteins and reprograms the cellular antioxidant response. 
Indeed, quantitative mass spectrometry profiling of Snail-expressing cells revealed >3-
fold elevation of many antioxidant enzymes180, including peroxiredoxins, superoxide 
dismutase, and thioredoxin. 
 
2.07. Conclusion 
     In summary, we present a ratiometric probe for live cell imaging and gel-based 
profiling of S-sulfenylation, and import redox post-translational modification. F-DiNap 
improves the selectivity and rate of sulfenic acid detection, enabling live-cell ratiometric 
fluorescence imaging of S-sulfenylation at the plasma membrane, as well as revealing a 
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new role for the transcription factor Snail in reprogramming an antioxidant response in 
malignancy. By extension, this approach should be transferrable to brighter dye 
scaffolds and to the development of α-substituted 1,3-dicarbonyls as both fluorescent 
reporters, affinity probes for mass spectrometry profiling of native S-sulfenylation, and 
19F-NMR probes for multimodal analysis of protein S-sulfenylation. 
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Chapter 3: 19F probes for the study of 
sulfenylation by NMR 
 
Abstract 
Contrary to the imaging in cultured cells, fluorescence is not in general an 
appropriate technique to in vivo work. Of the available in vivo imaging techniques, only 
nuclear spin techniques, which include nuclear magnetic resonance (NMR) and 
magnetic resonance imaging (MRI), allow us to probe the chemical state of a sensor or 
probe, and give several additional dimensions of information besides spacial location 
and concentration/bioaccumulation. The F-DiNap probe has a fluorine atom at the α-
position, and 19F is an excellent candidate for an NMR/MRI sulfenylation reporter. To 
this end, we be will lay the foundation for an in vivo MRI probe by developing a 19F-
based NMR probe. 
 
Individual contributions 
Christopher T.M.B. Tom designed and carried out all chemical synthesis, 
characterization, biochemical analysis, and 19F NMR of the fluorobarbituic acid 
derivatives.  
Jack E. Crellin carried out some of the HPLC selectivity, the mass spectrometry 
analysis, and kinetics experiments. 
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Christopher T.M.B. Tom and Prof. Brent R. Martin designed the experiments and 
wrote the manuscript.  
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3.01 Introduction 
The study of biological systems in vivo by fluorescence microscopy is greatly limited 
by the broad absorption by tissue of light across the ultraviolet and visible spectrum, 
which renders most organisms, save a few like zebrafish embryo, opaque. Far-infrared 
dyes have been used for some limited purposes181,182. PEGylated polymers183, some 
built with tumor-targeting oligosaccharide groups184, some are built from quantum dots 
or other mesoscale particles185. Long cyanine dyes can be reversibly photoswitched by 
thiol-ene addition to one of the double bonds to turn them off27. However, these dyes 
are, by necessity and design, have high molecular weights and possess a high degree 
of unsaturation that endows them with a number of different chemical and biochemical 
properties that renders them unsuitable for general study, e.g. low cellular permeability 
or solubility. Though our previous work represents a significant advancement by 
enabling live-cell imaging from previous requirements of fixed-cell labeling, imaging 
sulfenylation on plate-grown cancer cell lines in an oxygenated atmospheric 
environment is far from the native environment of blood-fed tissues in living organisms. 
Therefore, we would seek to expand our detection toolkit to enable imaging of 
sulfenylation in vivo to increase our understanding of this phenomenon in physiological 
systems.  
The prominent techniques that can image tissues in vivo include ultrasound, X-ray, 
positron emission tomography (PET), and magnetic resonance imaging, and their in 
vivo applications and factors affecting image sensitivity and resolution are described in 
detail in Appendix D and summarized in Figure 3.01. However, of these techniques, 
only nuclear magnetic resonance, (NMR), magnetic resonance imaging (MRI), and 
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magnetic resonance spectroscopy (MRS), which directly measure nuclear-spin, can 
directly measure the chemical environment of the reporter nucleus. Fortunately, one of 
the most powerful and sensitive nuclei for imaging includes 19F, lies at the heart and is 
the basis of our chemical switch.  
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Figure 3-01. Forms of in vivo imaging.  
a) X-rays are the oldest, and standard way to visualize hard images. Like most 
photography techniques, it produces a negative images where the X-rays cannot 
penetrate. b) PET scanners utilize short-lifetime β+-emitting isotopes such as 18F. Upon 
emission, the antimatter particle undergoes a collision and annihilation, resulting in a 
pair of gamma particles (red γ) going in antiparallel directions, which are detected by the 
ring. These can be reconstructed by computed tomography. This is not a direct 
measurement of 18F, only where 18F has been. c) In MRI/MRS, the specimen is placed 
into a strong magnetic field, where it is pulsed with a radio wave. The nature of the 
relaxation yields spectral information. d) Principles of NMR/MRI. Many nuclei such as 1H 
and 19F have non-zero magnetogyric moments, which upon alignment in a magnetic 
field results in a population of lower-energy nuclei that are aligned with the magnetic 
field (α) and a smaller population of higher-energy nuclei that is aligned against the 
magnetic field (β). Pulsing the sample with radio waves results in an excitation of the α-
state to the β-state. The relaxation from β-state to α-state yields spectral information in 
the form of nuclear magnetic resonance response, expressed in ppm, along with T1/T2 
information.  
 
As a reporter group, 19F is possesses single-atom minimalist functionality186 and, 
unlike 18F used in PET, is indefinitely stable. It has several convenient commercial 
active methylene compound starting materials (Scheme B-09 & B-010), as well as 
several powerful and commercially available sources of electrophilic (“F+”) and 
nucleophilic (“F-”) fluorine (Figure B-03), allowing for much greater synthetic reach over 
18F, which has no commercial products at all.  
As an spin-active nuclei 19F has comparable molar receptivity (83%) and isotopic 
abundance (100.0%) to 1H NMR, but unlike hydrogen it is virtually absent in biological 
samples, providing a low intrinsic background187. Due to the similarity of the Lamor 
frequency to hydrogen (300.1 MHz vs 282.4 MHz for a 7 T magnet), many 1H 
instruments and probes should be compatible and/or adaptable to detect 19F, 
significantly broadening its practical applications for utilizing existing NMR and MRI 
instruments. It also has a wide chemical shift range for organic molecules (>300 ppm) 
but peaks are typically sharp (FWHM ~0.01 ppm) and changes in chemical shift can be 
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measured down to ~1 ppm188. It has several other physical properties than can be 
exploited for detection purposes, including T1 and T2 relaxation times, and these 
properties and probes that leverage them are described in Appendix D. Thus, detection 
by 19F-NMR is highly sensitive to small chemical changes and this has been used to 
report biological activities or binding to cellular targets, in addition to biodistribution and 
pharmacokinetics.  
Of particular interest to us are mechanism-based small-molecule probes that change 
their 19F spectroscopic properties upon binding or reaction. In the near-term this allows 
us to examine the shifts of the reporter probes for biomolecules and cells in vitro inside 
an NMR. Our long-term goal, which is beyond the scope of this current research, is to 
develop in vivo imaging tools for In Figure 3-2e, this sensor was developed to measure 
monoamine oxidase A activity, which undergoes oxidation and β-elimination of an ortho-
fluorophenolate to induce a 4.2 ppm 19F chemical shift189. A β-galactosidase dual 19F 
MRS / 1H MRI was developed based on a trapped Fe+3 chalator that was freed after 
hydrolysis by β-gal190.  It has the additional feature of being a potential therapeutic-
diagnostic tool: rapidly dividing cancer cells take up more iron, so its chelation-
siderophore qualities can be leveraged at the same time the spectroscopic changes 
take place.  
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Figure 3-02. Established methods of 19F MRI detection191: probes that utilize the 
difference chemical transformation.  
a) In this case, the change from the phenyl ether to the phenoxide by the oxidation of 
monoamine oxidadase resulted in a clearly detectable -133.3 to -137.5 ppm change. b) 
Amide liunkage of a -CF3 containing aminocoumarin  vto a gadolinium T2-quencher via 
a caspase-9 recognition peptide results in a dual-functionality sensor. Upon cleavage, 
both the 19F and coumarin become detectable. 
 
Relevant to this,  to our discussion is the development of caspase-3-activated dual-
mode 19F/fluorescent sensor.192 A trifluoromethyl group is attached to an amino 
coumarin that is joined through that amine via an amide to the substrate peptide for 
caspase-3, DEVD. On the distal end is a Gd+3-DOTA complex. Upon cleavage of the 
amide releasing the amino coumarin, and as the -CF3 separates from the Gd quencher, 
fluorescence and 19F signal increases.  
From a long-term clinical perspective of in vivo work, unlike the aforementioned 
imaging techniques of X-ray and PET, radio waves and magnetic fields are non-ionizing 
radiation that is easily transmitted through the body, which increases their application 
for clinical and diagnostic potential, particularly in pregnancies where the fetus is highly 
susceptible to DNA damage.  
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3.02. Applications to DiNap, AMCs, and sulfenylation 
In our previous studies, we noticed that F-DiNap 19F NMR spectrum presented a 
large shift from -170 ppm to -120 ppm when sulfenylated, which piqued our interest as 
using this nucleus in combination with this chemical switch as an orthogonal detection 
method (Figure 3-03). 
 
Figure 3-03. The 19F chemical switch.  
By leveraging the changing chemical environment of fluorine resulting from the 
conjugation of α-fluoro AMCs as a means to assess sulfenylation by 19F nuclear-spin 
techniques. 
Perhaps other α-fluoro-dimedone analogues might display a similarly large chemical 
shift between the sp2-hybridized carbon in its anionic form and the sp3-hybridized 
neutral diketone thioether. Searching the literature for similar compounds, sure enough 
we find that the unbound α-fluorodimedone193 does in fact have have a different 
chemical shift than its sulfenylated analogue (Figure 3-04)194.  
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Figure 3-04. Chemical shifts of literature fluorodimedone and sulfenylated fluoro 
dimedone.  
a) 6-Me-α-F-Dimedone has two peaks corresponding to its diastereomers. When 
deprotonated, it collapses into one (TBA+ = tetrabutyl ammonium cation). Both spectra 
were taken in CDCl3. b) Upon sulfenylation, the 19F chemical shift becomes larger. All 
shifts relative to CFCl3 (0 ppm). 
 
And as we have already shown that the α-fluorine can increase the rate of the 
reaction by thousandfold or more, potentially allowing us to use a lower concentration of 
probe to compete with cellular reduction processes, we are interested seeing if effect 
extends to other AMCs. Therefore, we decided to explore 19F as a reporter for NMR and 
MRI-based probes. 
Though F-DiNap exhibits all the hallmarks of a successful in vitro ratiometric probe, 
the fluorescent aminonaphthalene scaffold is unnecessary for 19F NMR and the 
electron-rich aniline may present unfavorable biodistribution and metabolic properties in 
vivo. Furthermore, we wanted to ensure that our probe had maximum biocompatibiliy, 
taking into account pharmacaphore models and other groups. As the enolate-to-
diketone transition results in the loss of charge and hydrophilicity, we also wanted to 
ensure that the reacted probe-protein conjugate was soluble, which had presented a 
problem with F-DiNap at higher probe and protein loading. Intrigued, we decided to 
investigate the use of other 19F active methylene compounds (AMC) for the study of 
sulfenic acids with nuclear-spin instruments. We now aim to design minimalist, 
optimized 19F probes targeting sulfenylation. Based on our initial studies that were 
described in Chapter 2, in which we discovered that fluorination of traditional dimedone 
scaffolds were highly functional, we expect that other simplified 19F AMCs will also 
effectively label sulfenic acids. Determining the reactivity and spectra probes will lay the 
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foundation for analysis for protein oxidation in vivo, and allow us to determine the role of 
sulfenylation in the complex web of cysteine post-translational modifications. We further 
believe that such probes could potentially be used as diagnostic tools to detect the early 
buildup of oxidative damage. 
With these considerations in mind, we now propose to leverage the same chemical 
switch (Figure 3-03) that was developed to induce fluorescent spectroscopic shifts to 
produce NMR spectral shift in utilizing 19F as a minimal reporting group, thus taking a 
step towards our long-term goal to quantitatively detect sulfenylation in vivo using 
nuclear spin instrumentation. We have synthesized and tested an array of 19F-AMCs 
and use 19F-NMR to profile the reactivity and distinguish between various lysates and 
eventually, cell types. 
 
3.03 Results and discussion 
One drawback of using F-DiNap as a 19F probe is the relative insolubility of the 
conjugated probe. Due to the nature of the switch, the charged, soluble F-DiNap loses it 
and becomes much more insoluble, and protein precipitate is observed. Indeed, even 
with either the linear diethyl 2-fluoromalonate or ethyl fluoroacetoacetate showed 
significant protein precipitation in BL21 lysates overexpressing AhpC C166S at 34.5 
mg/mL (data not shown). Therefore, we sought to synthesize simple water-soluble 
probes. Numerous attempts to leverage electrophilic fluorinating agents such as 
Selectfluor™, XeF2, and AgF2 on dimedone and dimedone derivatives were 
unsuccessful, so we turned to the commercially available diethyl fluoromalonate and 
ethyl fluoroacetoacetate as starting materials, as well as a non-commercially available 
 77 
fluoroacetoacetone (Scheme B-01). Diethyl fluoromalonate effectively coupled with 
urea, guanidine, and amandine reagents to form 1,3-dicarbonyl-2-fluoro barbituic acid 
derivatives (Scheme B-02) by modified procedures195-200. We also synthesized one 
derivative from ethyl fluoro acetoacetate, which coupled less smoothly201. Because 
these are derivatives of fluorobarbituic acid, we decided to call them F-Barb’s. 
 
3.04 Profile F-barb derivatives against MeOVal-CysSA-Cbz 
In order to test our probes, we synthesized the sulfenamide-containing peptide 
MeOVal-CysSA-Cbz according to a modified literature procedures (Scheme B-
03)157,158. This peptide is an isolable sulfenic acid precursor. Upon exposure to water it 
spontaneously hydrolyzes to a sulfenic acid. It is unknown specifically which species is 
responsible for the reactivity with AMCs; the sulfonamide is known to react with active 
methylene compounds and other nucleophiles in ethanol and DCM157, indicating that 
while hydrolysis may be sufficient, it may not be necessary. Regardless, this may be a 
complex process in which the sulfonamide, sulfenic acid, and other side products might 
couple to the products. We also synthesized a simplified sulfonamide Pyr-SEt in one 
step to provide a secondary substrate (Scheme B-04). 
We combined compounds 5-7 with MeOVal-CysSA-Cbz in a NMR tube that 
contained PBS / 10% D2O with TFA as an internal standard (Figure 3-05, with 
procedure in Scheme B-05 and products in Scheme B-06, and table of chemical shifts 
in Table B-01). Both 5a and 6a complete conversion from the starting material peak at 
<-150 ppm to one at about -120 ppm. 5a’ showed partial conversion while 7a and 5b 
were unreactive. Surprisingly, Pry-SEt was unreactive (Scheme B-07, data not shown). 
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Figure 3-05. Reactions of equimolar amounts of 19F AMCs with MeOVal-CysSA-Cbz in 
PBS.  
5a and 6a showed clear full conversion to a reacted product, while 5a’ showed partial 
conversion. 7a and 5b were unreactive toward the sulfonamide.  
 
We profiled the reactivity of these F-Barb derivatives to see if the rate enhancement 
on FDiNap was a general phenomenon, or specific to that that AMC. We initially found 
that rate of reaction of 6a is too fast to be assayed by NMR or by the simple LCMS used 
by Carroll et al158, as by the time sample could be mixed and put into the instrument, the 
maximum ion counts and/or peak conversion was already obtained. Therefore we tried 
to quench the reaction as quickly as possible. We initially tried to quench the reaction 
with 100 mM HCl, but the reaction products degraded and no product could be detected 
by the LCMS; instead, we used 100 mM final acetic acid to stop the reaction. This acidic 
environment protonates the enolate form, diminishing the reactivity and slowing and 
quenching the reaction. 6a demonstrated fast rate kinetics of 214.5 M-1 s-1 (Figure 3-
06a). However, unlike 6a-pep, it appears as though there is rapid degradation of the 
product of 5a-pep and 5a’-pep after reaction (Figure 3-04b and Figure B-01). It is also 
possible that the acid rapidly degrades the sulfenic acid and/or sulfonamide. 
Surprisingly, Pyr-SEt was unreactive. 
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Figure 3-06. Rates of reaction of 5-7 with MeOVal-CysSA-Cbz.  
a) Rate curve of 1:10 mixture of 10 µM MeOVal-CysSA-Cbz to 100 µM 6a. b) Table of 
reaction rates of the 19F AMC probes. The reaction for 5a and 5a’ were unable to be fit 
due to their degradation. 7a was unreactive. 
 
 
3.05. Selectivity profile of F-barb 6a 
Based on these rate results, we decided to use 6a for the remainder of our studies. 
We incubated 6a with a series of biologically relevant small molecule nucleophiles, 
electrophiles, and oxidants such as peroxide, sugars (aldehydes), and the strong 
Michael acceptor maleimide, as well as disulfides, sulfinic acids, nitrosocysteine, and 
thiosulfones (Figure 3-07). Promisingly, none of these functional groups led to any 
reaction across the 19F-NMR spectra, suggesting the probe is highly selective for 
sulfenic acids and/or sulfenamides.  
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Figure 3-07. Selectivity profile of 6a with biological and biochemical reactants.  
All oxidants and reductants that were tested were unreactive. Of the electrophile 
disulfides, only the activated MMTS is reactive. Neither esters nor thioesters are 
reactive (ester: methyl acetate; thioester: S-ethyl benzylthioate). Aldehydes on their own 
were unreactive, but Michael acceptors such as acrolein and maleimide appeared to 
react. 
 
3.06. F-barb 6a with purified protein and in cell lysates 
Encouraged by these results, we then set out to ascertain if the sulfenylation of 
biological proteins could be determined with by 19F-NMR. BSA and AhpC C166S were 
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evaluated for reactivity (Figure 3-08). BSA appeared to smoothly convert; however, 
AhpC showed a large atypical peak at -178 ppm in addition to the typical peak at -121 
ppm. At this time it is unknown; however, considering its size it is unlikely that it could 
be a protein conjugate because the concentration is too high.  
 
 
Figure 3-08. Labeling of purified proteins with 6a 
 a) AhpC C166S. It is unknown what the peak at -178.54 ppm is. b) BSA shows the 
typical conversion peak at -121 ppm.  
 
We were then interested in whether we could observe this conversion in complex 
biological mixtures, and if this was oxidation-dependent. We treated BL21 lysates 
overexpressing AhpC C166S with either 1 mM NaSH or vehicle for 1 hr, and then added 
6a, 10% D2O, and TFA. Conversion was observed in the –NaSH but not in the +NaSH 
sample (Figure 3-09a). Similarly, when WT and C166S mutants were pretreated with 5 
mM GSH or vehicle then labeled with 6a, only those samples that had the expected 
sulfenic acid were labeled. 
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Figure 3-09. Reactions with the 19F 6a with cell lysates in PBS.  
a) Concentrated lysates (34.5 mg/mL) of BL21 cells overexpressing AhpC C166S were 
treated with vehicle (top) or sodium sulfide (bottom) have been differentiated from each 
other, with the reduced samples showing no labeling putatively due to the lack of 
sulfenic acids. This is recapitulated in b), where the concentrations of WT and C166S 
lysates were matched and then pretreated with 5 mM GSH or vehicle for 15 min. Only 
mutant lysates without GSH were reactive.  
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3.07. Conclusions 
We have demonstrated, first through our studies with F-DiNap, that F-AMCs may 
undergo a significant 19F NMR shifts upon conjugation to sulfenic acids. This shift is 
significant, often more than 50 ppm. By trimming off the aminonaphthalene core a
 nd synthesizing a number of different 19F pyrimidine AMC probes based on the 
barbituic acid scaffold from the commercially available diethyl fluoromalonate and ethyl 
fluoroacetoacetates, we have synthesized simplified, specialized probes for spin-based 
instruments. Additional probes can be synthesized from hydroxyl-pyrimidines (Scheme 
B-08) and from diethyl fluoromalonate (Scheme B-09) and ethyl fluoroacetoacetates 
(Scheme B-10). Many routes to α-fluorinate dimedone and dimedone derivatives were 
attempted, including a range of electrophilic “F+” reagents, nucleophilic F- sources, and 
attempting to modulate the reactivity of dimedone itself (Figure B3). In my hands, none 
of these appeared to work. Alkynyl versions of 6a, 6a-yne, can be adapted for 
biochemistry and proteomics (Scheme B-11). Each can be synthesized in gram scale in 
one step with simple purification. These probes have been demonstrated to work with 
small molecules sulfenic acids, and one of these probes, 6a, has been taken on to 
analyze proteins, show different levels of oxidation in lysates, and differentiate cells. 
Such NMR-based nuclear-spin measurements should be transferable to MRI- and 
MRS-based analysis, enabling for the first time in vivo study of protein sulfenylation.   
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Chapter 4: Conclusion 
 
As I define it (and others may differ), is that chemical biology as a field is about 
coming up with chemical answers to biological questions. In this document, we have 
described a number of the small-molecule redox transmitters, their byproducts and 
complex interplay. we have gone into detail on the redox regulatory mechanisms that 
govern this delicate balance between too much and too little oxidative fire. we have 
shown how those species can affect cysteine, the amino acid with the greatest number 
of oxidative states, and alluded to how those various states can interact, block, or 
augment each other. we have honed in on sulfenic acids, as they occupy as a key 
position as being easily reversible, modified by the prevalent ROS species (H2O2), and 
intersectional between nearly every other oxidative PTM, and we have tried to put their 
study in historical perspective. we have described some of the biology of these sulfenic 
acids, their role in growth signaling pathways and redox signaling and homeostasis. 
This the background to the biological problem described in Chapter 1, (part 1). 
Our problem, where we started four years ago, that problem arises from the nature 
of the tools described in Chapter 1 (part 2), which are used to image biological sulfenic 
acids within the cell: either the tools are fluorescent sensors, that change their chemistry 
and spectral properties, but don’t give any information about protein location; or they are 
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constitutively active probes that can describe the location but only after cellular fixation 
to wash away the rest of the active dye. The problem then became: how can we 
advance the field from fixed-cell labeling, with all its inherent problems, to live-cell 
imaging? Live-cell imaging more closely interrogates the true state of the cell, allows us 
to dynamically look at the same population of cells in a way that permits reproducible 
stimulation, and does not wash away the small organelles, vesicles, and cytosolic 
proteins that fixation does, or can. 
This was the basis of Chapter 2. And we accomplished that, in F-DiNap, a 
ratiometric aminonaphthalene probe that used rational chemical principles to promote 
an electronic change in the warhead that was in conjugation to the fluorophore. We 
showed reactivity, increased selectivity, and then – what was a real surprise – a 
massively accelerated rate.  
Having come up with an answer to this problem, we then moved on to the next 
question: how can we apply what we have learned about this chemical transformation to 
image sulfenylation in vivo? A finite number of techniques exist to do this, which I 
described in Chapter 3, and one of them serendipitously uses fluorine as a reporter 
group, or rather, our molecule fortunately had a fluorine atom at the heart of its chemical 
switch. This class of instrumentation – NMR, MRI, MRS – are collectively a powerful set 
of analytical tools to measure a number of properties about nuclear spin states. A 
number of fluorophore-free probes were made and characterized, and shown to react 
with the standard small-molecule sulfenamide substrate, on proteins and in complex 
lysates, showing a sharp, distinct, and reproducible new peak where one was not 
before.  
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With this, we have taken a large step towards developing a tool that can help in 
answering the true question: what is the role of sulfenic acids in mammalian biology? 
Since location informs function, and we have made one step towards examining this in 
the context of cellular location, we ask, where do sulfenic acids occur in the body, and 
how much, and in response to which stimuli, or diet, or diease? These questions remain 
unanswered.  
And even beyond this, we ask: how can we apply what we have learned here to 
other problems, other unanswered challenges that the tools of today cannot yet 
answer? How can we unravel this incredibly complex interacting networks of thousands 
or millions of interacting parts, working most of the time in near-perfect harmony, yet 
often appears to us to be just noise? 
There are all the questions we already know, and all the ones we don’t yet know 
because we don’t have the right tools and knowledge to even come up with them yet.  
So I present Chapter 5, the future directions, a collection of some of the random and 
crazy ideas that I’ve picked up and put down along the way, just in case someone wants 
to pick them up again and start asking questions. 
There will always be more questions to be answered. 
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Chapter 5: Future directions 
5.01 Introduction 
The study of protein oxidation is a rapidly evolving field. Constant need for new 
probes to evaluated the effects of ROS, RNS, and RSS on proteins, their visualization 
localization, and imaging it in vivo. The work described in Chapter 2 with F-DiNap 
represents a significant step forward in paving the way for live-cell imaging over the 
fixed-cell imaging that the field was previously limited to. The work described in Chapter 
3 represents the first steps in being able to apply this technology in vivo using nuclear-
spin instrumentation.  
Though we have made significant advances there are still many ways in which our 
probes could be improved. Herein we describe some of those improvements, as well as 
other biological redox states of cysteine groups that we may be able to apply some of 
our chemical rationale.  
5.02 Chapter 2 Variants and new mechanisms of F-DiNap fluorophores 
Improved dyes incorporating the fluoro-AMC ‘switch’: 
One of the problems of the DiNap dyes is that the aminonapthalene core is a 
relatively poor fluorophore, and that the ratio change is modest. Because we have 
identified the highly increased reactivity of fluoro-AMCs, we may be able to dispense 
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with the low-Φ low-ε properties of DiNap (which would be necessary if the reactivity of 
these probes remained at the typical 1-5 mM used for dimedone).  
 
Figure 5-01. Additional scaffold diversity for fluoro-AMC probes.  
 
 
X
OO O
O-
F
O
N B
F2
N N B
F2
N
O
O-
F O
O
F SR
X
OO O-
O
SR
F
R-SOH
Direct electronic pertubation
Indirect electronic purturbation (via PET)
Fluorophore release
XXX
R-SOH
H2O CO2
Fluorescence restored!
X = N, C-Aryl
e-
PET quenching
R'
X
N+
O
-O
F
n
R-SOH
Fluorophore release
R'
X
N+
O
O
F
n
RS
 90 
Examples of probes with these different mechanism of activation: 
 
Scheme 5-01. Direct electronic perturbation with a cyanine dye.  
We can also explore different mechanisms for the switch. F-DiNaps utilized direct 
electronic perturbation, in which fluorophore was directly electronically connected to the 
site of reaction. As we discussed before, there are two addition means of releasing the 
dye, chemical disruption of PET quenching, and fluorophore release 
 
 
 
Scheme 5-02. BODIPY PET quenchers.  
The second mechanism utilizes changes in the electronics to suppress PET 
following binding. On a hypothetical BODIPY dye, the electron-rich enolate of the 
pendant AMC suppresses the fluorescence of the BODIPY fluorophore by turning it into 
an electron-poor diketone. The electronics of this could be tuned and optimized by 
groups on the BODIPY system of –X off the top.  
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Scheme 5-03. Synthesis of a fluorescein-based chemically-induced fluorophore 
release.  
In the third mechanism, conjugation to a sulfenic acid leads to a chemical change in 
the dye. This renders an ester, that was formerly stabilized by being an enolate, into a 
fairly activated electrophile that is subject to hydrolysis and fluorophore release. It is 
likely that the starting material will have fluorescence all of its own, and that diminishing 
the ring size it diminish both the brightness and excitation wavelength. 
 
Figure 5-02. Further variants of the catch and release probes. All are built off of the 4-
hydroxy coumarin scaffold.  
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Scheme 5-04. BODIPY malonate dyes as sulfenic acid capture reagents and turn-
on dyes.  
The meso position for xanthene and BODIPY dyes seems to be critical for their activity. 
If there is too much double-bond character, either in a carbon-based “ene” format or 
with heteroatom ketone-like character, it disrupts the favorable electronics needed for 
fluiorescence. 
 
5.03. Simplified F-dimedone probes for proteomics 
Building off of dimedone and serendipitously experiencing a 1000+ fold increase in 
reaction rates, and we were also able to develop it for live-cell imaging. However, from a 
proteomic standpoint, the fluorescent part of the molecule is dispensable. While our 
efforts to electrophilically fluorinate dimedone repeatedly failed, with multiple substrates 
and with multiple electrophilic fluorine sources, it is still desirable to have an α-
fluorodimedone alkyne. Preferably this will also bear an amine, for functionality and to 
help make peptides more readily ionizable in the ESI. Below are some proposed routes 
to this:  
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Scheme 5-05. Synthesis of an alkyne F-dimedone 
 
Scheme 5-06. Expanded synthesis of ring-opening and cleavage using the 
Reformansy reaction. 
 
5.04. Reversible sulfenylation probes for fluorescence 
The cellular redox environment is dynamic. When cellular respiration goes up, so 
does the amount of free radicals and superoxide formation. When cellular signaling 
cascades are activated, such as the B-cell receptors on B-cell plasma membranes, the 
clustering induces NOX, which produces a localized burst of peroxide that diffuses out 
into a cell; thus a ‘wave of oxidation’ occurs between primary oxidants (Prx), secondary 
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oxidants (GSH), and finally getting diluted and reduced by the cell. Though FDiNap can 
capture, for the first time, stimulation within a cell, it cannot also see that cell return to 
normal. That takes reversible probes.  
Thiols and disulfises are the obvious choice to play these reversible roles. Thiols are 
highly reactive with sulfenic acids and disulfides are readily reduced by GSH and other 
reductive machinery. The principle is fairly simple: installation of a reactive thiol on an 
electronically important part of the fluorophore could allow the photophysical properties 
of the dye to change upon conjugation. The reactivity is tunable based on the pKa and 
electronics of the thiol itself, and the reactivity can be tuned so as to release the dye 
first, inactivating it again.  
 
Scheme 5-07. Examples of reversible and irreversible functional groups 
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Scheme 5-08. Using thiol/disulfide based probes as platforms for reversible dyes.  
The cellular environment is a reducing one, so upon release of an oxidant, then and 
only then will the probe react. If it is designed properly, then the disulfide-linked form 
should be “on” 
 
Thus far we have identified three different classes of dyes. The first two are xanthene 
dyes, based on fluorescein and rhodamine. The next one is on a BODIPY scaffold. 
Though there are many different reactive and reversible moieties, most of them are 
based on thiols. In each case the thiol is in the meso position, which in in its ‘keto’ 
resonance form interrupts some or all of the resonance that is important the fluorescent 
properties of the dye. After conjugation, the disulfide locks it in the fluorescent enol 
form. This persists until the wave of oxidation passes and cellular reduction properties 
change the local environment of the cell. As expected MMTS significantly changes the 
fluorescence properties of FluoSH, leading it to be more fluorescein-like, fluorescing 
bright green. Though this has not been fully explored, it is a promising lead for next-
generation reversible sulfenic-acid fluorescent probes.  
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Figure 5-03. Reversible fluorescent dyes.  
FluoSH was incubated with MMTS and TEA, at which point a dramatic change in 
fluorescent character, potentially due the proposed conversion to FluorSSR 
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Scheme 5-09. Synthesis of FluorSH.  
These come from fairly standard literature procedures. Dehydration the commercially 
available bis(2,4-dihydroxyphenyl)methanone (o,o’,p,p’-tetrahydroxybenzophenone) in a 
sealed tube yields the dihydroxy xanthenone. Simple replacement of the meso ketone 
form with Lawesson’s reagent results in FluorSH. Continuning on, triflation of the 
phenolic hydroxyl allows replacement of by any number of chemistries, followed by 
Lawesson’s reagent leading to RhoSH 
 
 
 
However, BODIPY one is not recommended to be prioritized because the literatures 
suggests that when this is in a free keto form, the -BF2- is no longer bound tightly to the 
dipyrroles, and dissociates, and the dye loses its fluorescent character. 
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Scheme 5-10. Degradation pathway of meso-reactive BODIPY 
 
5.05 Chapter 3 Reversible and irreversible NMR/MRI probes 
Though 19F NMR is an attractive method for the above reasons, the nuclear-spin 
based instrumentation can suffer from low sensitivity. To bridge the gap from imaging 
live cells to an in vivo system, appropriate instrumentation must be used. MRI is the 
ideal candidate for all the reasons covered extensively in Chapter 3. Its main problems 
are one of resolution and sensitivity. Specifically in the transition from NMR to 
MRI/MRS, resolution issues can be overcome by special pulse sequences using 
resonators specifically tuned to 19F. This approach can be used to reach nominal 
resolutions of as low as 156 µm, only 2-fold higher than the reported 78 µm by 1H 
MRI187 and similarly only twice the size of a macrophage. Such resolution is sharper 
than the fundamental limits of that of 18F PET, where the full-width half-max blurring 
effect of β+ range prior to γ decay is 0.54 mm202.  
The equation for signal to noise ratio is as follows203: 
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Where N is the % active nuclei in the sample, γ is the gyromagnetic ratio; B0 is the 
magnet field strength, T is temperature in Kelvins, I is the nuclear spin state, T1/T2 are 
the two relaxation constants, with a long T2 and a short T1 being desirable the, and 
tmeas is the number of scans or amount of time the measurements have been taken. 
.  Ways to optimize the signal to noise thus derive from this equation: 
Instrument side: 
• Increase field strength. Using higher-strength magnets, which improve 
signal-to-noise ratio by the 3/2 power of the field strength203 e.g going from 
a 200 MHz instrument to a 400 MHz instrument increases the S/N by a 
factor of 5.6. 
• Lower the temperature. Cryogenic NMR probes exist.  
• Increase scan times, which improves the signal-to-noise ratio at the 
square root of the number of scans. Generally the goal is to have the 
lowest number of scans produce the highest signal, and there are 
increasingly diminishing returns for longer times. 
Probe side: 
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• Choose an isotope that has a high abundance of active nuclei, like 1H or 
19F; a high gyromagnetic ratio, or a high spin state. However, these are 
constants for a given naturally abundant element, without enrichment. 
• Decrease T1 by proximity to other spin-active nuclei. This may either 
quench or enhance the probe, so optimization may be necessary.  
• Increase T2 removing proximity to other quenching spin-active nuclei, or 
removal from a large, slowly tumbling trapped state.  
• Increase effective concentration by adding degenerate nuclei that increase 
the S/N linearly.  
Since we have little control over the instrument that will be used and how long they 
can be used for, focus will be on probes that improve the latter set of improbements. 
Typical concentrations of small molecules measured in an NMR tube are on the 
millimolar scale, with practical sensitivity dipping into the tens of micromolar lower 
ranges. On the probe side, the signal-to-noise can also be enhanced by using 
polyfluorinated probes to present a multiple similar or identical fluorine atoms204. In this 
approach, we anticipate the output would not be a chemical shift observed from the α-
proton. Instead, as with our fluorescent probes, conjugation could act as a chemical 
switch to trigger an environmental change sensed by the so-called ‘antennae’ fluorine 
nuclei. This gain in signal (3- to 18-fold) amplifies the effect of conjugation to improve 
detection. In these cases, we would expect the signal change, in ppm, to be much 
smaller because the chemical alteration is not happening directly at the site of 
modification. Additionally, contrast agents utilize a paramagnetic metal proximal to the 
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pulsed nuclei to decrease the overall relaxation time. This can greatly increases the 
number of scans that can be taken, and increases the overall contrast and resolution of 
the image. Cell-permeable gadolinium contrast agents have been demonstrated205, as 
well as less-common manganese-porphyrins206. Organic radicals, such as one based 
on a TEMPO-dimedone hybrid, may also present small, oxidation state-sensitive 
paramagnetic electron spin rate-enhancing probes207. Finally, the use of higher-
reactivity 19F AMCs that conjugate more effectively to sulfenic acids in vivo would 
increase the concentration of sulfenic-acid conjugated 19F probe. However, to avoid 
increasing reactivity at the expense of selectivity, these optimized AMCs will be assayed 
against a similar panel of functional groups and thiol modifications by 19F-NMR in vitro.  
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Figure 5-04. 19F sulfenylation probes.  
a) The antenna effect can be used to enhance the sensitivity of NMR and MRI. The blue 
fluorine changes the charge state of the probe, which then changes the chemical 
environment of the green fluorine’s. The 6-fold stoichiometric increase results in 6-fold 
greater signal-to-noise. b) Examples of a 12-fold and a 18-fold antenna amplification 
probes. c) Transition metals can enhance the spin relaxation times, which allows for 
more scans to achieve higher signal to noise. d) Organic radicals can also decrease 
nuclear relaxation times to achieve higher signal to noise. 
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Figure 5.05. Examples of ligand-switching for lanthanide and gadolinium-based 
nuclear-spin probes.  
a) the acetoacetate moiety is a strong metal chelate due to the negative charge on the 
oxygens, forming part of a dentate ligand. However, when it reacts and becomes a 
diketone, that binding ability decreases. b) Likewise, when a nitrogen-bound amide 
chelate goes from the enolate form to the diketone form, this will change the electronics 
and binding of the metal and 19F.  
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Finally, should our probes find use in mouse and rat models, and sulfenylation prove 
to play an important role in various pathologies, 19F chemical shift probes may provide a 
potential bioimaging clinical diagnostic tools in MRI and MRS. Broad-spectrum cysteine 
alkylators (iodoacetamide, maleimide) can often be toxic, and irreversible alkylation by 
diagnostic compounds may permanently inactivate catalytic cysteine residues that are 
only temporarily and reversibly deactivated by oxidation. With this in mind, it would be 
desirable to have reversible probes that would have lower long-term toxicity than those 
described above. Fluorous thiol probes (Figure 3-10a) form easily reducible disulfides. 
However, due to the putatively low inherent concentration of sulfenic acids and the high 
rate of disulfide exchange (kon ≈ koff), sensitivity may be very low. On the other hand, it 
has recently been shown that linear AMCs can form reversible conjugates with sulfenic 
acids (Figure 3-10b)208, but in these cases kon >> koff, increasing the reacted conjugate 
concentration while still allowing for clearance. ‘ 
 
Figure 5-06. Reversible 19F probes.  
Irreversible cysteine alkylators such as maleimide and iodoacetamide tend to be toxic to 
cells and animals. Creating reversible probes, which may be metabolized and excreted, 
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is a much more viable solution for sulfenylation probes. a) Disulfide bonds are easily 
reduced by intracellular thiols. b) Linear AMCs can be cleaved by reducing agents such 
as DTT, TCEP, and glutathione. Such probes may lead to much lower levels of toxicity. 
 
 
5.06. Sulfinic acid probes for nitrosothiols. 
It was recently shown in our lab that nitrosothiols and sulfinic acids are compliments 
of each other in that each modifies the other. Nitrosocysteine widely implicated as a part 
of RNS redox stress and can inhibit palmitoylation.  The resulting thiosulfonate is a 
highly activated disulfide and GSH attacks at the more reduced sulfur, regenerating the 
sulfinic acid and forming a more typical cystine-like disulfide. Electron-rich sulfinic acids 
will be better nucleophiles, but they’ll also be more susceptible to oxidation to the 
sulfonic acid. Likewise, electron-poor sulfinic acids, while being worse nucleophiles, will 
be more resistant to overoxidation.  
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Figure 5-07. Reversible sulfinic acid probes.  
These probes form thiosulfonates, which are highly reactive with thiols. Depending on 
the electronics of the sulfinic acid, an electron rich sulfinic acid may favor the 
thiosulfonates and resist cleavage, but may get rapidly and irreversibly overoxidized. 
The reverse is true for electron-poor sulfinic acids. 
 
 
Fluorescent reversible SNO probes: 
We can apply this rationale to fluorescent probes:  
 
Scheme 5-11. Reversible SNO probe, FluorSO2H.  
The electron rich anionic sulfinic acid moiety at the meso position potentially quenches 
fluorescence as do the reduced thiols. Upon conjugation to RSNO, this results in a 
thiosulfonate, restoring fluorescence to the probe. Thiosulfonates are highly reactive 
(MMTS is an example) so the addition would be putatively rapidly reversible.  
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Scheme 5-12. Reversible SNO probe, BODIPY-SO2H.  
Likewise, sulfinating at the meso position of BODIPY may allow for rapid, reversible, 
and selective RSNO probes.  
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19F SNO probes.  
Fluorine NMR or MRI may also find use in sulfinic acid-mediated analysis 
nitrosocysteine. The commercially available sodium trifluoromethyl sulfinate may react 
with nitrosothiols. Once bound, the three fluorine atoms go from experiencing charged 
local microenvironment to an uncharged one, potentially shifting the 19F NMR shift.,  
Scheme 5-13. Reversible 19F NMR/MRI RSNO probes. 
 
The problem with this reaction is that the strong electron-withdrawing capabilities of 
the trifluoromethyl group may negatively affect the reaction kinetics of the sulfinate, 
while also leading to a more active thiosulfonate.  
Other sorts of sulfinic acid probes can likely be used. This reversibility makes it ideal 
for living specimens because no toxic buildup or permanent protein modifications, 
however because of its reversibility, the bound form may exist in only a very small 
concentration, too far below reasonable detection limits. Though similar strategies such 
as paramagnetic proximity and multiple degenerate fluorine atoms can be used, this will 
still likely be below the detection limit except in the case of extreme RNS overload. 
However, this will only be determined experimentally.  
F3C SO2- RSNO F3C SO2SR+
PBS
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Scheme 5-14. Other reversible NMR/MRI RSNO probes. 
 
 
 
 
5.07. Thioester fixation: 
Thioesters are another reversible PTM of cysteine, usually appended as an acyl 
chain of the 16-carbon palmitic acid. This helps to localize a protein to the cell 
membrane or other membrane compartment. Because location informs function, this 
has wide implications in many aspects of cell biology that is beyond the scope to talk 
about in this document. However, of note, it seems that several palmitoyl acyl 
transferases (PATs) containing the DHHC motif, and not entirely specific for palmitic 
acid and indeed can accept a variety of saturated and unsaturated acids.  
When palmitoylation is studied, the typical tool is to add 17-ODYA, or use the biotin 
switch to cleave the thioester for capture the resulting thiol. Each of these cleaves the 
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thioester bond, or adds exogenous reagents. Therefore, the goal of thioester fixation is 
to maintain the thiol-side (Rs) and the carbonyl side (Rc) and thus maintain the 
information held in that bond. 
Nucleophilic additions to the thioester via an push-pull (umpolung) mechanism: 
The thioester carbonyl is an excellent electrophile, while the sulfur is an excellent 
nucleophile. A reagent that can first attach the nucleophile, and then from its 
tetrahedreal intermediate capture the sulfur without it leaving is a difficult proposition, 
but there is precedent 
The Bayer-Villager oxidation turns an ketone into an ester, where a nucleophilic 
peroxide attacks the carbonyl, and the R-group is transferred/captured intramolecularly.  
 
Scheme 5-15. The Bayer-Villager on esters. 
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Scheme 5-16. Comparison of Bayer-Villager and a hypothetical thioester version.  
Comparing them side-by-side: 
 
 
Scheme 5-17. Using persulfides to form acyl persulfides from thioesters. 
Examples of each possible geometries are found below. 
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Figure 5-08. Various reaction geometries of nucleophilic fixation probes.  
The probe (red dot/line) can be of various length to add into the two-atom C-S bond.  
The easiest analogy to the Bayer-Villager to try is the use of sulhydryl thiols 
(Scheme 5-17). However this leaves an activated disulfide that can either be hydrolyzed 
or attacked by other thiols (green arrow).  
On the other hand, carbon nucleophiles have no such reversibility problem. We 
proposed using benzylidine compounds (R2 = aryl) to form an anion on one of the distal 
carbons, assisted by Lewis acids and base. This soft anion can attack the soft thioester. 
Given the right metal, this can hold the intermediate in the proper orientation so that 
upon collapse to the thioester’s tetrahedral intermediate, the sulfur transfers to the 
strong Michael acceptor of the benzylidine. The produce is a stable triketone-thioether.  
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Figure 5-09. TLC profiling of α-halo ketones as 3-member transition states.  
 
Our assay used pyrene as a floureescent reporter group and NAc-Cys-COOMe as a 
polar reporter, and we were looking for any spots off the two rows, the top being 
unreacted and the bottom being hydrolyzed thioester. After over 500 conditions, it was 
β-keto ester that was brought to our attention with the higher spots on the TLC plate S-
18 (right) with mild conversion to a higher Rf spot. We then decided to pursue a new 
reaction geometry.  
 
 
Scheme 5-18. Metal chelated umpolung thioester fixation probes. 
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Figure 5-08. Thioester fixation is still and elusive creature.  
This crossover experiment shows that it still has the potential to work. The amount of 
data that one can get out of this is remarkable. The pyrene fluorophore tracks the Rc of 
TE-1 (red box) when imaged under the gelbox, while the cysteine is a polar tracking 
group for Rs. The aniline of Rc of TE-3 (sky blue box) is a polar group there, while the 
mercaptobenzyl group of the Rs is a nonpolar one. If there were crossover between 
these two, it would result in a polar/polar or non-polar/non-polar pair and we would see 
spots well above or below beyond the Rf of the mixed polar/non-polar pairs. The 
benzylidine B-9 (dark green box), has a nitrophenyl moiety, that instead of fluorescing, 
quenches the area around it (dark green arrows; dark spots in gelbox lane). That way, 
we always know where that goes. Incubating B-9 with the Rs side of each thioester 
results in two distinct spots, the BnSH (blue arrow) increasing in Rf, while the CysSH 
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(red arrow) was held back. In separate experiments with TE-3 + B-9 (magenta arrows, 
forming TEFix-3) and TE-1 + B-9 (bright green arrows, TEFix-1), neither of these 
producers were seen. And, in our crossover experiment (last lane), where B-9 is 
incubated with both thioesers in the presence of the Lewis acid and base, both of the 
previous set of spots are seen, but no new peaks are obvserved. This indicates the 
potential for these reagents to yet be successful in thioester fixation, if the appropriate 
troubleshooting was choosen. 
 
It is important to consider all the different geometries and which ones are considered 
favorable (3,6) and which ones are considered unfavorable (4,5,7). For instance, the 
Bayer-Villager has a 3-membered transition state, probably contributing to its success. 
The first example with the sulfhydrylated thiols mimicked this, and used a 3-member 
transition state. However, the carbon nucleophiles have a 6-member transition state 
between the β-carbon of the double bond, and the thiol.  
 
Electrophilic additions from the α-carbon (aldol reaction, aldol condensation) 
Perhaps a safer alternative to this nucleophilic addition is taking advantage of the 
unique properties the thioester for an electrophilic addition. This prevents any potential 
breaking of the bond. Due to the poor n = 2 and n = 3 overlap between the thioester 
sulfur and the carbonyl carbon, there is limited resonance between the two. This 
contributes to the weakness of the thioester in one sense, but also increases it 
nucleophilic character by allowing for a higher enolization. Because of the small amount 
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of resonance contribution by the sulfur, it is estimated the thioesters react much like 
ketones. Using the appropriate organocatalyst and appropriate aldehyde substrate may 
result in a product that maintains the connection of Rc to Rs, while allowing 
functionalization. Generally we would seek to do the following:  
 
Scheme 5-19. Aldol reactions of thioesters.  
 
Hyrolyzed EDC may provide the ideal Lewis-acid – Bronstead-base paired catalyst 
for the aldol condensation of thioesters and aldehydes. Because of the small amount of 
resonance contribution by the sulfur, it is estimated the thioesters react much like 
ketones. Using the appropriate organocatalyst and appropriate aldehyde substrate may 
result in a product that maintains the connection of Rc to Rs, while allowing 
functionalization.  
 
Scheme 5-20. Biomimetic organocatalysis.  
Using hydrolyzed EDC as a combination Lewis-acid/Bronstead base to activate and 
deprotonate the thioester.  
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Other more complex organo-Lewis acids can be used in conjunction with an exogenous 
base. Such organization may help to not only deprotonate the thioester itself, but 
coordinate with the alhydehyde as well, bringing it into physical proximity and using 
hydrogen bonds to activate it/stabilize the anion intermediate.  
 
Scheme 5-21 More complex bifunctional biguanidinium Lewis acids.  
This catalyst coordinates both the enolate of the thioester and the aldehyde itself in 
a conformationally favorable arrangement. It has strong Lewis acid character due to its 
positively charged group. 
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5.08. Random ideas. 
Methods to create chemicaly uncaged sulfinic acid in situ 
Sulfonyl chlorides 
Sulfonyl chloride is a reasonably stable functional group that is slow to hydrolyze. It can 
be turned into a sulfenic acid by nucleophilic thiols, in which they go through a 
thiosulfonate intermediate, consuming one reducing equivalent (2 GSH). The problem 
may be that it may react with other functional groups semi-irreversibly, such as serine 
hydrolases. The initial product may also be fluorescent. 
 
Scheme 5-22. Sulfonyl chlorides as nucleophilically uncaging groups.  
 
Thiosulfonates 
Thiosulfonates are a more mild approach, more selective for thiols, and are less prone 
to non-productive pathways. They can travel freely in the oxidized extracellular region, 
but upon exposure to the reducing environment of the cell, the high thiol content rapidly 
cleaves it, where it can react with nitrosothiols.  
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Scheme 5-23. Thiosulfonates as reducttively uncaging groups. 
 
However, if these are both R = alkyl thiosulfonates, they will have the sample 
fluorescence, leading to high background. This can partially be overcome by tethering a 
quencher to the reduced end of the thiosulfonate. 
 
Scheme 5-24. The use of a quencher to diminish non-reduced probe background. 
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A method to make thiosulfonate peptides: 
 
Scheme 5-25. Just in case you need it and didn’t want to go through the SNO 
route. 
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Appendices 
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Appendix A: Rapid bioorthogonal 
ratiometric live-cell imaging of protein S-
sulfenylation 
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A.1. General procedures and materials for experimental methods. 
All chemistry was performed with dry solvents of the highest purity available, except 
where noted. All glassware was flame-dried and the reactions were performed under a 
slight positive pressure of inert gas unless otherwise noted. 4-bromo-1,8-naphthalic 
anhydride was obtained from TCI Chemical. Diethyl fluoromalonate was obtained from 
Matrix Scientific. Zinc chloride and diethyl malonate were obtained from Alfa Aesar. 
Cesium carbonate, sodium azide, L-proline, copper metal, and diethyl methylmalonate 
were obtained from Sigma-Aldrich. Compounds were purified by normal-phase flash 
chromatography on silica gel (Machary-Nagel), unless otherwise noted. NMR spectra 
were collected on a Varian MR400 premium shielded magnet, with either a Varian 5 mm 
AutoX dual broadband probe or Varian autoswitchable quad probe. 1H and 13C drifts 
were corrected against residual solvent peaks209; 19F were corrected using 
trifluoroacetic acid (δ = -76.5 ppm) as a standard. NMR spectra were analyzed using 
Mestrenova (Mestrelab Research). Low-resolution mass spectra were obtained on a 
Micromass LCT time-of-flight (TOF) instrument with electrospray ionization (ESI) 
coupled to a HPLC pump with a rheodyne loop injector. High-resolution mass spectra 
were collected on an Agilent Q-TOF (accuracy 1-5 ppm) with in-line photodetector 
array, either in direct-injection mode or through a Waters 10 cm C18 column with a 5-
95% water:acetonitrile gradient, 5 mL / min, 15 minutes.  
Fluorescence Spectroscopy. All spectroscopy was done in Hellma Analytics quartz 
precision cells 10x2 mm. Fluorescence spectra were collected on a Varian Cary Eclipse 
fluorescence spectrophotometer with 5 nm excitation and emission slit widths. 
Absorbance measurements were collected on a Varian Cary 100 Bio UV-visible 
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spectrophotometer. Lucifer yellow (Sigma-Aldrich) was used as a quantum yield 
standard by matching absorbance to DiNap at the excitation maxima, and integrating 
the emission intensity, correcting for refractive index as necessary.  
HPLC analysis. High-performance liquid chromatography separations were performed 
on a Waters HPLC 1525 binary pump system with an in-line Waters 2707 autosampler, 
reverse-phase column, Waters 2998 photodiode array (PDA), and Waters fraction 
collector III. Samples were injected and run through an Atlantis prep T3 (10 x 250 mm) 
C18 column equilibrated at 5% acetonitrile / water (0.1% formic acid), held at this solvent 
composition for 1 min, and linearly increased to 95% until 12 min, and held at this 
solvent composition for 1 min before being re-equilibrated to 5% acetonitrile : water. 
Solvent elution was 5 mL / min. Absorption spectra were collected through the PDA, 
and data were analyzed using Waters Empower software. Elution traces were collected 
at the approximate maximum wavelength for each compound (dimedone: 280 nm; 
DiNaps 488 nm).  
SDS-PAGE analysis. Samples were either combined immediately with loading buffer 
and heated to 95˚C for 10-15 min, or, as necessary, small molecules were removed by 
a modified trichloroacetic acid (TCA) precipitation. Briefly, proteins were precipitated by 
adding 0.2 volumes of a 50% w / v mixture of TCA / water, centrifuged (1000 x g for 3 
minutes), and the supernatant removed. Next, the protein pellet was sonicated and 
washed in cold methanol (3x) and acetone (1x), and resuspended in 6 M urea in SDS 
gel loading buffer. Proteins were separated using pre-cast 12% acrylamide gels 
(BioRad) run at 160 V for 70 minutes. Western blots were transferred to Millipore 
Immobulon FL paper with 100 V input over 70 minutes. We found that for all AMCs 
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tested, there was a major cross-reaction with the polyacrylamide gel. To prevent this, 
samples were either first processed by TCA precipitation (Figures S4 and S6) or 
transferred to PVDF membranes for direct fluorescence analysis (Figures 2, 3, 4, and 
S5). The following antibodies were used in this study: mouse α-His6 (Qiagen), mouse α-
GAPDH (Millipore), mouse α-E-cadherin (Millipore), rabbit anti-beta-actin (Cell 
SIgnaling). All DiNap gel-based imaging was performed on a GE Typhoon Scanner 
using the 488 nm laser line using the 555 / 20 nm emission filter. Near-infrared western 
blot imaging was performed with an Azure Biosystems c600 system.  
Mammalian cell culture. A431, HeLa, HEK293T, and MDA-MB-231 cells were grown 
in DMEM media with 10% FBS and penicillin / streptomycin. CH27 cells were grown in 
DMEM media with 15% FBS with L-Glutamine, 1 g / L glucose, and 110 mg / L sodium 
pyruvate with penicillin / streptomycin in the presence of 50 µM 2-mercaptoethanol. 
MCF10A cells were transduced with retrovirus produced from pPGS-hSnail-fl.Flag-NEO 
(Addgene plasmid no. 25695) and pCL-Ampho packaging vector. After two days, cells 
were selected with 600 µg / ml G418 (Life Technologies). MCF10A vector and Snail1 
cells were cultured in DMEM / F12 base medium (Thermo) supplemented with 5% 
dialyzed horse serum, 20 ng / ml recombinant human epidermal growth factor 
(Shenandoah), 0.5 mg / ml hydrocortisone (Sigma), 100 ng / ml cholera toxin (Sigma), 
and 10 µg / ml insulin (Sigma). After probe incubation, cells were washed 3x with PBS 
and mechanically scraped from the dish. Protein levels were quantified prior to SDS-
PAGE using the DC protein assay (BioRad).  
Cloning and Mutagenesis of E.coli AhpC and human GAPDH.  Whole genomic DNA 
was extracted from Top10 E.coli using TRIzol Reagent (Life Technologies) according to 
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manufacturer’s protocol. TRIzol reagent was also used to extract RNA from HEK293T 
cells. cDNA was synthesized from 1 µg of total RNA using SuperScriptIII reverse 
transcriptase (Life Technologies). The bacterial gene for AhpC (Uniprot ID: P0AE08) 
was amplified from E. coli genomic DNA using Phusion DNA polymerase chain reaction 
(PCR), with primers containing BamHI and XhoI restriction sites (underlined) (5’-
TTTGGATCCGTCCTTGATTAACACCAAAATTAA-3’, 5’-
TTTCTCGAGTTAGATTTTACCAACCAGGTCC-3’). Human GAPDH was amplified from 
HEK293t cDNA with the primers 5’-TTTGGATCCGGGGAAGGTGAAGGTCGGAGTC -
3’ and 5’- TTTCTCGAGTTACTCCTTGGAGGCCATGTG-3’ containing BamHI and XhoI 
restriction enzyme sites (underlined). After restriction enzyme digestion, each the AhpC 
and GAPDH fragment was ligated (T4 DNA ligase, NEB) into pET45b between BamHI 
and XhoI sites to insert an N-terminal His tag. The AhpC-C166S mutant was created by 
quick change site-directed mutagenesis with primers 5’-
CACCCAGGTGAAGTTTCCCCGGCTAAATGGAAAG-3’ and 5’- 
CTTTCCATTTAGCCGGGGAAACTTCACCTGGGTG-3’. All sequences were confirmed 
by sequencing (University of Michigan DNA Sequencing Core) 
Expression and Purification of AhpC-C166S and GAPDH.  For large-scale 
recombinant expression in bacteria, 1 L of TB media with 50 µg / mL carbenicillin was 
inoculated with the appropriate BL21 strain and grown with shaking at 250 rpm at 37 °C. 
When the OD600 = 0.6, the cultures were induced with 0.5 mM IPTG and temperature 
was reduced to 22 °C. After shaking for 16 hours, E. coli were harvested by 
centrifugation. Pellets were stored at -80 °C until purification. All purification steps were 
carried out at 4 °C. To frozen (-80 °C) pellets from 1 L of E. coli culture grown in TB, 40 
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mL of lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol) was added. Pellets 
were lysed by sonication, and cell debris was pelleted by centrifugation at 12,000 x g for 
30 minutes. Lysate was either used at this point, or AhpC or GAPDH was purified from 
the supernatant using TALON (Clontech) resin according to manufacturer’s protocol. 
Fractions containing the desired recombinant protein (as indicated by SDS-PAGE) were 
pooled and transferred to dialysis tubing (10,000 MWC), and dialyzed into 20 mM Tris 
pH 8.0 with 30 mM NaCl to remove imidazole. Protein was concentrated using 10,000 
MWC spin concentrators, aliquoted and stored at -80 °C. 
Rate measurements of dimedone with glyceraldehyde. Dimedone (0.5 mM final 
concentration) was added to PBS in an HPLC vial. To this was added a solution of from 
stock solutions of glyceraldehyde at 5, 10, 15, 20, 30, 40, 80 and 160 mM final 
concentrations. Aliquots were removed by HPLC and initial t = 0 was run, and then 
subsequent time points at 15 minute intervals using the standard methods. The area 
under the dimedone curve at 254 nm was recorded. These data were globally fit, 
yielding a rate constant of 0.059 ± 0.0036 M-1 s-1. 
Rate measurements for H- and F-DiNap. A 2.67 mg / mL solution of Ahpc C166S 
overexpressed BL21 lysate was prepared with 5, 1, 0.1, and 0.02 mM final concentation 
DiNap 3a or 3c in 0.3 mL PBS. At defined timepoints, 40 µL aliquots were added to 1.5 
mL tubes containing 10 µL 100% w/v trichloroacetic acid to quench the reaction and 
precipitate proteins. Samples were centrifuged 5 min at 20,000 xg, and the supernatant 
was removed. Next, 1 mL methanol added and the samples were sonicated and 
centrifuged again to wash the pellet. This wash procedure was repeated 1x with MeOH 
and 1x with acetone. The samples were allowed to completely air-dry, before being 
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resuspended in 50 µL 1x loading buffer, heated at 95 ˚C for 15 minutes, and analyzed 
via SDS-PAGE. Protein bands were quantified using ImageJ, and protein loading was 
normalized using either coomassie blue staining or α-His6 immunostaining.  
Computational methods. All quantum chemical calculations were performed using the 
Q-Chem 4.3 ab initio quantum chemistry package.210 Gas-phase geometry 
optimizations with explicit water solvent were carried out with the hybrid B3LYP density 
functional211,212 in the spin restricted formulism, and the double-zeta, LANL2DZ basis 
set.213-215 The ωB97X-D functional216 was used to calculate single point energies with 
the PCM solvation model using water as the implicit solvent (in addition to explicit 
solvent). The solvent-corrected single point energies used the triple-zeta, polarized cc-
pVTZ basis set.217-219 Thermodynamic corrections were applied to the solvated energies 
using the B3LYP/LANL2DZ level of theory and a temperature of 298.15 K. The Growing 
String Method (GSM) was used to determine the exact transition state and minimum 
energy reaction path for each proposed elementary step.220-222 By optimizing the 
reaction path, GSM provides verification that the saddle point connects the reactant to 
product geometries through a single transition state. GSM was considered converged 
when the RMS gradient at the transition state node reached less than 0.0005 HT/Å. 19 
nodes along the string were used to represent the reaction paths. Natural orbital 
analysis was performed using the NBO 5.0 code223 in the Q-Chem 4.3 package. 
TIRF microscopy. Cells were plated on 35 mm #1.5 glass-bottomed cultuwre dishes 
(MatTek Corporation, Ashland, MA). Cells were incubated with 1 mM H-DiNap or F-
DiNap in Tyrode’s buffer. Imaging was performed on an Olympus IX81-XDC inverted 
microscope with a cellTIRF module, a 100X UAPO TIRF objective (NA=1.49), and 
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active Z-drift correction (ZDC) (Olympus America, Center Valley, PA). Images were 
acquired on an iXon-897 EMCCD camera (Andor, South Windsor, CT).  TIRF excitation 
was accomplished using a 488 nm diode laser (Sapphire 488 LP, Coherent) and a 402 
nm diode laser (CUBE 405-50FP, Coherent). Excitation intensities were adjusted to give 
approximately equal emission between UV and blue excitation.  Excitation and emission 
was filtered using the quadband dichroic mirror LF405/488/561/635-4X-A-000 
(Semrock, Lake Forest, IL). Images were analyzed using MATLAB (The MathWorks, 
Natick, MA).  
Confocal microscopy.  Cells were plated on #1.5 glass-bottomed culture dishes and 
imaged on a Nikon A1R+ laser scanning confocal microscope with a 60 × 1.4  Plan Apo 
VC oil objective. Cells were incubated with 1 mM F-DiNap in growth media for 15 
minutes and imaged without washing. Sequential excitation was accomplished using 
405- and 488-nm lasers, and emission was gathered through a 500-550nm bandpass 
filter using a pinhole diameter of 116.2 microns. A stagetop humidified incubation 
chamber (Okolab) was used to maintain the cells at 37 °C and 5% CO2.  Z-stacks were 
captured using an optical thickness of 375 nm in Z. Exposures were adjusted to the 
maximum dynamic range while avoiding saturation. Images were analyzed with NIS-
Elements AR software (Nikon).  
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II. Synthetic Schemes 
Scheme A1. Mechanistic rationale for α-substituted active methylene compounds. 
In cyclic active methylene compounds, such as dimedone, the pKa of the α-proton is 
below physiological pH and is deprotonated. The enolate then reacts with a sulfenic 
acid to form a thioether. The second α-proton presumably has a similar, if not lower pKa 
and is deprotonated after sulfenic acid conjugation. From this mechanism, it is clear that 
the first α-deprotonation step is necessary for the reaction, but the second plays no role 
in sulfenic acid conjugation. Therefore, replacement of one of the α-protons with a small 
blocking group (Me, F) was hypothesized to allow the probe to conjugate. Probes 
lacking a second α-proton should be trapped in a diketone form. The enolate-to-
diketone transition, and the corresponding chemical and electronic changes, is creates 
a chemical ‘switch’. 
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Scheme A2. General procedure for conversion of 4-bromo-1,8-naphthalic 
anhydride to bromo-DiNap 2a-c. 
 
 
Using a modified literature procedure224, zinc chloride (3.0 eq) was added to a round-
bottom flask. The reaction flask was equipped with a magnetic stir bar, a reflux 
condensor, and an oil bubbler. Thionyl chloride (20 mL) was added and the 
heterogeneous mixture was brought to a reflux for 30 minutes, or whenever gas 
production ceased. The thionyl chloride was removed by rotary evaporation until the 
zinc chloride appeared as a free-flowing white powder. 4-Bromo-1,8-naphthalic 
anhydride (1.0 eq) and diethyl malonate 1 (10 eq) were added to the flask. This was 
outfitted with an efficient reflux condenser, and the mixture was heated to reflux (~200 
˚C) for 6 hours or until no more gas is evolved. The remaining malonate was removed 
by distillation under vacuum, after which point the solid was washed with 1 N HCl and 
filtered. The solid was dissolved in a 1:1 mixture of MeOH and 1 N NaOH, and the 
remaining solid was removed by filtration. The DiNap was precipitated again with 6 N 
HCl and filtered. The solid was dried under reduced pressure, and washed with DCM to 
remove residual malonate and naphthalic anhydride. As necessary, it was recrystallized 
from a mixture of water and methanol. 
Br
OO
Br
OO
X
ZnCl2, neat
reflux, 3 hr
2a. 80%
2b. 98%
2c. 40%1a. X = -H
1b. X = -CH3
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X
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DiNapBr 2a. Zinc chloride (3.0 eq, 7.38 g, 54 mmol), bromonaphthalic anhydride (1.0 
eq, 5.0 g, 18 mmol), and diethyl malonate (10 eq, 27.5 mL, 181 mmol) were used as 
described. 3.95 g (80%) of the title compound was collected.  1H NMR (401 MHz, 
DMSO-d6) δ 8.34 (dd, J = 8.4, 1.2 Hz, 1H), 8.30 (dd, J = 7.3, 1.2 Hz, 1H), 8.09 – 8.01 
(m, 2H), 7.83 (dd, J = 8.5, 7.3 Hz, 1H), 6.13 (s, 1H). 13C NMR (100 MHz, DMSO-d6) δ 
174.40, 173.84, 131.53, 130.84, 130.07, 128.30, 128.18, 128.14, 127.81, 127.75, 
127.06, 126.29, 105.34. ESI-MS: [M+H] 274.9702 (predicted 274.9702) 
Me-DiNapBr 2b. Zinc chloride (3.0 eq, 6.87 g, 50 mmol), bromonaphthalic anhydride 
(1.0 eq, 4.66 g, 17 mmol), and diethyl 2-methylmalonate (10 eq, 28.6 mL, 168 mmol) 
were used as described. 4.76 g (98%) of the title compound was collected. 1H NMR 
(400 MHz, DMSO-d6) δ 8.05 (d, J = 6.7 Hz, 1H), 7.95 (d , J = 8.1 Hz, 1H), 7.79 (d, J = 
7.5Hz, 1H), 7.70 (d, J = 7.6 Hz, 1H), 7.52 (t, J = 7.1 Hz, 1H), 1.94 (s, 3H). 13C NMR (100 
MHz, DMSO-d6) δ 163.22, 163.09, 130.43, 130.25, 129.37, 127.79, 127.49, 127.18, 
127.12, 126.60, 126.18, 125.83, 113.10, 8.79.  ESI-MS: [M+H] 288.8957 (predicted 
288.8959) 
F-DiNapBr 2c. Zinc chloride (3.0 eq, 22.1 g, 160 mmol), bromonaphthalic anhydride 
(1.0 eq, 15.0 g, 54 mmol), and diethyl fluoromalonate (5.0 eq, 48 g, 270 mmol) were 
used as described. 6.50 g, (41%) of the title compound. 1H NMR (401 MHz, Methanol-
d4) δ 8.53 – 8.49 (m, 1H), 8.49 – 8.44 (m, 1H), 8.22 (d, J = 7.9 Hz, 1H), 8.04 (d, J = 7.9 
Hz, 1H), 7.85 – 7.79 (m, 1H). 13C NMR (100 MHz, DMSO-d6) δ 142.82, 140.44, 133.46, 
133.08, 131.78, 130.95, 129.67, 128.87, 128.57, 128.24, 126.65, 125.87, 124.42. 13C 
NMR (100 MHz, dmso) δ 142.82, 140.44, 133.46, 133.08, 131.78, 130.95, 129.67, 
128.87, 128.57, 128.24, 126.65, 125.87, 124.42.  19F NMR (377 MHz, Methanol-d4) δ -
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164.84. ESI-MS: [M+H] 230.0612 (230.0612 predicted).  
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Scheme A3. General procedure for conversion of DiNapBr 2a-c to DiNap 3a-c. 
 
 
 
Using a modified literature procedure225, DMSO (30 mL) was purged of gas by 
sonication under vacuum for a minimum of 15 minutes. 2 (1.0 eq) is added to a Schlenk 
flask. Next, copper metal (1.1 eq), sodium azide (3.0 eq), L-proline (1.4 eq), and cesium 
carbonate (2.5 eq) were added. The flask was then purged under a steady stream of 
nitrogen for at least 15 minutes. Degassed DMSO was then added to the dry 
ingredients and the mixture was put on a preheated metal block at 100 ˚C for six hours 
under inert gas. After the solution was cooled, 6 N HCl was added until a fluffy red 
precipitate was produced. The solid was filtered, washed with 1 N HCl, and eluted with 
methanol. The material was dry-loaded onto silica (10x mass relative to theoretical 
product) and eluted through a silica gel column with a 0 - 10% MeOH:DCM gradient. 
DiNap 3a. Starting with 2a (1.95 g), 1.37 g (91%) of the title compound was isolated. 
1HNMR (400 MHz, DMSO-d6) δ 9.38 (s, 2H), 9.02 (d, J = 8.0 Hz, 1H), 8.68 (d, J = 7.6 
Hz,1H), 8.38 (d, J = 9.0 Hz, 1H), 7.83 (t, J = 7.9 Hz, 1H), 6.98 (t, J = 4.5 Hz, 2H). 13C 
NMR (100 MHz, DMSO-d6) δ 170.38, 167.96, 160.48, 137.71, 132.53, 132.48, 127.33, 
124.68, 121.77, 120.10, 112.36, 107.95, 100.78.  ESI-MS: [M+H] 212.0705 (212.0706 
predicted). Purity by HPLC >95%. 
NH2
OHO
X
Br
O
X
NaN3, Cu0, L-proline,
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100˚C, 4 hr
3a. 91%
3b. 99%
3c. 75%HO
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Me-DiNap 3b. Starting with 2b (1.0 g), 0.769 g (99%) of the title compound was 
isolated. 1H NMR (401 MHz, DMSO-d6) δ 9.39 (s, 2H), 8.86 (d, J = 8.0 Hz, 1H), 8.67 (d, 
J = 7.6Hz, 1H), 8.53 (d, J = 9.0 Hz, 1H), 7.70 (t, J = 7.9 Hz, 1H), 6.93 (d, J = 9.0 Hz, 
1H), 2.17 (s, 3H). 13C NMR (101 MHz, dmso) δ 170.50, 163.70, 158.61, 137.17, 137.11, 
131.39, 130.53, 125.68, 124.31, 122.51, 119.78, 111.79, 111.75, 9.49.  ESI-MS: [M+H] 
226.0863 (predicted  226.0863). Purity by HPLC >95%. 
F-DiNap 3c. Starting with 2c (506 mg), 0.395 g (75%) of the title compound was 
isolated. 1H NMR (401 MHz, DMSO-d6) δ 8.59 (d, J = 8.2Hz, 1H), 8.33 (d, J = 6.8 
Hz,1H), 8.18 (d, J = 8.5Hz,1H), 7.62 (t, J = 7.9Hz,1H), 6.83 (d, J = 8.5 Hz, 1H). 13C 
NMR (100 MHz, DMSO-d6) δ 163.35 (d, J = 9.9 Hz), 157.73, 151.12 (d, J = 11.7 Hz), 
142.00, 139.64, 135.43, 130.28, 129.86, 124.21 (d, J = 16.2 Hz), 122.96, 119.76, 
111.53, 111.40. 19F NMR (377 MHz, DMSO-d6) δ -159.34.  HR ESI-MS: [M+H] 
230.0609 (predicted 230.0612).  Purity by HPLC >95%. 
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Scheme A4. General procedure to synthesize conjugated DiNap dye standards. 
 
 
DiNap 3 (1.0 eq) was added in methanol (5 mL) to a round bottom flask, followed by 
addition of diisopropylethylamine (DIPEA) (1.2 eq). Next, methyl methane thiosulfonate 
(MMTS) (1.1 eq) was added to the flask, and the reaction was allowed to stir overnight 
at room temperature.  Silica gel (20 times mass of 3) was added directly to this flask 
and the solvent was removed under vacuum.  The dry powder was added to the top of a 
silica gel column, and eluted with a DCM:MeOH gradient (MeOH 0-5%).  The first eluted 
species was collected. 
MeS-DiNap (4a). Starting with 86 mg of 3a, 38 mg (36%) was isolated. 1H NMR (401 
MHz, DMSO-d6) δ 10.06 (s, 1H), 8.53 (d, J = 8.2 Hz, 1H), 8.33 (d, J = 7.0 Hz, 1H), 8.12 
(d, J = 8.4 Hz, 1H), 7.60 (t, J = 7.8 Hz, 1H), 7.36 (s, 2H), 6.78 (d, J = 8.4Hz,1H), 2.22 (s, 
3H). 13C NMR (100 MHz, DMSO-d6) δ 226.49, 153.30, 133.06, 133.01, 129.46, 129.01, 
128.36, 128.29, 128.12, 124.02, 120.37, 108.96, 108.57, 17.57. HR ESI-MS: [M+H] 
258.0583 (predicted 258.0583). 
MeSF-DiNap (4c). Starting with 40 mg of 3c, 18 mg (37%) was isolated. 1H NMR (401 
MHz, Methanol-d4) δ 8.45 (dd, J = 8.4, 1.2 Hz, 1H), 8.32 (dd, J = 7.2, 1.2 Hz, 1H), 8.20 
(d,J = 8.4Hz, 1H), 7.65–7.56 (m, 1H), 6.88 (d, J = 8.4 Hz, 1H), 2.19 (d, J = 2.3 Hz, 3H). 
19F NMR (377 MHz, Methanol-d4) δ -167.06. HR ESI-MS: [M+H+]+ 276.0486 (predicted 
NH2
OHO
X
3a,c
NH2
OO
X
MMTS, DIPEA
MeOH
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276.0489), [M-F-]+ 256.0428 (predicted 256.0428), [M+Na+]+ 298.0307 (predicted 
298.0308).   
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Scheme A5. Probe competition with cellular thiols 
a) Protein sulfenic acids (RSOH) are produced from hydrogen peroxide at a variety of 
different rates depending on the chemical environment of cysteine (k1) The probe reacts 
(k2) and competes with intracellular reducing agents such as glutathione GSH (k3). b) 
The fraction of labeling is dependent on the rate and concentration of probe, as well as 
the rate and concentration of reductant. c) At 0.1 mM concentrations, and assuming that 
AhpC C166S reduction with 5 mM intracellular GSH is similar to the rate of glutathione 
reduction of HSA (*), then roughly 2% of AhpC C166S sulfenic acids should be labeled 
with H-DiNap 3a. c) By contrast, under similar conditions, 95% of AhpC C166S sulfenic 
acids should be labeled with F-DiNap 3c due to the thousandfold increase in reaction 
rate.  
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Scheme A6. Sulfenylation and sources of protein carbonylation 
Proteins are typically carbonylated by one of two ways. a) In primary carbonylation, 
hydroxyl radicals are produced from a single-electron reduction of peroxide by 
Cu+1/Cu+2 or Fe+2/Fe+3. These highly reactive species directly oxidize electron-rich 
residues in a diffusion-limited fashion, resulting in surface aldehydes. b) In secondary 
carbonylation, polyunsaturated fatty acids (PUFAs) such as aracadonic acid (shown) 
are exposed to peroxide, and through complex reaction pathways may lead to α,β-
unsaturated aldehydes (enals). These react preferentially with exposed cysteine 
residues, but also lysine and histidine residues, decorating the exterior surface of 
proteins with β-linked aldehydes. c) In combination with cofactors, the functional driving 
input for sulfenylation, and primary and secondary carbonylation is hydrogen peroxide. 
Because dimedone is reactive with all three oxidative modifications, this makes it 
difficult to distinguish carbonylation from sulfenylation with dimedone that lacks a 
blocking group at the α-position. 
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A.3. Supplementary Tables 
Table A-01. Fluorescence properties of DiNap probes. 
 
 
Table A-02. Relative rates of protein bands reacting with 3a or 3c. 
 
 
Table A-03. Natural orbitals of α-carbon of the H- and F-DiNaps. 
 
 
All energies are in kcal/mol. 
  
Rate constant (M-1 s-1)
Protein band 3a 3c k3c/k3a
25 kDa 0.376 623 1,700
50 kDa 0.194 585 3,000
75 kDa 0.126 Too fast to measure (est.>10,000) >80,000
80 kDa 0.0511 1144 22,000
FDiNap HDiNap H-F
Orbital Occupancy Energy Occupancy Energy
s 0.883 -110.44 0.971 -102.28 0.088 7.96
px 0.615 -25.73 1.219 -29.49 0.604 -3.46
py 1.078 -28.24 1.068 -25.10 -0.01 3.23
pz 1.208 -79.69 1.171 -65.89 -0.037 13.74
EnergyOccupancy
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A.4. Supplementary Figures 
Figure A-01. F-DiNap and Dyn-2 label a similar profile of proteins.  
BL21 lysates (100 µg in 100 µL) overexpressing Ahpc C166S were incubated with 5 
mM of F-DiNap or DYn2 for 1 hr. The reaction was stopped by TCA precipitation, at 
which point the DYn-2 sample was treated with 1 mM CuSO4, 1 mM TCEP, 1 mM 
Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine, and 50 µM rhodamine azide, and 
analyzed by SDS-PAGE. Though there were minor difference, as some proteins were 
labeled with F-DiNap more effectively, and some were labeled with Dyn-2 more 
effectively, the overall profile is similar.  
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Figure A-02. 3c reacts in an oxidation-dependent manner.  
F-DiNap labeling of BL21 cell lysates overexpressing AhpC (C166S) is oxidation 
dependent, nearly eliminating labeling after treatment with 5 mM TCEP for 1 hour. A 
slight increase is observed upon peroxide treatment, indicating that most of the protein 
is in the oxidized state basally in bacterial cell lysates. NT = no treatment. 
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Figure A-03. Peroxide diminishes labeling at higher concentrations.  
Pre-treatment of BL21 cell lysates overexpressing AhpC (C166S) for 1 hr at 37˚C 
followed by 1 mM F-DiNap for 1 hr indicates a decreased labeling at higher peroxide 
concentrations, perhaps due to overoxidation to sulfinic (RSO2-) and sulfonic (RSO3-) 
acids. It is interesting to note that it seems difficult to oxidize the unmodified protein to 
any large extent, indicating that it already exists in a stable oxidized form.   
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Figure A-04. Dimedone competes with FDiNap for labeling. 
Pre-treatement of BL21 cell lysates overexpressing AhpC (C166S) with dimedone in the 
indicated amounts for 1 hr at 37˚C followed by 1 mM F-DiNap at 37˚C for 1 hr. At higher 
concentrations, dimedone competes with F-DiNap for labeling.  
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Figure A-05. F-DiNap reacts with a sulfenamide standard. 
A cyclic sulfenamide MeOVal-CysSA-Cbz was prepared by literature procedure158. 
DiNap 3c (100 mM stock in DMSO; final concentration, 1 mM) was added to the 
sulfonamide (100 mM stock in DMSO; final concentration, 1 mM) was reacted in PBS 
for 1 hr. HPLC analysis reveals the formation of a new species, as confirmed by HRMS 
XXXX.  
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Figure A-06. F-DiNap shows a 19F NMR shift upon conjugation in aqueous buffer.  
To a mixture of 10% D2O in PBS (pH 7.4) was added with 33 µM trifluoroacetic acid 
(TFA) and DiNap 3c (100 mM stock in DMSO; final concentration, 1 mM). (a) The 9F 
NMR of F-DiNap and TFA. (b) Subsequently the cyclic sulfonamide MeOVal-CysSA-
Cbz (100 mM stock in DMSO; final concentration, 1 mM) was reacted for 1 hr with F-
DiNap. (c) Fluorine is sensitive to chemical environment, and F-DiNap shifts from -
170.52 to -120.69 ppm upon reaction. 
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Figure A-07. Dimedone reacts with MMTS in aqueous buffer.  
Dimedone (5 mM) or F-DiNap (5 mM) and MMTS (15 mM) were combined in PBS, 
incubated for 30 minutes, and analyzed by HPLC using a photodiode array detector.
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Figure A-08. Fluorescence spectra of 3a and 4a.  
(a) The 400 nm excitation of 3a is reduced after sulfenic acid conjugation (4a). (b) 
Hypothetical model for the reduction in 400 nm excitation after conjugation. We 
hypothesize the free enolate electrons donate into the empty d-orbitals of sulfur, which 
can alter absorption from the dimedone portion of the molecule.  
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Figure A-09. F-DiNap changes its fluorescence excitation spectra below the probe pKa.  
 
Data is normalized to 1 to highlight changes in the peak excitation. Excitation spectra 
were collected by monitoring emission intensity at 550 nm. Emission spectra were 
collected by exciting at the maximum wavelength of each pH (pH 7.4: 450 nm; pH 2: 
495 nm). 
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Figure A-10. DiNap probe pKa values.  
 
Measurements were acquired from 100 µM solutions of each DiNap probe in buffered 
solutions at the defined pH values. The ratio of the 488 nm fluorescence excitation 
intensity was divided by the 405 nm excitation intensity, plotted and fit to sigmoidal 
curve with the half-max inflection point taken as the pKa. . 
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Figure A-11. Reaction rates of DiNaps in BL21 lysates.  
 
F-DiNap shows an accelerated rate over H-DiNap with towards other unidentified 
proteins n bacterial cell lysates. In all cases, H-DiNap reacts on the order of minutes 
and hours, while F-DiNap reacts on the order of seconds to minutes. In some cases, as 
with the 75 kDa band, the reaction rate exceeded our ability to measure, even at 20 µM. 
Additional protein bands were collected, with an overall average rate constant of 0.11 M-
1 s-1 for H-DiNap, while F-DiNap had an average rate constant of 380 M-1 s-1.  
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Figure A-12. Chemical simulation of a sulfenic acid and F-DiNap.  
 
In silico calculations were performed to model the reaction of methyl sulfenic acid with 
DiNap probes to determine the basis for the observed rate enhancement. This analysis 
revealed the positioning of water molecules is critical to protonate the sulfenic acid 
hydroxyl prior to substitution. Direct substitution of the sulfenic acid hydroxyl without 
protonation was prohibitive (ΔG of +60 kCal/mol). In the presence of proximal waters, 
the simulation reported a ΔΔG‡3a-3c of 10.1 kCal/mol, yielding a theoretical 2x107 rate 
increase, yet this acceleration was not caused by hydrogen bonding between the 
sulfenic acid and fluorine. Instead, the most obvious difference between H-DiNap and F-
DiNap was the observation that the F-DiNap fluorine bends out of plane and distorts 
from sp2 geometry, yielded simulated dihedral angles at the α-carbon of 119.9˚ for H-
DiNap, and 116.7˚ for F-DiNap. We hypothesize that the high electron density of fluorine 
adjacent to the electron-rich dimedone enolate leads to an electrostatic repulsion effect 
in which the 2p-π C-F overlap is partially destabilized. The C-F bond is also much 
longer than is typical for an sp2 or aromatic carbon (1.36-1.38 vs 1.404 Å for F-DiNap). 
Fluorine carbanions situated between one or two strongly electron-withdrawing groups 
may adopt structures more closely resembling sp3 tetrahedra226, leading us to 
hypothesize that the α-carbon becomes a mixed sp2-sp3 center in which the sp3 
character destabilizes the carbanion and increases its reactivity. However, analysis of 
the natural bond orbitals shows that there is virtually no sp3 character on the α-carbon 
(Table S3). Instead, the C-F px strongly decreases the occupancy of the α-carbon, while 
the pz mildly back-donates. The net effect is that the pz on the α-carbon decreases by 
0.6 eV (13.8 kCal/mol). We speculate that this decrease in energy allows the purely sp2-
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hybridized center to more readily rehybridize to sp3 upon proximity to an appropriate 
nucleophile (Figure S8c). Therefore, the pseudo-tetrahedral center is primed for attack 
and transition to full nucleophile. Furthermore, F-DiNap has a driving force of 5.4 
kCal/mol larger than H-DiNap, which according to the Bell-Evans-Polanyi principle also 
brings down its ΔG‡. As our model only accounted for an aqueous environment, each 
protein’s local microenvironment may lead to suboptimal conditions to take full 
advantage of the higher reactivity of the fluorous probe. Nevertheless, rate 
enhancements of up to 20,000x are observed. 
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Figure A-13. Dimedone reacts with pyridoxal.  
 
Dimedone (5 mM final) or F-DiNap (5 mM final) and pyridoxal (15 mM final) were added 
in PBS, incubated for 30 minutes, and subsequently analyzed by HPLC using a 
photodiode array detector.  The same solution was analyzed on LC-HRMS to confirm 
the presence of the single and double adduct. 
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Figure A-14. Dimedone reacts with glyceraldehyde.  
 
Dimedone (5 mM final) or F-DiNap (5 mM final) and glyceraldehyde (15 mM final) were 
added in PBS, incubated for 30 minutes, and subsequently by HPLC using a 
photodiode array detector.  The same solution was analyzed on LC-HRMS to confirm 
the presence of the single adduct. 
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Figure A-15. Rates of dimedone condensation with glyceraldehyde.  
 
0.5 mM dimedone (final concentration) was added to a HPLC vial. To this was added a 
solution of glyceraldehyde at varied concentrations. An initial t = 0 was run, and then 
subsequent time points at 15 minute intervals. The area under the dimedone curve at 
254 nm was recorded. These data were globally fit, yielding a rate constant of 0.059 ± 
0.0036 M-1 s-1. 
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Figure A-16. Dimedone reacts with ene-als.  
 
Dimedone (5 mM final) or F-DiNap (5 mM final) and acrolein or acrolein + N-acetyl 
cysteine (5 mM final each) were added in PBS, incubated for 30 minutes, and analyzed 
using by HPLC using a photodiode array detector. 
  
 160 
Figure A-17. Hexenal and acrolein form stable protein conjugates with H-DiNap 
 
A 5 mM solution of the each of the probes below was added to BL21 cell lysates 
overexpressing AhpC (C166S) for 1 hr at 37˚C followed by 5 mM 3a or 3c. No 
aldehydes on their own contributed to additional labeling, however, hexenal and 
acrolein (but not cinnamaldehyde) lead to a large increase in labeling for H-DiNap but 
not F-DiNap, indicating some mechanism of the α,β-unsaturated aldehydes. 
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Figure A-18. F-DiNap profiling of S-sulfenylation in different cell lines.  
 
Cells were labeled with F-DiNap (5 mM) for 1 hour at 37 ˚C, washed with PBS, collected 
by scraping form the dish, and lyzed by sonication. After normalizing for protein 
concentration, lysates were separated by SDS-PAGE and transferred to PVDF 
membrane for GAPDH western blotting (Cy5) and F-DiNap (Ex: 488 nm, Em: 555/20 
nm) fluorescence imaging. 
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Figure A-19. Time-dependent ratiometric labeling of CH-27 B-cells.  
 
Adherent cells were labeled with H-DiNap or F-DiNap (1 mM) and ratiometric images 
(image collected with 488 nm excitation / image collected with 405 nm excitation) were 
measured at 2-minute increments at room temperature in Tyrodes buffer. Image size is 
81 µm x 81 µm. Below is a histogram of the ratio increase by pixel.  
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Figure A-20. Hydrogen peroxide rapidly increases F-DiNap ratios.  
 
CH27 B-cells were treated with F-DiNap (1 mM) for 15 minutes prior before stimulation 
and imaged by TIRF microscopy. To stimulate redox stress, hydrogen peroxide (1 mM 
final) was added. An immediate increase is observed in the 488 nm / 405 nm excitation 
ratio. Scale bar = 20 µm. 
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Figure A-21. F-DiNap selectivity panel. 
 
F-DiNap is highly selective against every reactant tested, which includes oxidants, 
reductants, and electrophile classes that are either biological relevant or used in 
biochemical manners. F-DiNap was tested at 1 mM and each additive was added at 5 
mM, incubated for an hour at 25 ˚C. The solvent gradient was with MeCN (B) and H2O 
(A), each with 0.1% formic acid. that was run is  0-2 min 5% B, run to 95% B at 12 min, 
then hold at 95% B until 15 min. 
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A.5. NMR spectra 
1H NMR: DiNapBr (2a)  
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13C NMR: DiNapBr (2a) 
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1H NMR: Me-DiNapBr (2b) 
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13C NMR: Me-DiNapBr (2b) 
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1H NMR: F-DiNapBr (2c) 
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13C NMR: F-DiNapBr (2c) 
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19F NMR: F-DiNapBr (2c) 
 
  





	










	



















	




	 
 172 
1H NMR: H-DiNap (3a) 
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13C NMR: H-DiNap (3a) 
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1H NMR: Me-DiNap (3b) 
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13C NMR: Me-DiNap (3b) 
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1H NMR: F-DiNap (3c) 
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13C NMR: F-DiNap (3c) 
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19F NMR: F-DiNap (3c) 
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1H NMR: H-MeS-DiNap (4a) 
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13C NMR: H-MeS-DiNap (4a) 
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1H NMR: F-MeS-DiNap (4c) 
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19F NMR: F-MeS-DiNap (4c) 
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19F NMR: FDiNap (3c) in PBS / 10% D2O 
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19F NMR: Pep-FDiNap (5c) in PBS / 10% D2O 
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A.6. HPLC Spectra 
HPLC trace of H-DiNap (3a). Absorbance at 488 nm. 
 
HPLC trace of Me-DiNap (3b). Absorbance at 488 nm. 
 
 
HPLC trace of F-DiNap (3c). Absorbance at 488 nm. 
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Appendix B: 19F probes for the study of 
sulfenylation in nuclear-spin 
instrumentation 
 
B.1. General procedures and materials for experimental methods. 
All chemistry was performed with dry solvents of the highest purity available, except 
where noted. All glassware was flame-dried and the reactions were performed under a 
slight positive pressure of inert gas unless otherwise noted. Diethyl fluoromalonate was 
obtained from Matrix Scientific. Ethyl fluoroacetoacetate was obtained from Acros 
Organics. Compounds were purified by normal-phase flash chromatography on silica 
gel (Machary-Nagel), unless otherwise noted. NMR spectra were collected on a Varian 
MR400 premium shielded magnet, with either a Varian 5 mm AutoX dual broadband 
probe or Varian autoswitchable quad probe. NMR spectra of biological samples were 
collected on a 500 MHz (11.7 Tesla) premium shielded magnet possessing two high 
band and one low band radio frequency channels; 14 bit 80 MHz ADC provides 
effective 20 bit dynamic range at 10 kHz spectral width. The instrument has two probes: 
a Varian 5 mm PFG OneNMR probe and a Varian 5 mm PFG H/F/[X] triple resonance 
AutoX probe. 1H and 13C drifts were corrected against residual solvent peaks209 and/or 
TMS (0.0 ppm); 19F were corrected using trifluoroacetic acid (δ = -76.5 ppm) as a 
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standard. NMR spectra were analyzed using Mestrenova (Mestrelab Research). Low-
resolution mass spectra were obtained on a Micromass LCT time-of-flight (TOF) 
instrument with electrospray ionization (ESI) coupled to a HPLC pump with a rheodyne 
loop injector. High-resolution mass spectra were collected on an Agilent Q-TOF 
(accuracy 1-5 ppm) with in-line photodetector array, either in direct-injection mode or 
through a Waters 10 cm C18 column with a 5-95% water:acetonitrile gradient, 5 mL / 
min, 15 minutes.  
HPLC analysis. High-performance liquid chromatography separations were performed 
on a Waters HPLC 1525 binary pump system with an in-line Waters 2707 autosampler, 
reverse-phase column, Waters 2998 photodiode array (PDA), and Waters fraction 
collector III. Samples were injected and run through an Atlantis prep T3 (10 x 250 mm) 
C18 column equilibrated at 5% acetonitrile / water (0.1% formic acid), held at this solvent 
composition for 1 min, and linearly increased to 95% until 12 min, and held at this 
solvent composition for 1 min before being re-equilibrated to 5% acetonitrile: water. 
Solvent elution was 5 mL / min. Absorption spectra were collected through the PDA, 
and data were analyzed using Waters Empower software. Elution traces were collected 
at the approximate maximum wavelength for each compound (dimedone: 280 nm; 
DiNaps 488 nm).  
SDS-PAGE analysis. Samples were either combined immediately with loading buffer 
and heated to 95˚C for 10-15 min, or, as necessary, small molecules were removed by 
a modified trichloroacetic acid (TCA) precipitation. Briefly, proteins were precipitated by 
adding 0.2 volumes of a 50% w / v mixture of TCA / water, centrifuged (1000 x g for 3 
minutes), and the supernatant removed. Next, the protein pellet was sonicated and 
 188 
washed in cold methanol (3x) and acetone (1x), and resuspended in 6 M urea in SDS 
gel loading buffer. Proteins were separated using pre-cast 12% acrylamide gels 
(BioRad) run at 160 V for 70 minutes. Western blots were transferred to Millipore 
Immobulon FL paper with 100 V input over 70 minutes. We found that for all AMCs 
tested, there was a major cross-reaction with the polyacrylamide gel. To prevent this, 
samples were either first processed by TCA precipitation (Figures S4 and S6) or 
transferred to PVDF membranes for direct fluorescence analysis (Figures 2, 3, 4, and 
S5). The following antibodies were used in this study: mouse α-His6 (Qiagen), mouse α-
GAPDH (Millipore), mouse α-E-cadherin (Millipore), rabbit anti-beta-actin (Cell 
SIgnaling). All DiNap gel-based imaging was performed on a GE Typhoon Scanner 
using the 488 nm laser line using the 555 / 20 nm emission filter. Near-infrared western 
blot imaging was performed with an Azure Biosystems c600 system.  
Mammalian cell culture. A431, HeLa, HEK293T, and MDA-MB-231 cells were grown 
in DMEM media with 10% FBS and penicillin / streptomycin. CH27 cells were grown in 
DMEM media with 15% FBS with L-Glutamine, 1 g / L glucose, and 110 mg / L sodium 
pyruvate with penicillin / streptomycin in the presence of 50 µM 2-mercaptoethanol. 
MCF10A cells were transduced with retrovirus produced from pPGS-hSnail-fl.Flag-NEO 
(Addgene plasmid no. 25695) and pCL-Ampho packaging vector. After two days, cells 
were selected with 600 µg / ml G418 (Life Technologies). MCF10A vector and Snail1 
cells were cultured in DMEM / F12 base medium (Thermo) supplemented with 5% 
dialyzed horse serum, 20 ng / ml recombinant human epidermal growth factor 
(Shenandoah), 0.5 mg / ml hydrocortisone (Sigma), 100 ng / ml cholera toxin (Sigma), 
and 10 µg / ml insulin (Sigma). After probe incubation, cells were washed 3x with PBS 
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and mechanically scraped from the dish. Protein levels were quantified prior to SDS-
PAGE using the DC protein assay (BioRad).  
Cloning and Mutagenesis of E.coli AhpC and human GAPDH.  Whole genomic DNA 
was extracted from Top10 E.coli using TRIzol Reagent (Life Technologies) according to 
manufacturer’s protocol. TRIzol reagent was also used to extract RNA from HEK293T 
cells. cDNA was synthesized from 1 µg of total RNA using SuperScriptIII reverse 
transcriptase (Life Technologies). The bacterial gene for AhpC (Uniprot ID: P0AE08) 
was amplified from E. coli genomic DNA using Phusion DNA polymerase chain reaction 
(PCR), with primers containing BamHI and XhoI restriction sites (underlined) (5’-
TTTGGATCCGTCCTTGATTAACACCAAAATTAA-3’, 5’-
TTTCTCGAGTTAGATTTTACCAACCAGGTCC-3’). Human GAPDH was amplified from 
HEK293t cDNA with the primers 5’-TTTGGATCCGGGGAAGGTGAAGGTCGGAGTC -
3’ and 5’- TTTCTCGAGTTACTCCTTGGAGGCCATGTG-3’ containing BamHI and XhoI 
restriction enzyme sites (underlined). After restriction enzyme digestion, each the AhpC 
and GAPDH fragment was ligated (T4 DNA ligase, NEB) into pET45b between BamHI 
and XhoI sites to insert an N-terminal His tag. The AhpC-C166S mutant was created by 
quick change site-directed mutagenesis with primers 5’-
CACCCAGGTGAAGTTTCCCCGGCTAAATGGAAAG-3’ and 5’- 
CTTTCCATTTAGCCGGGGAAACTTCACCTGGGTG-3’. All sequences were confirmed 
by sequencing (University of Michigan DNA Sequencing Core) 
Expression and Purification of AhpC-C166S and GAPDH.  For large-scale 
recombinant expression in bacteria, 1 L of TB media with 50 µg / mL carbenicillin was 
inoculated with the appropriate BL21 strain and grown with shaking at 250 rpm at 37 °C. 
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When the OD600 = 0.6, the cultures were induced with 0.5 mM IPTG and temperature 
was reduced to 22 °C. After shaking for 16 hours, E. coli were harvested by 
centrifugation. Pellets were stored at -80 °C until purification. All purification steps were 
carried out at 4 °C. To frozen (-80 °C) pellets from 1 L of E. coli culture grown in TB, 40 
mL of lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol) was added. Pellets 
were lysed by sonication, and cell debris was pelleted by centrifugation at 12,000 x g for 
30 minutes. Lysate was either used at this point, or AhpC or GAPDH was purified from 
the supernatant using TALON (Clontech) resin according to manufacturer’s protocol. 
Fractions containing the desired recombinant protein (as indicated by SDS-PAGE) were 
pooled and transferred to dialysis tubing (10,000 MWC), and dialyzed into 20 mM Tris 
pH 8.0 with 30 mM NaCl to remove imidazole. Protein was concentrated using 10,000 
MWC spin concentrators, aliquoted and stored at -80 °C. 
19F NMR studies. A standardized solution of 10% D2O in PBS and 33 µM TFA was 
prepared. A 100 mM F-Barb stock in DMSO was added to the solution (1 mM final 
concentration), followed by either MeO-Val-CysSA-Cbz or a protein. These were 
measured on a 19F NMR.  
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B.2. Synthetic Schemes 
Scheme B1: potential 19F AMCs based on 1,3-dicarbonyl compounds. 0a and 0b 
are commercially available. 0c is not commercially available, but theoretically 
accessible.  
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Scheme B2. Synthesis of 19F AMC probes. 
 
General procedure for the synthesis of cyclic AMCs 5a, 5a’, and 5b195-197,201 
To a solution of urea (1.0 eq) was added NaOEt (1.2 eq). After stirring at reflux (78˚C) 
for 5 minutes, the α-fluoro-β-carbonyl ester was added in one portion (1.1 eq). A 
precipitate formed rapidly, and the reaction was allowed to stir at reflux for 4-16 hr, at 
which point the reaction is quenched with concentrated HCl, adjusting the pH to 3. The 
reaction is filtered with a Buchner funnel, gently rinsed with a small amount of cold 
water, then thoroughly washed with ethanol, acetone, and diethyl ether and allowed to 
dry.  
 
General procedure for the synthesis of cyclic AMCs 6a, 7a198-200 
To a solution of containing suspensions of the HCl salts of guanidine or amidine (1.0 eq) 
was added NaOEt (2.4 eq). After stirring at reflux (78˚C) for 5 minutes, the α-fluoro-β-
carbonyl ester was added in one portion (1.1 eq) to the heterogeneous solution. The 
reaction was allowed to stir at reflux for 4-16 hr, at which point the reaction is quenched 
with concentrated HCl to pH 3. The reaction is filtered with a Buchner funnel, gently 
rinsed with a small amount of cold water, then thoroughly washed with ethanol, acetone, 
and diethyl ether and allowed to dry.  
 
R1
O
F
O
R2 HN
R3
NH2
N N
F
R1 R2
R3NaOEt, EtOH
reflux, 4-16 hr
+
 193 
5a. (5-fluoropyrimidine-2,4,6(1H,3H,5H)-trione): Starting with 0.85 g urea, 1.80 g (87%) 
of 5a was recovered. 1H NMR (401 MHz, DMSO-d6): 11.40 (d, J = 11.40, 2H), 9.15, (s, 
br, 1H), 6.01 (d, J = 6.06, 5.95, 1 H). 19F NMR (377 MHz, DMSO-d6): -216.01, -210.21. 
19F NMR (377 MHz, D2O): -203.66, -120.67. 19F NMR (377 MHz, PBS / 10% D2O): -
203.65. HRMS ESI: m/z 147.0181 [M+H] (expected 147.0201). 
 
5a’. (5-fluoro-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione): Starting with 1.54g 
dimethyl urea, 2.07g (83%) of 5a’ was recovered. 1H NMR (401 MHz, DMSO-d6): 3.08 ( 
br, s, 6H). 19F NMR (377 MHz, DMSO-d6): -211.55, -205.37, -168.92. 19F NMR (377 
MHz, D2O): -189.89, -178.34, -120.68. 19F NMR (377 MHz, PBS / 10% D2O): -198.90. 
HRMS ESI: m/z 175.0498  [M+H] (expected 175.0514).  
 
6a. (2-amino-5-fluoropyrimidine-4,6-diol) Starting with 1.27 g of guanidine HCl, 1.52 g 
(79%) of 6a was recovered. 1H NMR (401 MHz, DMSO-d6): 7.24 (2H), 5.11 (d J = 5.17 
5.05). 19F NMR (377 MHz, DMSO-d6): -199.68, -140.79. 19F NMR (377 MHz, D2O): -
120.68. 19F NMR (377 MHz, PBS / 10% D2O): -196.19. HRMS ESI: m/z 146.0346 [M+H] 
(expected 146.0360). 
 
7a. (5-fluoro-2-methylpyrimidine-4,6-diol) Starting with 1.43 g of methyl amidine HCl, 
1.34 g (62%) of 7a was recovered. 1H NMR (401 MHz, DMSO-d6) 2.03 (s, 3H): 19F NMR 
(377 MHz, DMSO-d6): -200.65, -189.14. 19F NMR (377 MHz, D2O): -187.98, -178.49, -
120.68. 19F NMR (377 MHz, PBS / 10% D2O): -187.99. HRMS ESI: m/z 145.0399 [M+H] 
(expected 145.0408). 
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5b (5-fluoro-6-methylpyrimidine-2,4(1H,3H)-dione) Starting with 1.50 g of urea, 703 mg 
(19%) of 5b was recovered. 1H NMR (401 MHz, DMSO-d6): 11.04 (s, 1H), 10.36 (s, 1H), 
1.96 (s, 3H). 19F NMR (377 MHz, D2O): -173.18, -120.71. 19F NMR (377 MHz, PBS / 
10% D2O): -120.67.  HRMS ESI m/z 145.0402 [M+H] (expected 145.0408). 
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Scheme B3 Synthesis of MeOVal-CysSA-Cbz 
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MeOValCysSACbz was synthesized according to modified literature procedures158: 
 
ValOMe. To a 250 mL flask was added 50 mL of MeOH. This was cooled with ice and 
(6.46 g, 4.46 mL, 1.2 eq) of thionyl chloride was added dropwise with rapid stirring. The 
evolution of gas was monitored (SO2) and when this ceased the solution was stirred for 
another half-hour before L-valine was added in one portion. The reaction was brought to 
reflux for 16 hrs, cooled, the volume was reduced by rotary evaporation. The reaction 
was taken up into 150 mL EtOAc, rinsed with 3 x 50 mL portions of 1 N NaOH, and 1 x 
50 mL portion of brine. The organic layer was dried over MgSO4, filtered, and collected, 
and then he solvent was removed by rotary evaporation, and further removed under 
high vaccum (< 0.1 torr). Spectral information matched that of published literature. 
 
CystineCbz. Cystine (2.5 g) and sodium carbonate (2.76 g, 2.5 eq) was added to 50 
mL 1:1 H2O / MeOH and cooled on ice. Catalytic DMAP was added (0.1 eq). To this 
was dropwise added Cbz-Cl (4.44 g, 3.70 mL 2.5 eq) and allowed to warm to room 
temperature and react for 16 hrs. The volume was reduced and the mixture slowly 
acidified with 6 N HCl to pH 2. 200 mL of EtOAc was added, and this was extracted with 
3 x 50 mL portions of 1 N HCl, rinsed with water, and then with brine. The organic layer 
was dried over MgSO4, filtered, and collected, and then the solvent was removed by 
rotary evaporation, and further removed under high vaccum (< 0.1 torr). Spectral 
information matched that of published literature. 
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MeOVal-Cystine-Cbz. To a 250 mL round-bottom flask was added 100 mL THF and 
5.3 g cysteine-Cbz, 3 g Val-OMe (2.2 eq), 5.0 g EDC*HCl (2.5 eq), and 636 mg DMAP 
(0.5 eq). This reaction was allowed to stir overnight at room temperature, after which the 
volume is reduced, and the reaction taken up in EtOAc, and extracted with 1 N HCl (3 x 
50 mL portions) and 10% NaHCO3 (3 x 50 mL portions), and washed with brine. The 
organic fractions were dried with MgSO4, and filtered, and collected, and then the 
solvent was removed by rotary evaporation, and further removed under high vaccum (< 
0.1 torr). 5.15 g was recovered (69%) and spectral information matched that of 
published literature. 
 
MeOVal-CysSA-Cbz. To a flame-dried round-bottom flask was added 560 mg of 
MeOVal-Cystine-Cbz and dry DCM (20 mL). To this was added dry pyridine (502 µL, 8 
eq) and the reaction vessel was cooled to -78˚C in an efficient Dewar and a large 
amount of dry ice in acetone. Bromine (88 µL, 2.2 eq) was dissolved in 5 mL dry DCM 
and added dropwise to the reaction mixture under nitrogen. This was allowed to warm 
to room temperature slowly and react overnight. 10 g of silica was added to the vessel 
and the reaction was dried down. This was dry-loaded onto a silica gel column and 
purified with a 0-50% acetone:DCM gradient. 415 mg (73%) of product was collected, 
and spectral information matched published data.  
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Scheme B4. Synthesis of Pyr-SEt 
 
 
Pyr-SEt. In a modified literature procedure227, to a 100 mL flame-dried two-neck round-
bottom flask was added sodium hydride as a 60% suspension in mineral oil (1.337 g, 34 
mM, 4.2 eq), which was thoroughly washed with hexanes (3 x 25 mL portions) under 
nitrogen. This was suspended in 25 mL dry THF and cooled on an ice bath. 2-
pyrrolidinone (2.50 mL, 33 mM, 4 eq), was added dropwise to this solution with stirring 
and allowed to equilibrate for 1 hr with the evolution of gas. In a separate 25 mL flame-
dried round-bottom flask, to a solution of ethyl disulfide (1 g, 8.2 mM, 1 eq) and dry 
acetonitrile (10 mL) was added elemental bromine (1.31 g, 8.2 mM, 1 eq), and this was 
allowed to react for 1 hr. Following this, the solution was added dropwise via cannula to 
the suspension of sodium pyrrolidinonate, which was accompanied by a loss of color. 
This was allowed to warm to room temperature, and left to react for one hour. Hexanes 
(100 mL) was added to the heterogeneous reaction, which was then filtered through a 
plug of glass wool to remove pyrrolidinate and other salts. The solvent was removed 
under vacuum, and the crude mixture was purified by flash chromatography on a 0-2% 
methanol gradient in dichloromethane. Fractions were combined, and 1.56g (66%) was 
collected as a light brown liquid. 1H NMR (401 MHz, Chloroform-d) δ: 3.58 (t, J = 7.1 Hz, 
2H), 2.79 (q, J = 7.4 Hz, 2H), 2.40 (t, J = 8.1Hz, 2H), 2.04 (tt, J = 7.8, 6.8Hz, 2H), 1.22 
(t, J = 7.4Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 177.87, 77.33, 77.01, 76.69, 52.85, 
30.96, 30.24, 18.83, 13.16. HRMS ESI+ 146.0634 (M+H+ calc 146.0640) 
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Scheme B5. Reaction of 5-7 with MeOVal-CysSA-Cbz: 
 
General procedure for the 19F NMR evaluation of the reactivity of 5-7 with 
MeOVal-CysSA-Cbz: 
To a 1.5 mL Eppendorf tube was added 980 uL of a standard solution of PBS with 10% 
D2O and TFA as an internal standard. To this was added 10 µL of a 100 mM solution of 
5-7 in DMSO, and then quickly 10 µL of a 100 mM solution of MeOVal-CysSA-Cbz in 
DMSO was added and the solution mixed thoroughly. After 1 hr, the solution was 
transferred to an NMR tube and analyzed.  
 
General procedure for the LC-HRMS evaluation of the reactivity of 5-7 with 
MeOVal-CysSA-Cbz: 
To a 1.5 mL Eppendorf tube was added 980 uL PBS. To this was added 10 µL of a 100 
mM solution of 5-7 in DMSO, and then quickly 10 µL of a 100 mM solution of MeOVal-
CysSA-Cbz in DMSO was added and the solution mixed thoroughly. After 1 hr, the 
solution was injected on the LCMS and analyzed.  
 
General procedure for the evaluation of the rates of reaction of 5-7 by LC-HRMS 
with MeOVal-CysSA-Cbz: 
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To a 1.5 mL Eppendorf tube was added 980 uL PBS. To this was added 10 µL of a 100 
mM solution of 5-7 in DMSO, and then quickly 10 µL of a 100 mM solution of MeOVal-
CysSA-Cbz in DMSO was added and the solution mixed thoroughly. Immediately, a 100 
µL portion aliquot was removed and put into a 100 µL vial with AcOH. This is repeated 
for the described number of timepoints, and these are analyzed by LC-HRMS. The 
mass peak for each compound is extracted and the ion count is collected. As possible, 
this is fit to a one-phase association curve, in which the kobs is extracted and the krxn is 
determined. 
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Scheme B6. Structures of 5-pep – 7-pep: 
 
 
  
N N
F
N NH
F
NH2
N NH
F
O
O
O
O OOO
HH
S
HN
O
O
O
HN
OMeO N N
F
O
O
O
S
HN
O
O
O
HN
OMeO
S
HN
O
O
O
HN
OMeO
S
HN
O
O
O
HN
OMeO
5a-pep 5a'-pep
6a-pep 7a-pep
N
H
N
F
OO
S
HN
O
O
O
HN
OMeO
5b-pep
 202 
Scheme B7. Reaction of Pyr-SEt with 5a  
 
To a 1.5 mL Eppendorf tube was added 980 uL of a standard solution of PBS with 10% 
D2O and TFA as an internal standard. To this was added 10 µL of a 100 mM solution of 
5-7 in DMSO, and then quickly 10 µL of a 100 mM solution of Pyr-SEt in DMSO was 
added and the solution mixed thoroughly. After 1 hr, the solution was transferred to an 
NMR tube and analyzed.  
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Scheme B8. Planned procedure for the conversion of hydroxy-19F AMC probes to 
amino-19F AMC probes197,198 
 
To a solid amount of an hydroxy-pyrimidine was added neat thionyl chloride at room 
temperature. This reaction was brought to reflux and the evolution of gas was 
monitored. When no more gas (-SOCl2 and -HCl) is produced, the reaction is cooled, 
and the remaining thionyl chloride is carefully removed by rotary evaporation. The 
resulting perchloro pyrimidine was dissolved in THF, and a number of equivalents of 
sodium azide is added equal to the number of chlorines plus an additional half. This is 
allowed to stir for 4 hours, and conversion is checked by TLC. If necessary, the reaction 
is heated to reflux overnight. Following this, a number of equivalents of sodium sulfide is 
directly added to the same solution equal to the number of chloro sites plus one. The 
evolution of gas is monitored (-N2). The THF is removed, and the reaction is taken up 
into EtOAc, and the reaction is then extracted with 1 N NaOH to remove inorganics.  
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Scheme B9. Other potential expanded 19F AMC derivatives based on diethyl 
fluoromalonate. 
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Scheme B10. Other potential scaffolds based on ethyl fluoro acetoacetate 
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Scheme B11. Proposed synthesis of 6a-yne 
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B.3. Supplementary Tables 
Table B1. Chemical shifts before and after MeOVal-CysSA-Cbz treatment 
 
 
  
19F chemical shifts, in ppm
Starting material post- MeOVal-CysSA-Cbz: result
5a -203.65 -120.68 ppm complete conversion
5a’ -198.90 -198.92, -120.68 ppm partial conversion
6a -196.19 -120.69 ppm complete conversion
7a -187.99 -188.01 ppm no reaction
5b -120.67 -120.67 ppm no reaction
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B.4. Supplementary Figures 
Figure B-01. Rate measurements of 19F AMCs with MeOVal-CysSA-Cbz.  
Into a 1.5 mL Eppendorf tube was added 880 µL of PBS. To this, 100 µL of a 100 mM 
DMSO stock of 5-7 was added, and then 10 µL of a 100 mM DMSO stock of MeOVal-
CysSA-Cbz was added, then the reaction was immediately quenched at given time 
points with AcOH, and the pseudo-first order kinetics was calculated if possible. a) 5a 
shows a rapid increase, and then degradation. b) The initial time points of 5a show a 
rapid (1700 M-1 s-1) increase. c) 5a’ also shows the same rapid increase, followed by a 
degradation. d) 6a shows a clean kinetics curve, with first-order kinetics of 215 M-1 s-1. 
e) 7a produced no expected products, consistent with 19F NMR studies. 
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Figure B-02. Toolkit for the α-fluorination of dimedone and dimedone analogues 
 
 
  
X
O O
X
O O
Br
X
O O
Br Br
X
O O
SMe
X
O O
RHO
X
O O
I
R
N+
F
N+
F
Cl Cl N+
F
N
SS
F
O
O
O
O N+
N+
Cl
F
KF HF(aq) Pyridine*(HF)x
XeF2 AgF2
AgF
X
O
Br
MeO
X
OMeO
Cu+xFx
Substrates
F+
F-
OO
F
OEt
OO
F
EtO OEt
OO
F
AMC-F
 210 
B.5. NMR spectra 
1H NMR: MeOVal-CysSA-Cbz in CDCl3 
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13C NMR: MeOVal-CysSA-Cbz in CDCl3 
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1H NMR: 5a in DMSO 
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19F NMR: 5a in DMSO 
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19F NMR: 5a in D2O  
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19F NMR: 5a in PBS / 10% D2O 
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19F NMR: 5a-pep (5a + MeOVal-CysSA-Cbz) in PBS / 10% D2O  
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19F NMR: 5a’ in DMSO 
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19F NMR: 5a’ in DMSO  
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19F NMR: 5a’ in D2O  
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19F NMR: 5a’ in PBS / 10% D2O  
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19F NMR 5a’-pep (5a’ + MeOVal-CysSA-Cbz) in PBS / 10% D2O 
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1H NMR: 6a in DMSO  
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19F NMR: 6a in DMSO 
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19F NMR: 6a in D2O   
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19F NMR: 6a in PBS / 10% D2O 
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19F NMR: 6a-pep (6a + MeOVal-CysSA-Cbz) in PBS / 10% D2O   
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19F NMR: 6a-pep (6a + MeOVal-Cys-Cbz) in PBS / 10% D2O after 5 min 
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1H NMR: 7a in DMSO  
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19F NMR: 7a in DMSO   
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19F NMR: 7a in D2O  
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19F NMR: 7a in PBS / 10% D2O  
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19F NMR: 7a-pep (7a + MeOVal-CysSA-Cbz) in PBS / 10% D2O  
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1H NMR: 5b in DMSO  
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19F NMR: 5b in D2O  
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19F NMR: 5b in PBS / 10% D2O  
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19F NMR: 5b-pep (5b + MeOVal-CysSA-Cbz) in PBS / 10% D2O 
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19F NMR: PyrSEt + 6a 
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19F NMR: BL21 cell lysates o/e AhpcC166S + NaSH ( 1 mM) + 6a (1 mM) 
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19F: NMR. BL21 cell lysates o/e AhpcC166S + NaSH ( 1 mM) + 6a (1 mM) 
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19F NMR: BL21 cell lysates o/e AhpcC166S, fluorine background 
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19F NMR: 6a in PBS, stability 
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19F NMR: BL21 cell lysates o/e AhpcC WT + GSH + 6a in PBS 
 
 
  
-21
-200
-190
-180
-170
-160
-150
-140
-130
-120
-110
-100
-90
-80
-70
-60
f1 (ppm
)
ct_1051-5-19F
STANDARD FLUORINE PARAM
ETERS
 243 
19F NMR: BL21 cell lysates o/e AhpcC WT - GSH + 6a in PBS 
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19F NMR: BL21 cell lysates o/e AhpcC C166S + GSH + 6a in PBS 
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19F NMR: BL21 cell lysates o/e AhpcC C166S - GSH + 6a in PBS 
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B.6 Mass Spectra 
Time course of 10 µM MeOVal-CysSA-Cbz with 100 µM 6a 
  
Time course of 100 µM MeOVal-CysSA-Cbz with 1000 µM 6a  
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6a + MeOVal-CysSA-Cbz 
  
 248 
6a standard, 100 µM 
 
 
MeOVal-CysSA-Cbz standard, 100 µM 
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LCMS Sensitivity trials 
Testing the detection limits for the 6a-pep. The samples were mixed with a 1:10 ratio of 
6a to MeOVal-CysSA-Cbz, and were immediately analyzed. a) 25 µM 6a. b) 50 µM 6a. 
c) 100 µM 6a. d) 250 µM 6a. e) 500 µM 6a. 
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Appendix C: Additional proteins 
involved in the redox regulation of the 
cell 
For instance, the redox balance of the ER is one of the most precarious in the cell, 
as it governs the transition from the reducing environment of the intracellular space that 
favors cysteine thiol to the oxidative environment of the extracellular space, which 
favors cysteine disulfides. This oxidative modification is an integral part of extracellular 
protein structure; however, proteins with multiple-to-numerous cysteine residues may 
have many incorrect disulfide possibilities that a rapidly overoxidizing environment may 
disrupt228. This is corrected by chaperones known as protein disulfide isomerases 
(PDIs)  
One such chaperone is Ero1 (ER oxidoreductin 1), and it is implicated in maintaining 
endoplasmic reticulum redox balance and proper protein folding228. When Ero1 is 
knocked down, translated proteins accumulate229 and demonstrate a higher levels of 
unfolded protein response, implying that Ero1 helps properly arrange disulfide bonds 
and fold the protein and/or provides the oxidizing equivalents to another PDI which 
helps to chaperone the nascent protein (Figure 1-Xa)228. Ero1 contains four active-site 
cysteine residues coupled to a proximal flavin cofactor, which in conjunction with 
molecular oxygen provides the necessary oxidation equivalents to form proper 
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disulfides. A distal pair of cysteines far from the catalytic site regulates the activity; when 
the oxidizing environment of the ER is at appropriate levels, these residues remain as 
free thiols and the PDI and substrate thiol oxidation activity is maintained230. However, 
when the oxidative environment is high, these distal cysteine residues form a disulfide, 
which inhibits the oxidative PDI activity, slowing the formation of peroxide and mediating 
the rate at which disulfides can form. Cells expressing the dual cysteine-to-alanine 
mutants of the regulatory cysteines showed an increase in the UPR and decreased 
viability, Glutathione levels in the ER play a role in reducing these cysteines and letting 
Ero1 sense redox state.  
Critically, for every disulfide bond formed by Ero1, one equivalent of H2O2 is formed 
and two equivalents of O2 consumed. Thus during high levels of production of secretory 
proteins, Ero1 can account for nearly 25% of the ROS production in the cell228,231,232. So 
during low levels of oxidation, Ero1 is active, helping to form disulfide bonds and 
creating ROS, helping to maintain levels of ROS needed to function as a PDI. In this 
sense, Ero1 it is self-regulating, with negative feedback resulting from overactivity 
and/or oxidation. In most cases, it appears as though the majority of Ero1 is in the 
oxidized, inactive form, thereby limiting the amount of peroxide formed230. This explains 
the various levels of redox-mediated regulation: disulfide sensing, disulfide exchange, 
and ROS production.  
Within the oxidizing environment of the endoplasmic reticulum (ER) and the Golgi 
apparatus, where proteins destined for the extracellular domain are folded and disulfide 
bonds are formed, sulfenic acids are the putative intermediate for this233. Given that 
Ero1 produces peroxide, which induces disulfide formation, this seems likely. Thus 
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regulation of oxidative environments and protein oxidation has implications in secreted 
protein folding, which accounts for an estimated ⅓ of all translated proteins, so on a 
macroscopic level, sulfenic acids are of enormous importance231. 
Linking the ER stress to the rest of the cell, Sestrin2 can help mediate cellular 
response in the rest of the cell. The Sestrin family of proteins (SESN) includes three 
redox-sensing isoforms (Sestrin1, Sestrin2, Sestrin3) that help govern antioxidant 
response (Figure 1-xb and 1-xc). Each member is widely implicated in the complex and 
diverse redox-balance activities throughout the cell234.  
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Figure C-01. The antioxidant and redox response proteins of the cell.  
a) Ero1 modulates the redoxi balance of the ER though its ROS-producing PDI activity. 
As the oxidative load of he ER increases, the PDI-capacity and ROS generation 
decreases. Pink group is a flavin cofactor. b) Oxidative stress activates a number of 
different pathways, many o which lead to the activation of the Sestrin family of proteins. 
c) The Sestrins activate several different antioxidant pathways, including Nrf2, which 
induces a positive antioxidant feedback loop with Sestrin 2.  
  
Sestrin2 is involved in ER stress and this stress induces Sestrin2 and helps to 
increase the survivability of a cell. When too much protein is being made and the UPR 
is activated, IRE1α and PERK go on to activate the mTORC1 pathway, shutting down 
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protein synthesis and increasing autophagy235. When Sestrin2 is blocked, protein 
biosynthesis continues, and exacerbates the stress on the ER. 
Sestrins can be induced by a number of pathways responding to oxidative stress. 
Sestrin1 is induced by hydrogen peroxide in a p53-dependant manner234. Sestrin2 is 
partially determinate on p53, but can also be induced by NMDA-receptor signaling in 
neurons234,236, which produces ROS. Sestrin2 can also be induced by activation of the 
transcription factor Nrf2, and by the JNK/AP-1 signaling cascade234,236-240. Nrf2 
increases the antioxidant program of the cell, which can be stimulated by oncogenes241. 
Sestrin3 is stimulated by the oxidative damage and activation of the of FoxO 
transcription factors234.  
Silencing any of the Sestrins by siRNA results in increased accumulation of ROS 
and decreased survivability234. There exists a sequence with small but definitive 
homology to Mycobacterium tuberculosis protein AhpD, which helps to regenerate the 
bacterial peroxyredoxin AhpC. Though Sestrins do not directly regenerate Prx, it may 
help form complexes with other reductases, such as sulfiredoxin (Srx)234,237. Further 
upstream, Sestrins can increase Nrf2 expression, which can induce Srx expression, 
which can increase the concentration of active Prx by reducing the buildup of 
overoxidized, inactive Prx104. 
Indeed, the sestrin family of proteins (SESN) family of proteins is one of the primary 
redox-sensing proteins that help govern antioxidant response. It widely implicated in 
many redox-balance activities throughout the cell. 
In the nervous system, reactive oxygen species are involved in chronic neuropathic 
pain response. Both H2O2 and O2˚- are involved pain sensitization, and suppressing 
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NADPH oxidase isoforms NOX2 and NOX4 diminishes pain response242. Upon pain 
stimulation, Sestrin2 helps modulate the pain response through its antioxidant 
properties, and helps activate the activating transcription factor 3 (ATF3) after sensory 
nerve injury (SNI)242.  
When small-molecule mitochondrial inhibitors of electron transport chain complex I 
(piericidin A) and III (myxothiazol) were applied to cells, the gene encoding for Sestrin2, 
SESN2 was upregulated236. The activating transcription factor 4 (ATF4) plays a key 
roles in the integrated stress response (ISR), and it was found that blocking ISR blocked 
SESN2 expression236. This indicates that SESN2 plays a key regulatory role in 
mitochondrial health and stress.  
In macrophages, Sestrin2 almost completely diminished the Toll-Like Receptor 
(TLR) response to lipopolysaccharide (LPS) stimulation and release of NO˚ by iNOS 
and H2O2 by NOX239. In these cells, high levels of both ROS and RNS are produced in a 
so-called ‘resparatory burst’ that play an antibioltic role endogenously. The high 
expression of both types of species is sufficient to produce other species including 
peroxynitrite (ONOO-) and myeloperoxidase can convert peroxide to hypochlorite. 
Expression of pro-inflamatory cytokines TNF-α, IL-6, and IL-1β was reduced as well239. 
This seems to happen by inhibition of MAPK/P38/JNK, preventing downstream 
activation of ROS/RNS sources and AP-1 (c-jun)239. 
Sestrins, as described above, are implicated in many forms of antioxidant response, 
across different cell lines and are necessary for the health of various organelles, 
especialy those with strong oxidative potential.  
Small heat-shock proteins such as Hsp25 and Hsp 27243, which at times double as 
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redox chaperone proteins, can upregulate the amount of glutathione by increasing the 
amount of glucose-6-phosphate dehydrogenase244. They also may increase the amount 
of glutathione reductase and glutathione transferase245.  
Under low-to-moderate degrees of oxidative stress, heat shock factor 1 (HSF1) is 
liberated from binding to Hsp’s, where it then goes to act as a transcription factor to 
upregulate Hsp production levels245. Overoxidation levels, however, inhibit this transition 
and DNA binding, preventing this activity. HSF1 activation also leads to an increase in 
reduced gluathione levels (GSH), which helps reestablish the appropriate redox 
balance245.  
The caspases are a family of aspartate-specific cysteine proteases that are often 
associated with cell death. Their catalytic cysteine needs to be free for activity; 
alkylating agents can block their action246. The cell-death initator protein caspase-9 is a 
pro-apoptotic protease that has a catalytically active redox-sensitive cysteine in its 
active site247. Oxidation of this cysteine causes it to associate with the apoptotic 
protease-activating factor 1 (Apaf1), which leads to more pro-apoptotic events. This 
binding association occurs through a intermolecular disulfide bond to Apaf1, which 
would explain why ROS induces this association. Interestingly, RNS and nitrosylation at 
these catalytic cysteines of caspases blocks its catalytic and apoptotic potential248-250 
from upstream apoptotic factors such as cytochrome c. However, it seems as other 
factors such as Fas can denitrosylate other caspases, such as caspase-3249.  Caspase-
3, however, is activated by thioredoxin and other antioxidants246. Caspase-2 blocks 
ROS stress and is activated by ROS251. Casp2-/- knockout mice show phenotypic signs 
of advanced aging and reduced resistance to oxidative pressure. Without the 
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antioxidant properties of Caspase-2, Casp2-/- mice experience ROS accumulation and 
the activation of the FOXO-Nrf2 pathway leading to reduced levels of SOD and Prx-
GSH, as well as Jnk activation leading to increased IL-6 and IL 1β levels. 251,252 
Peroxyredoxins, while playing the role of primary antioxidant protein, can also play a 
role in redox signaling cascades253. Cytokine-induced oxidation of Prx2 results in the 
formation of a disulfide, which is traditionally thought to be reduced by Trx. Instead, the 
oxidative equivalent gets transferred to the transcription factor STAT3, which after 
disulfide formation goes on to form dimers and tetramers and increases its activity.  
YajL/DJ1 is an antioxidant protein that has a conserved cysteine that is modified as 
a stable sulfinic acid in crystal structures. YajL/DJ1 has been found to protect cells 
against sulfenylation and form mixed disulfides with sulfenic acids on proteins254. 
Mutations to this cysteine are implicated in early-onset Parkinson’s disease and 
parkinsonism255 and trigger global cellular response across many types of antioxidant 
proteins256. 
And finally, the catalytic cysteine of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) is susceptible to oxidation257, where it forms either disulfides on Cys152 (cat) 
and Cys156, or cysteic acid (sulfonic acid) on Cys152. When this occurs it interferes 
with critical phase of glycolysis where glyceraldehyde-3-phosphate is oxidatively 
transformed into 1,3-bisphosphoglycerate. This halts the production of pyruvate and the 
subsequent production of ATP through the mitochondrial electron transport train, which 
is a key source of oxidative stress and drain on the supply of NADPH. Instead, it 
reroutes metabolism through to the pentose phosphate pathway, generates reducing 
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units of NADPH that is a key cofactor and electron source for the rexodins and 
glutathione reductase.   
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Appendix D: Non-invasive methods of 
imaging tissues and chemical state in 
vivo  
 
D.01. X-Rays and Computed Tomography  
Two-dimensional X-rays, and more recently, X-ray CT (X-CT computed tomography), 
was the first technology to enable the non-invasive imaging of  
macrostructures258-261. The high-energy photons are able to penetrate bodily tissue and 
are particularly useful for studying both differences in density between tissues and the 
hard skeletal structures (Figure 3-1a). These can be enhanced by the use of contrast 
agents, particularly barium for the gastrointestinal track and a variety of iodine262 
compounds are used to image the vasculature and other body compartments. However, 
the ability to image non-metal elements on second- and third-row of the periodic table is 
severely restricted, and without the addition of contrast agents is unable to image the 
transparent proteins.  
 
D.02. Positron emission tomography 
By contrast, Positron Emission Tomography (PET) is a highly sensitive technique. It 
involves the introduction of isotopes that undergo an anti-electron i.e. positron (β+) 
decay, which upon collision and annihilation with an electron produces a pair of high- 
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energy γ particles (always 511 keV due to the β/β= annihilation energetics) that are 
detected by the instrument (Figure 3-1b)263-265. The location of decay is computed and 
the three-dimensional structure is reconstructed. β+-emitting isotopes include 11C (t1/2 
~20 min), 13N (t1/2 ~10 min), 15O (t1/2 ~2 min), etc., with the most common being 18F (t1/2 
~110 min)266,267. There are also numerous other nuclei267,268 with different β+-emission 
energies.  
The production of these isotopes occurs in a cyclotron where the appropriate 
progenitor nuclei are bombarded by high-energy particles. For 20Ne !18F, the particle 
energy can be quite low (0-2 MeV), as opposed to higher-energy transitions such as 
68Ge ! 68Ga, which occurs only on national-lab scale beamlines operating at greater 
than 100 MeV266.  
The β+-emission energy determines the average path length before decay, which 
correlates in a non-linear manner to the β+-emission energy, usually in the realm of 
MeV. The full-width at half-max (FWHM) for a β+ particle ejected from 18F has 0.64 MeV 
of energy and travels, on average, 0.54 mm before it loses enough of that energy to 
capture an electron and annihilate. For a β+ particle ejected from 82Rb at 3.35 MeV, the 
FWHM is 6.14 mm. A single grain of 18F would appear to be 1.2 mm with perfect 
instrumentation; a single grain of 82Rb would appear to be 1.2 cm. Thus the energy of 
the ejection / lifetime of the decay is the fundamental limiting factor on the spacial 
resolution202.  
For the reason of ease of production, and one of the shortest β+-decay path and 
highest resolution, 18F is one of the most popular radionuclei for PET. 
18Fluordeoxyglucose (FDG) is the prevalent radiotracer in 90% of PET scans, and is 
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used as a metabolic sensor of rapidly-dividing oncogenic cells269. Such energy-
consuming tumors uptake the sensor, which is then trapped inside cells by 
phosphorylation with hexokinase and is thus unable to diffuse or be transported outside 
the cell, leading to a selective bioaccumulation of radionuclei270.  
Due to the expense of producing these radioisotopes, it is typically a secondary 
imaging technique should X-ray/CT fail to observe abnormal physiological structures. 
Thus, strong practical limitations of this technique include the requirement that short-
lived radioisotopes must be produced on-site by cyclotrons and subsequently 
synthetically incorporated into the radiotracer and rapidly purified. This chemistry, 
particularly the 18F chemistry, has the difficulty of always racing the uphill battle against 
rapid nuclear decay for incorporation into the sensor that is necessary to ensure the 
sensitivity of the technique.  This decay leads to much of the potential radiolabel is lost 
by the time the synthesis and purification is done, paradoxically decreasing the 
sensitivity of the technique. Given this additional constraint, many of the typical rules for 
organic synthesis no longer apply: consider a hypothetical organic chemical reaction 
that ideally gets a quantitative chemical conversion after 9 hours with 19F, with a two-
hour purification and one hour for analysis resulting in ~100% yield. However, this 
timeframe represents roughly nearly seven half-lives for 18F, which will only result a 
radioyield of product of ~1%. This necessitates specialized chemistry to be developed 
for rapid incorporation the sensor271. Thus expensive and mandatory on-site production 
of the radionuclei, rapid decay, and lack of access to an enormous range of reactions 
that a synthetic organic chemist has access to remains a great drawback. 
From our perspective, the most significant drawback is that while information on the 
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spacial position and concentration/bioaccumulation are have reasonably high resolution 
and sensitively collected, the technique itself is an indirect measurement of ejected 
positrons that decay into the gamma rays. These gamma particles contain no 
information about the chemical environment of the nuclei before its two-step decay, 
always emitting at 511 keV, limiting its use to only determining the location of 
bioaccumulation and clearance.  
 
D.03. Nuclear Magnetic Resonance, Magnetic Resonance Imaging 
Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) 
utilize high-field magnets and radio frequency pulses to probe the nuclear spin-state 
and chemical environment of receptive nuclei (Figure 3-1c).  
MRI and NMR operate on the same principles (Figure 3-1d), an excellent review of 
all pertinent topics can be seen here272. First, a sample containing a nuclei with a non-
zero magnetogyric spin state. Active spin ½ nuclei include, but are not limited to: 1H, 
13C, 11B, 15N, 29Si, 31P, and 19F.  The sample is then subjected to a strong magnetic field 
(for a 400 MHz magnet this is 9.4 T, roughly 150,000 times the strength of the earth’s 
magnetic field), which aligns the nuclei into two states: a lower-energy α, and a higher-
energy β. The α population is aligned with the field, and the β against. Upon excitation 
with radio frequency (Rf) light, some of the α transfers to β, which produces a nuclear 
magnetic resonance response, i.e. the chemical shift tensor273. This response can 
probe for the chemical environment of the nuclei i.e local chemical structure. Other 
forms of information that can be collected are the T1 (spin-lattice) and T2 (spin-spin) 
relaxation times, which are two different phenomena that result in the degradation of the 
 263 
NMR/MRI signal. T1 is the decrease in the population of β back to α as signal intensity 
in the z plane normal to the magnetic field B0. This results from the population of 
magnetic spin states approaching parity after excitation and repopulating their non-
excited form. It is essentially how fast the excited β nuclei return to the α state, and 
typically having a short T1 is favorable because once the nuclei have relaxed, another 
pulse can be applied. T2 involves the loss of the coherence of the magnetization in the 
xy plane perpendicular to B0, contributing to signal line broadening. T2 is like a top that 
begins to wobble off axis, which diffuses the nuclear alignment spin state in the 
measured z direction.  
Simply put, a short T1 decay leads to the ability to take an increased number of 
scans in a given amount of time and thus a higher effective sensitivity, while a low T2 
leads to rapid decoherence and broadening in the signal, which causes a decrease in 
the S/N. Repeated pulses increase the S/N by a factor of n½. Thus increasing the 
number of scans from 16 to 32 will yield roughly a 41% increase in S/N. A decrease in 
 
Table D-01. T1 and T2 relaxation times of 1H under a 1.5 T field strength.  
Different tissues have different relaxation times due to the concentration of other small 
molecules present in the matrix274. 
 
In 1.5 T magnet
Tissue T1 (ms) T2 (ms)
Adipose tissues 240-250 60-80
Whole blood (deoxygenated) 1350 50
Whole blood (oxygenated) 1350 200
Cerebrospinal fluid (similar to pure water) 4200 - 4500 2100-2300
Gray matter of cerebrum 920 100
White matter of cerebrum 780 90
Liver 490 40
Kidneys 650 60-75
Muscles 860-900 50
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T2 is often correlated with larger molecules such as proteins, micelles, or solid- or 
pseudosolid-state material. Thus, a high T2/T1 is a desirable “on” state for the 
sensor/probe to ensure the highest S/N in the shortest amount of time. In practice, T2 
can never be longer than T1 due to the fact that after T1 relaxation, the nucleus is 
relaxed into a stable alignment with the B0. In MRI and MRS, the chemical shift 
(environment), intensity (concentration in a given environment), T1 and T2 relaxation 
times can all be used to gather clinically useful information (Table 3-1). These factors 
depend on not only the covalent chemical environment of the probed nuclei, but also the 
small-molecule and biological macromolecule composition of the tissue. For instance, 
the increased T2 of oxygenated whole blood over deoxygenated whole blood is due to 
the paramagnetic electron spin state of the unpaired electrons in molecular oxygen. 
Thus nuclear-spin techniques represent an extremely versatile means to evaluate 
parallel factors in chemical environment.  
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Figure D-01. Established methods of 19F MRI detection191.  
a) One of the more common uses of 19F sensors for MRA is in the use of perfluorinated 
compounds that undergo oxygen concentration-dependent decreased T1 relaxation 
times. b) Other paramagnetic elements such as gadolinium and manganese can 
enhance T1 relaxation times; however, they can also decrease T2 relaxation times, 
leading to signal broadening. Thus the contrast agents must be carefully designed. c) 
Colocalization of 19F and a quencher can lead to a decrease in signal, and upon release 
an increase in S/N is established. d) Coordination of hydrophobic fluoro compounds to 
blood results in the coordination to hydrophobic sponge of HSA. Upon treatment, the 
compound becomes more hydrophilic and is released from the serum albumin. This 
increases the T2 relaxation time, reducing line broadening and increasing S/N. 
 
While being a much less sensitive technique than PET, it allows multidimensional 
additional modes of study over simply determining spacial position and concentration 
(bioaccumulation). To demonstrate this, amyloidophilic tracers were used to analyze 
plaques via 19F and 1H in vivo187. Both FSB (Figure 3-Xi) and BSB275 (Figure 3-Xii) are 
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structurally similar to the Congo Red (CR), which is known to bind to β-amyloid plaques. 
Upon administration of these sensors, Higuchi et al recreated the three-dimensional 
structure of the brain using spin-echo rapid acquisition with relaxation enhancement 
(RARE) sequence designed for 19F. The 19F images were obtained on a 400 MHz / 9.4 
T imaging spectrometer over the course of 90 min looking directly at a peak at about -
118.7 ppm276 (Figure 3-Xa). Because extremely high background of protons in the brain 
and their similarity to each other in terms of chemical shifts (ppm), the 1H scans utilized 
T1-weighted gradient-echo coronal 1H magnetic resonance images to differentiate 
tissues from each other (Figure 3-Xb). Together, the two modes of analysis confer a 
multidimensional analysis, increasing the confidence of the measurement (Figure 3-Xc). 
In contrast, BSB has no 19F, but it produces the same T1 enhancement of the amyloid 
regions, while the vehicle (DMSO) does not have that effect, which is recapitulated by 
examining FSB and CR side-by-side (Figure 3-Xe-g). Figures 3Xd,e are confirming that 
the sensor / dye are colocalized with the plaque.  
As a reporter group, 19F is possesses single-atom minimalist functionality186 and, 
unlike 18F, is indefinitely stable. It has several convenient commercial active methylene 
compound starting materials (Scheme B9 & B10), as well as several powerful and 
commercially available sources of electrophilic (“F+”) and nucleophilic (“F-”) fluorine 
(Figure B3), allowing for much greater synthetic reach over 18F, which has no 
commercial products at all.  
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Figure D-02. Illustration of the potential of 19F MRI over/combined with 1H MRI.  
i) FSB is a Congo Red-like sensor that binds to β-amyloid plaques. ii) BSB is a similar 
probe, but it lacks the 19F reporter group. a,e) 19F imaging of FSB/BSB. b,f) 1H time 
resolved imaging with FSB/vehicle. c.g) Merge of 19F/1H images, and 1H spectrum of a 
FSB/CR coinjection. d,h) Fluorescence imaging of brain slices. Images taken from 
reference187. 
 
A wide array of effective and clever 19F NMR/MRI contrast and imaging agents have 
been developed277. An early use of 19F sensors are as interrogators of oxygen tension. 
Upon administration, the sensors biodistribute to the appropriate tissues, and the T1 
spin-lattice relaxation time has been found to be linearly dependent on the partial 
pressure of the paramagnetic molecular oxygen (pO2) (Figure 3-2a)278. Other 
paramagnetic elements and ions can be used, such as gadolinium (Figure 3-2b) to 
reduce T1 and increase S/N; however, these may have the side effect to reduce T2, 
leading to line broadening and effective signal quenching. Careful design of the sensors 
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is necessary to ensure optimal signal, however, once this effect is achieved, a number 
of physical parameters of can be achieved including chemical shift of the fluorine (δ, 
ppm), T1/T2 relaxation times (ms), and pH and thermal response279. General methods 
for the 19F NMR signal quenching by colocalization either occur by macrostructure 
containment280 or by covalent connection, with increase in signal occurring when these 
structures or connections are disrupted (Figure 3-2c and 3-2d). Fluorine-containing 
nanoparticles were encased in a disulfide-bridged gadolinium shell281. The Gd+3 
complex in this case enhanced the T2, and not T1, relaxation time, leading to 
broadening of signal and loss of magnetic coherence. Upon cleavage with TCEP, the 
signal increased dramatically.  
A simple way to linearly increase S/N is to increase the number of fluorines204, and 
even better, degenerate fluorines, as is the case with the perfluorinated 15-crown-5282, 
which features 20 chemically identical fluorines, resulting in a 20-fold S/N increase.  
 
From a long-term clinical perspective of in vivo work, unlike the aforementioned 
imaging techniques of X-ray and PET, radio waves and magnetic fields are non-ionizing 
radiation that is easily transmitted through the body, which increases their application 
for clinical and diagnostic potential, particularly in pregnancies where the fetus is highly 
susceptible to DNA damage.  
  
 269 
References 
  
 270 
References 
 (1) Phelan, S. A. Antioxidants & Redox Signaling 1999, 1, 571. 
 (2) Milo, R. P., R. 2016; Vol. 2016. 
 (3) Berner, R. A. Proceedings of the National Academy of Sciences 1999, 96, 
10955. 
 (4) Mach, W. J.; Thimmesch, A. R.; Pierce, J. T.; Pierce, J. D. Nurs Res Pract 2011, 
2011, 260482. 
 (5) Geider, R. J.; Delucia, E. H.; Falkowski, P. G.; Finzi, A. C.; Grime, J. P.; Grace, 
J.; Kana, T. M.; La Roche, J.; Long, S. P.; Osborne, B. A.; Platt, T.; Prentice, I. C.; Raven, J. A.; 
Schlesinger, W. H.; Smetacek, V.; Stuart, V.; Sathyendranath, S.; Thomas, R. B.; Vogelmann, 
T. C.; Williams, P.; Woodward, F. I. Global Change Biology 2001, 7, 849. 
 (6) Wood, P. M. Biochemical Journal 1988, 253, 287. 
 (7) Widomska, J.; Raguz, M.; Subczynski, W. K. Biochimica et Biophysica Acta 
(BBA) - Biomembranes 2007, 1768, 2635. 
 (8) Collman, J. P.; Brauman, J. I.; Halbert, T. R.; Suslick, K. S. Proceedings of the 
National Academy of Sciences of the United States of America 1976, 73, 3333. 
 (9) Jastroch, M.; Divakaruni, A. S.; Mookerjee, S.; Treberg, J. R.; Brand, M. D. 
Essays in biochemistry 2010, 47, 53. 
 (10) Lambeth, J. D. Nature reviews. Immunology 2004, 4, 181. 
 (11) Bielski, B. H. J.; Allen, A. O. The Journal of Physical Chemistry 1977, 81, 1048. 
 (12) Rao, P. S.; Hayon, E. The Journal of Physical Chemistry 1975, 79, 397. 
 (13) Lemire, J. A.; Harrison, J. J.; Turner, R. J. Nat Rev Micro 2013, 11, 371. 
 (14) Requena, J. R.; Chao, C. C.; Levine, R. L.; Stadtman, E. R. Proceedings of the 
National Academy of Sciences of the United States of America 2001, 98, 69. 
 (15) Moller, I. M.; Rogowska-Wrzesinska, A.; Rao, R. S. Journal of proteomics 2011, 
74, 2228. 
 (16) Thomas, E. L. Infection and Immunity 1979, 23, 522. 
 (17) Lau, D.; Mollnau, H.; Eiserich, J. P.; Freeman, B. A.; Daiber, A.; Gehling, U. M.; 
Brümmer, J.; Rudolph, V.; Münzel, T.; Heitzer, T.; Meinertz, T.; Baldus, S. Proceedings of the 
National Academy of Sciences of the United States of America 2005, 102, 431. 
 (18) Papayannopoulos, V.; Metzler, K. D.; Hakkim, A.; Zychlinsky, A. The Journal of 
Cell Biology 2010, 191, 677. 
 (19) Davies, M. J. Journal of Clinical Biochemistry and Nutrition 2011, 48, 8. 
 (20) Cotton, F. A. W., G. Advanced Inorganic Chemistry; 5th ed.; Wiley-Interscience: 
New York, 1988. 
 (21) Moncada, S.; Palmer, R. M. J.; Higgs, E. A. Biochemical Pharmacology 1989, 38, 
1709. 
 (22) Vanini, F.; Kashfi, K.; Nath, N. Redox Biology 2015, 6, 334. 
 271 
 (23) Bradley, S. A.; Steinert, J. R. Oxidative medicine and cellular longevity 2016, 
2016, 5681036. 
 (24) Chaudhury, A. Frontiers in medicine 2014, 1, 8. 
 (25) Courtney, M. J.; Li, L. L.; Lai, Y. Y. Frontiers in cellular neuroscience 2014, 8, 
252. 
 (26) Zhu, J.; Song, W.; Li, L.; Fan, X. Molecular brain 2016, 9, 30. 
 (27) Dempsey, G. T.; Bates, M.; Kowtoniuk, W. E.; Liu, D. R.; Tsien, R. Y.; Zhuang, X. 
Journal of the American Chemical Society 2009, 131, 18192. 
 (28) Zhao, Y.; Vanhoutte, P. M.; Leung, S. W. Journal of pharmacological sciences 
2015, 129, 83. 
 (29) Hibbs, J. B.; Taintor, R. R.; Vavrin, Z.; Rachlin, E. M. Biochemical and 
Biophysical Research Communications 1988, 157, 87. 
 (30) Green, S. J.; Scheller, L. F.; Marletta, M. A.; Seguin, M. C.; Klotz, F. W.; Slayter, 
M.; Nelson, B. J.; Nacy, C. A. Immunology letters 1994, 43, 87. 
 (31) Angulo, J.; Wright, H. M.; Cuevas, P.; Gonzalez-Corrochano, R.; Fernandez, A.; 
Cuevas, B.; La Fuente, J. M.; Gupta, S.; Saenz de Tejada, I. The journal of sexual medicine 
2010, 7, 2681. 
 (32) Hopper, R. A.; Garthwaite, J. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 2006, 26, 11513. 
 (33) Pacher, P.; Beckman, J. S.; Liaudet, L. Physiological reviews 2007, 87, 315. 
 (34) Augusto, O.; Bonini, M. G.; Amanso, A. M.; Linares, E.; Santos, C. C. X.; De 
Menezes, S. l. L. Free Radical Biology and Medicine 2002, 32, 841. 
 (35) Jansson, E. A.; Huang, L.; Malkey, R.; Govoni, M.; Nihlen, C.; Olsson, A.; 
Stensdotter, M.; Petersson, J.; Holm, L.; Weitzberg, E.; Lundberg, J. O. Nat Chem Biol 2008, 4, 
411. 
 (36) Lindenmann, J.; Matzi, V.; Neuboeck, N.; Ratzenhofer-Komenda, B.; Maier, A.; 
Smolle-Juettner, F. M. Diving and hyperbaric medicine 2010, 40, 213. 
 (37) Chiku, T.; Padovani, D.; Zhu, W.; Singh, S.; Vitvitsky, V.; Banerjee, R. J Biol 
Chem 2009, 284, 11601. 
 (38) Dominy, J. E.; Stipanuk, M. H. Nutrition reviews 2004, 62, 348. 
 (39) Furne, J.; Saeed, A.; Levitt, M. D. American journal of physiology. Regulatory, 
integrative and comparative physiology 2008, 295, R1479. 
 (40) Bełtowski, J.; Jamroz-Wiśniewska, A. Molecules 2014, 19, 21183. 
 (41) Szabo, C. Nature reviews. Drug discovery 2007, 6, 917. 
 (42) Qiu, X.; Villalta, J.; Lin, G.; Lue, T. F. Journal of andrology 2012, 33, 529. 
 (43) Tan, B. H.; Wong, P. T.; Bian, J. S. Neurochemistry international 2010, 56, 3. 
 (44) Han, Y.; Qin, J.; Chang, X.; Yang, Z.; Tang, X.; Du, J. Biochem Biophys Res 
Commun 2005, 327, 431. 
 (45) Pan, J. G.; Zhang, J.; Zhou, H.; Chen, L.; Tang, Y. H.; Zheng, Y. Respiratory 
physiology & neurobiology 2011, 178, 230. 
 (46) Morikawa, T.; Kajimura, M.; Nakamura, T.; Hishiki, T.; Nakanishi, T.; Yukutake, 
Y.; Nagahata, Y.; Ishikawa, M.; Hattori, K.; Takenouchi, T.; Takahashi, T.; Ishii, I.; Matsubara, 
K.; Kabe, Y.; Uchiyama, S.; Nagata, E.; Gadalla, M. M.; Snyder, S. H.; Suematsu, M. 
Proceedings of the National Academy of Sciences of the United States of America 2012, 109, 
1293. 
 (47) Wei, X.; Zhang, B.; Cheng, L.; Chi, M.; Deng, L.; Pan, H.; Yao, X.; Wang, G. 
Brain Research 2015, 1622, 292. 
 (48) Qu, K.; Chen, C. P. L. H.; Halliwell, B.; Moore, P. K.; Wong, P. T.-H. Stroke 2006, 
37, 889. 
 (49) Blackstone, E.; Morrison, M.; Roth, M. B. Science (New York, N.Y.) 2005, 308, 
518. 
 272 
 (50) Morrison, M. L.; Blackwood, J. E.; Lockett, S. L.; Iwata, A.; Winn, R. K.; Roth, M. 
B. The Journal of trauma 2008, 65, 183. 
 (51) Goldstein, M. Journal of Emergency Nursing 2008, 34, 538. 
 (52) McGuffie, C.; Wyatt, J.; Kerr, G.; Hislop, W. Journal of Accident & Emergency 
Medicine 2000, 17, 38. 
 (53) Blumenthal, D. C.; Kassner, R. J. J Biol Chem 1980, 255, 5859. 
 (54) Wu, L.; Wang, R. Pharmacological Reviews 2005, 57, 585. 
 (55) Lamb, D. C.; Lei, L.; Warrilow, A. G.; Lepesheva, G. I.; Mullins, J. G.; Waterman, 
M. R.; Kelly, S. L. Journal of virology 2009, 83, 8266. 
 (56) Hu, S.; Kincaid, J. R. FEBS Letters 1992, 314, 293. 
 (57) Estabrook, R. W.; Franklin, M. R.; Hildebrandt, A. G. Annals of the New York 
Academy of Sciences 1970, 174, 218. 
 (58) Forster, R. E. Annals of the New York Academy of Sciences 1970, 174, 233. 
 (59) Taillé, C.; El-Benna, J.; Lanone, S.; Dang, M.-C.; Ogier-Denis, E.; Aubier, M.; 
Boczkowski, J. Journal of Biological Chemistry 2004, 279, 28681. 
 (60) Thorup, C.; Jones, C. L.; Gross, S. S.; Moore, L. C.; Goligorsky, M. S. American 
Journal of Physiology - Renal Physiology 1999, 277, F882. 
 (61) Willis, D.; Tomlinson, A.; Frederick, R.; Paulclark, M. J.; Willoughby, D. A. 
Biochemical and Biophysical Research Communications 1995, 214, 1152. 
 (62) Coburn, R. F.; Mayers, L. B. Am J Physiol 1971, 220, 66. 
 (63) Stone, J. R.; Marletta, M. A. Biochemistry 1994, 33, 5636. 
 (64) Alcaraz, M. J.; Fernandez, P.; Guillen, M. I. Current Pharmaceutical Design 
2003, 9, 2541. 
 (65) Johnson, R. A.; Kozma, F.; Colombari, E. Brazilian journal of medical and 
biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade 
Brasileira de Biofisica ... [et al.] 1999, 32, 1. 
 (66) Brune, B.; Ullrich, V. Molecular pharmacology 1987, 32, 497. 
 (67) Glaum, S. R.; Miller, R. J. Molecular pharmacology 1993, 43, 965. 
 (68) Stevens, C. F.; Wang, Y. Nature 1993, 364, 147. 
 (69) Jacquez, J. Respiratory Physiology; McGraw-Hill, 1979. 
 (70) Zgiczynski, J. M.; Stelmaszynska, T. Biochimica et biophysica acta 1979, 567, 
309. 
 (71) Chung, J.; Wood, J. L. Archives of biochemistry and biophysics 1970, 141, 73. 
 (72) Way, J. L. Annual review of pharmacology and toxicology 1984, 24, 451. 
 (73) Pavlakovic, G.; Eyer, C. L.; Isom, G. E. Brain Res 1995, 676, 205. 
 (74) Borowitz, J. L.; Gunasekar, P. G.; Isom, G. E. Brain Research 1997, 768, 294. 
 (75) Gunasekar, P. G.; Prabhakaran, K.; Li, L.; Zhang, L.; Isom, G. E.; Borowitz, J. L. 
Neuroscience Research 2004, 49, 13. 
 (76) Kirkup, S. E.; Cheng, Z.; Elmes, M.; Wathes, D. C.; Abayasekara, D. R. 
Reproduction (Cambridge, England) 2010, 140, 943. 
 (77) Cadas, H.; di Tomaso, E.; Piomelli, D. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 1997, 17, 1226. 
 (78) Das, U. N.; Fams Nutrition (Burbank, Los Angeles County, Calif.) 2003, 19, 62. 
 (79) Spickett, C. M. Redox Biology 2013, 1, 145. 
 (80) Kruman, I.; Bruce-Keller, A. J.; Bredesen, D.; Waeg, G.; Mattson, M. P. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 1997, 17, 5089. 
 (81) Reed, T. T.; Pierce, W. M.; Markesbery, W. R.; Butterfield, D. A. Brain Research 
2009, 1274, 66. 
 (82) Stevens, J. F.; Maier, C. S. Molecular Nutrition & Food Research 2008, 52, 7. 
 (83) Baldwin, A. S., Jr. Annual review of immunology 1996, 14, 649. 
 (84) Orlowski, R. Z.; Baldwin, A. S., Jr. Trends Mol Med 2002, 8, 385. 
 273 
 (85) Satoh, T.; Okamoto, S. I.; Cui, J.; Watanabe, Y.; Furuta, K.; Suzuki, M.; 
Tohyama, K.; Lipton, S. A. Proc Natl Acad Sci U S A 2006, 103, 768. 
 (86) Mustafa, A. K.; Gadalla, M. M.; Snyder, S. H. Science signaling 2009, 2, re2. 
 (87) Fisher, A. Antioxidants & Redox Signaling 2009, 11, 7. 
 (88) Grek, C. L.; Zhang, J.; Manevich, Y.; Townsend, D. M.; Tew, K. D. J Biol Chem 
2013, 288, 26497. 
 (89) Dawson, R. M. C., p 16. 
 (90) Spaans, S. K.; Weusthuis, R. A.; van der Oost, J.; Kengen, S. W. Frontiers in 
microbiology 2015, 6, 742. 
 (91) Poole, L. B.; Nelson, K. J. Molecules and cells 2016, 39, 53. 
 (92) Amir Aslani, B.; Ghobadi, S. Life sciences 2016, 146, 163. 
 (93) Glorieux, C.; Zamocky, M.; Sandoval, J. M.; Verrax, J.; Calderon, P. B. Free 
radical biology & medicine 2015, 87, 84. 
 (94) Nordberg, J.; Arnér, E. S. J. Free Radical Biology and Medicine 2001, 31, 1287. 
 (95) Mustacich, D.; Powis, G. Biochemical Journal 2000, 346, 1. 
 (96) Gupta, V.; Carroll, K. S. Biochimica et Biophysica Acta (BBA) - General Subjects 
2014, 1840, 847. 
 (97) Pan, J.; Carroll, K. S. ACS Chemical Biology 2013, 8, 1110. 
 (98) Zhang, D.; Macinkovic, I.; Devarie-Baez, N. O.; Pan, J.; Park, C. M.; Carroll, K. 
S.; Filipovic, M. R.; Xian, M. Angewandte Chemie (International ed. in English) 2014, 53, 575. 
 (99) Jeong, J.; Jung, Y.; Na, S.; Jeong, J.; Lee, E.; Kim, M. S.; Choi, S.; Shin, D. H.; 
Paek, E.; Lee, H. Y.; Lee, K. J. Molecular & cellular proteomics : MCP 2011, 10, M110.000513. 
 (100) Dalle-Donne, I.; Carini, M.; Orioli, M.; Vistoli, G.; Regazzoni, L.; Colombo, G.; 
Rossi, R.; Milzani, A.; Aldini, G. Free radical biology & medicine 2009, 46, 1411. 
 (101) Fraenkel-Conrat, H. Journal of Biological Chemistry 1955, 217, 373. 
 (102) Eisen, H. N.; Belmam, S. The Journal of experimental medicine 1953, 98, 533. 
 (103) Shechter, Y.; Patchornik, A.; Burstein, Y. Journal of Biological Chemistry 1974, 
249, 413. 
 (104) Armstrong, D. A.; Buchanan, J. D. Photochemistry and Photobiology 1978, 28, 
743. 
 (105) Parker, D. J.; Allison, W. S. Journal of Biological Chemistry 1969, 244, 180. 
 (106) Ehring, R.; Colowick, S. P. J Biol Chem 1969, 244, 4589. 
 (107) Allison, W. S.; Benitez, L. V.; Johnson, C. L. Biochemical and Biophysical 
Research Communications 1973, 52, 1403. 
 (108) Allison, W. S. Accounts of Chemical Research 1976, 9, 293. 
 (109) Penn, R. E.; Block, E.; Revelle, L. K. Journal of the American Chemical Society 
1978, 100, 3622. 
 (110) McGrath, A. J.; Garrett, G. E.; Valgimigli, L.; Pratt, D. A. Journal of the American 
Chemical Society 2010, 132, 16759. 
 (111) Wages, P. A.; Lavrich, K. S.; Zhang, Z.; Cheng, W.-Y.; Corteselli, E.; Gold, A.; 
Bromberg, P.; Simmons, S. O.; Samet, J. M. Chemical Research in Toxicology 2015, 28, 2411. 
 (112) Brown, D. I.; Griendling, K. K. Free radical biology & medicine 2009, 47, 1239. 
 (113) Baez, N. O. D.; Reisz, J. A.; Furdui, C. M. Free radical biology & medicine 2015, 
80, 191. 
 (114) Sivaramakrishnan, S.; Cummings, A. H.; Gates, K. S. Bioorganic & medicinal 
chemistry letters 2010, 20, 444. 
 (115) Zhou, H.; Singh, H.; Parsons, Z. D.; Lewis, S. M.; Bhattacharya, S.; Seiner, D. R.; 
LaButti, J. N.; Reilly, T. J.; Tanner, J. J.; Gates, K. S. Journal of the American Chemical Society 
2011, 133, 15803. 
 (116) Paulsen, C. E.; Truong, T. H.; Garcia, F. J.; Homann, A.; Gupta, V.; Leonard, S. 
E.; Carroll, K. S. Nature Chemical Biology 2012, 8, 57. 
 274 
 (117) Paulsen, C. E.; Truong, T. H.; Garcia, F. J.; Homann, A.; Gupta, V.; Leonard, S. 
E.; Carroll, K. S. Nat Chem Biol 2012, 8, 57. 
 (118) Truong, T. H.; Carroll, K. S. Biochemistry 2012, 51, 9954. 
 (119) Tanner, J. J. P., Z. D.; Cummings, A.H.; Zhou, H.; and Gates, K.S. Antioxidants 
& Redox Signaling 2011, 15, 21. 
 (120) Ho, G. P.; Selvakumar, B.; Mukai, J.; Hester, L. D.; Wang, Y.; Gogos, J. A.; 
Snyder, S. H. Neuron 2011, 71, 131. 
 (121) Majmudar, J. D.; Konopko, A. M.; Labby, K. J.; Tom, C. T.; Crellin, J. E.; 
Prakash, A.; Martin, B. R. J Am Chem Soc 2016, 138, 1852. 
 (122) Lavis, L. D.; Raines, R. T. ACS Chemical Biology 2008, 3, 142. 
 (123) Lichtman, J. W.; Conchello, J.-A. Nat Meth 2005, 2, 910. 
 (124) Huang, B.; Babcock, H.; Zhuang, X. Cell, 143, 1047. 
 (125) Grimm, J. B.; English, B. P.; Chen, J.; Slaughter, J. P.; Zhang, Z.; Revyakin, A.; 
Patel, R.; Macklin, J. J.; Normanno, D.; Singer, R. H.; Lionnet, T.; Lavis, L. D. Nat Meth 2015, 
12, 244. 
 (126) Wardman, P. Free radical biology & medicine 2007, 43, 995. 
 (127) Mizukami, S.; Takikawa, R.; Sugihara, F.; Shirakawa, M.; Kikuchi, K. 
Angewandte Chemie International Edition 2009, 48, 3641. 
 (128) Xuan, W.; Pan, R.; Cao, Y.; Liu, K.; Wang, W. Chemical Communications 2012, 
48, 10669. 
 (129) Montoya, L. A.; Pluth, M. D. Chemical Communications 2012, 48, 4767. 
 (130) Zhu, B.; Gao, C.; Zhao, Y.; Liu, C.; Li, Y.; Wei, Q.; Ma, Z.; Du, B.; Zhang, X. 
Chemical Communications 2011, 47, 8656. 
 (131) Liu, C.; Pan, J.; Li, S.; Zhao, Y.; Wu, L. Y.; Berkman, C. E.; Whorton, A. R.; Xian, 
M. Angewandte Chemie International Edition 2011, 50, 10327. 
 (132) Qian, Y.; Karpus, J.; Kabil, O.; Zhang, S.-Y.; Zhu, H.-L.; Banerjee, R.; Zhao, J.; 
He, C. Nat Commun 2011, 2, 495. 
 (133) Cao, X.; Lin, W.; Zheng, K.; He, L. Chemical Communications 2012, 48, 10529. 
 (134) Miller, E. W.; Albers, A. E.; Pralle, A.; Isacoff, E. Y.; Chang, C. J. Journal of the 
American Chemical Society 2005, 127, 16652. 
 (135) Kojima, H.; Nakatsubo, N.; Kikuchi, K.; Kawahara, S.; Kirino, Y.; Nagoshi, H.; 
Hirata, Y.; Nagano, T. Analytical Chemistry 1998, 70, 2446. 
 (136) Gabe, Y.; Urano, Y.; Kikuchi, K.; Kojima, H.; Nagano, T. Journal of the American 
Chemical Society 2004, 126, 3357. 
 (137) Sasaki, E.; Kojima, H.; Nishimatsu, H.; Urano, Y.; Kikuchi, K.; Hirata, Y.; Nagano, 
T. Journal of the American Chemical Society 2005, 127, 3684. 
 (138) Hu, J. J.; Wong, N.-K.; Ye, S.; Chen, X.; Lu, M.-Y.; Zhao, A. Q.; Guo, Y.; Ma, A. 
C.-H.; Leung, A. Y.-H.; Shen, J.; Yang, D. Journal of the American Chemical Society 2015, 137, 
6837. 
 (139) Chen, Y.; Zhu, C.; Yang, Z.; Chen, J.; He, Y.; Jiao, Y.; He, W.; Qiu, L.; Cen, J.; 
Guo, Z. Angewandte Chemie International Edition 2013, 52, 1688. 
 (140) Montoya, L. A.; Pearce, T. F.; Hansen, R. J.; Zakharov, L. N.; Pluth, M. D. The 
Journal of Organic Chemistry 2013, 78, 6550. 
 (141) Bouffard, J.; Kim, Y.; Swager, T. M.; Weissleder, R.; Hilderbrand, S. A. Organic 
Letters 2008, 10, 37. 
 (142) Albers, A. E.; Dickinson, B. C.; Miller, E. W.; Chang, C. J. Bioorganic & medicinal 
chemistry letters 2008, 18, 5948. 
 (143) Du, L.; Li, M.; Zheng, S.; Wang, B. Tetrahedron Letters 2008, 49, 3045. 
 (144) DeLeon, E. R.; Gao, Y.; Huang, E.; Arif, M.; Arora, N.; Divietro, A.; Patel, S.; 
Olson, K. R. American Journal of Physiology - Regulatory, Integrative and Comparative 
Physiology 2016. 
 275 
 (145) Heim, R.; Prasher, D. C.; Tsien, R. Y. Proceedings of the National Academy of 
Sciences of the United States of America 1994, 91, 12501. 
 (146) Shaner, N. C.; Patterson, G. H.; Davidson, M. W. Journal of Cell Science 2007, 
120, 4247. 
 (147) Østergaard, H.; Henriksen, A.; Hansen, F. G.; Winther, J. R. The EMBO Journal 
2001, 20, 5853. 
 (148) Østergaard, H.; Tachibana, C.; Winther, J. R. The Journal of Cell Biology 2004, 
166, 337. 
 (149) Hanson, G. T.; Aggeler, R.; Oglesbee, D.; Cannon, M.; Capaldi, R. A.; Tsien, R. 
Y.; Remington, S. J. Journal of Biological Chemistry 2004, 279, 13044. 
 (150) Zhao, Y.; Jin, J.; Hu, Q.; Zhou, H.-M.; Yi, J.; Yu, Z.; Xu, L.; Wang, X.; Yang, Y.; 
Loscalzo, J. Cell Metabolism, 14, 555. 
 (151) Enyedi, B.; Zana, M.; Donkó, Á.; Geiszt, M. Antioxidants & Redox Signaling 
2012, 19, 523. 
 (152) Qian, J.; Klomsiri, C.; Wright, M. W.; King, S. B.; Tsang, A. W.; Poole, L. B.; 
Furdui, C. M. Chemical Communications 2011, 47, 9203. 
 (153) Poole, L. B.; Klomsiri, C.; Knaggs, S. A.; Furdui, C. M.; Nelson, K. J.; Thomas, M. 
J.; Fetrow, J. S.; Daniel, L. W.; King, S. B. Bioconjugate chemistry 2007, 18, 2004. 
 (154) Truong, T. H.; Garcia, F. J.; Seo, Y. H.; Carroll, K. S. Bioorg Med Chem Lett 
2011, 21, 5015. 
 (155) Liang, L.; Astruc, D. Coordination Chemistry Reviews 2011, 255, 2933. 
 (156) Seo, Y. H.; Carroll, K. S. Proceedings of the National Academy of Sciences of 
the United States of America 2009, 106, 16163. 
 (157) Shiau, T. P.; Erlanson, D. A.; Gordon, E. M. Organic Letters 2006, 8, 5697. 
 (158) Gupta, V.; Carroll, K. S. Chemical Science 2016, 7, 400. 
 (159) Qian, J.; Wani, R.; Klomsiri, C.; Poole, L. B.; Tsang, A. W.; Furdui, C. M. 
Chemical communications (Cambridge, England) 2012, 48, 4091. 
 (160) Gupta, V.; Carroll, K. S. Biochimica Et Biophysica Acta-General Subjects 2014, 
1840, 847. 
 (161) Poole, T. H.; Reisz, J. A.; Zhao, W.; Poole, L. B.; Furdui, C. M.; King, S. B. J. Am. 
Chem. Soc. 2014, 136, 6167. 
 (162) Ellis, H. R.; Poole, L. B. Biochemistry 1997, 36, 13349. 
 (163) Paulsen, C. E.; Carroll, K. S. Chem. Rev. 2013, 113, 4633. 
 (164) Devarie-Baez, N. O.; Silva Lopez, E. I.; Furdui, C. M. Free radical research 2015, 
1. 
 (165) Crump, K. E.; Juneau, D. G.; Poole, L. B.; Haas, K. M.; Grayson, J. M. European 
Journal of Immunology 2012, 42, 2152. 
 (166) Poole, L. B.; Zeng, B.-B.; Knaggs, S. A.; Yakubu, M.; King, S. B. Bioconjugate 
Chem. 2005, 16, 1624. 
 (167) Reddie, K. G.; Seo, Y. H.; Muse Iii, W. B.; Leonard, S. E.; Carroll, K. S. Mol. 
BioSyst. 2008, 4, 521. 
 (168) Benitez, L. V.; Allison, W. S. The Journal of biological chemistry 1974, 249, 6234. 
 (169) Qian, J.; Klomsiri, C.; Wright, M. W.; King, S. B.; Tsang, A. W.; Poole, L. B.; 
Furdui, C. M. Chemical communications 2011, 47, 9203. 
 (170) Yang, J.; Gupta, V.; Carroll, K. S.; Liebler, D. C. Nature Communications 2014, 5. 
 (171) Liu, C. T.; Benkovic, S. J. J. Am. Chem. Soc. 2013, 135, 14544. 
 (172) Qian, J.; Klomsiri, C.; Wright, M. W.; King, S. B.; Tsang, A. W.; Poole, L. B.; 
Furdui, C. M. Chem. Commun. 2011, 47, 9203. 
 (173) Stewart, W. W. Cell 1978, 14, 741. 
 (174) Gupta, V.; Carroll, K. S. Biochim. Biophys. Acta, Gen. Subj. 2014, 1840, 847. 
 (175) Deb, M. L.; Bhuyan, P. J. Tetrahedron Lett. 2005, 46, 6453. 
 276 
 (176) Kudirka, R.; Barfield, Robyn M.; McFarland, J.; Albers, Aaron E.; de Hart, 
Gregory W.; Drake, Penelope M.; Holder, Patrick G.; Banas, S.; Jones, Lesley C.; Garofalo, 
Albert W.; Rabuka, D. Chem. Biol. 2015, 22, 293. 
 (177) Requena, J. R.; Chao, C. C.; Levine, R. L.; Stadtman, E. R. Proc. Natl. Acad. Sci. 
U. S. A. 2001, 98, 69. 
 (178) Cairns, R. A.; Harris, I. S.; Mak, T. W. Nat. Rev. Cancer 2011, 11, 85. 
 (179) Ye, X.; Weinberg, R. A. Trends in Cell Biology 2015, 25, 675. 
 (180) Hernandez, J. H. D., D.; Majumudar, J.D.; Won, S.J.; Martin, B.R. 2016, In 
Revision. 
 (181) Frangioni, J. V. Curr Opin Chem Biol 2003, 7, 626. 
 (182) Fei, X.; Gu, Y. Progress in Natural Science 2009, 19, 1. 
 (183) Hong, G.; Zou, Y.; Antaris, A. L.; Diao, S.; Wu, D.; Cheng, K.; Zhang, X.; Chen, 
C.; Liu, B.; He, Y.; Wu, J. Z.; Yuan, J.; Zhang, B.; Tao, Z.; Fukunaga, C.; Dai, H. Nat Commun 
2014, 5. 
 (184) Wu, H.; Zhao, H.; Song, X.; Li, S.; Ma, X.; Tan, M. Journal of Materials Chemistry 
B 2014, 2, 5302. 
 (185) He, X.; Gao, J.; Gambhir, S. S.; Cheng, Z. Trends in molecular medicine 2010, 
16, 574. 
 (186) Gerig, J. T. Biophysical Society 2001, 35. 
 (187) Higuchi, M.; Iwata, N.; Matsuba, Y.; Sato, K.; Sasamoto, K.; Saido, T. C. Nat 
Neurosci 2005, 8, 527. 
 (188) Kitamura, N.; Tanaka, K.; Chujo, Y. Bioorganic & Medicinal Chemistry Letters 
2013, 23, 281. 
 (189) Yamaguchi, K.; Ueki, R.; Nonaka, H.; Sugihara, F.; Matsuda, T.; Sando, S. 
Journal of the American Chemical Society 2011, 133, 14208. 
 (190) Yu, J.-X.; Kodibagkar, V. D.; Liu, L.; Zhang, Z.; Liu, L.; Magnusson, J.; Liu, Y. 
Chemical Science 2013, 4, 2132. 
 (191) Tirotta, I.; Dichiarante, V.; Pigliacelli, C.; Cavallo, G.; Terraneo, G.; Bombelli, F. 
B.; Metrangolo, P.; Resnati, G. Chemical Reviews 2015, 115, 1106. 
 (192) Ye, D.; Shuhendler, A. J.; Pandit, P.; Brewer, K. D.; Tee, S. S.; Cui, L.; 
Tikhomirov, G.; Rutt, B.; Rao, J. Chemical Science 2014, 5, 3845. 
 (193) Saleur, D.; Bouillon, J.-P.; Portella, C. The Journal of Organic Chemistry 2001, 
66, 4543. 
 (194) Fuchigami, T.; Shimojo, M.; Konno, A. The Journal of Organic Chemistry 1995, 
60, 3459. 
 (195) Stein, A.; Gregor, H. P.; Spoerri, P. E. Journal of the American Chemical Society 
1956, 78, 6185. 
 (196) Puig-de-la-Bellacasa, R.; Giménez, L.; Pettersson, S.; Pascual, R.; Gonzalo, E.; 
Esté, J. A.; Clotet, B.; Borrell, J. I.; Teixidó, J. European Journal of Medicinal Chemistry 2012, 
54, 159. 
 (197) Al-Turkistani, A. A.; Al-Deeb, O. A.; El-Brollosy, N. R.; El-Emam, A. A. Molecules 
2011, 16, 4764. 
 (198) Jansa, P.; Holý, A.; Dračínský, M.; Kolman, V.; Janeba, Z.; Kostecká, P.; 
Kmoníčková, E.; Zídek, Z. Medicinal Chemistry Research 2014, 23, 4482. 
 (199) Varano, F.; Catarzi, D.; Squarcialupi, L.; Betti, M.; Vincenzi, F.; Ravani, A.; 
Varani, K.; Dal Ben, D.; Thomas, A.; Volpini, R.; Colotta, V. European Journal of Medicinal 
Chemistry 2015, 96, 105. 
 (200) Provins, L.; Christophe, B.; Danhaive, P.; Dulieu, J.; Durieu, V.; Gillard, M.; 
Lebon, F.; Lengelé, S.; Quéré, L.; van Keulen, B. Bioorganic & Medicinal Chemistry Letters 
2006, 16, 1834. 
 (201) Abdel-Rahman, T. M. Journal of Heterocyclic Chemistry 2005, 42, 1257. 
 277 
 (202) Moses, W. W. Nuclear instruments & methods in physics research. Section A, 
Accelerators, spectrometers, detectors and associated equipment 2011, 648 Supplement 1, 
S236. 
 (203) Fruede, D. Spectroscopy - Ch 4: NMR, 2006. 
 (204) Schwarz, R.; Schuurmans, M.; Seelig, J.; Künnecke, B. Magnetic Resonance in 
Medicine 1999, 41, 80. 
 (205) Yamane, T.; Hanaoka, K.; Muramatsu, Y.; Tamura, K.; Adachi, Y.; Miyashita, Y.; 
Hirata, Y.; Nagano, T. Bioconjugate chemistry 2011, 22, 2227. 
 (206) Lee, T.; Zhang, X. A.; Dhar, S.; Faas, H.; Lippard, S. J.; Jasanoff, A. Chemistry & 
biology 2010, 17, 665. 
 (207) Spirk, S.; Madl, T.; Pietschnig, R. Organometallics 2008, 27, 500. 
 (208) Gupta, V.; Carroll, K. S. Chemical Communications 2016, 52, 3414. 
 (209) Gottlieb, H. E.; Kotlyar, V.; Nudelman, A. Journal of Organic Chemistry 1997, 62, 
7512. 
 (210) Shao, Y.; Gan, Z.; Epifanovsky, E.; Gilbert, A. T. B.; Wormit, M.; Kussmann, J.; 
Lange, A. W.; Behn, A.; Deng, J.; Feng, X.; Ghosh, D.; Goldey, M.; Horn, P. R.; Jacobson, L. D.; 
Kaliman, I.; Khaliullin, R. Z.; Kuś, T.; Landau, A.; Liu, J.; Proynov, E. I.; Rhee, Y. M.; Richard, R. 
M.; Rohrdanz, M. A.; Steele, R. P.; Sundstrom, E. J.; Woodcock, H. L.; Zimmerman, P. M.; 
Zuev, D.; Albrecht, B.; Alguire, E.; Austin, B.; Beran, G. J. O.; Bernard, Y. A.; Berquist, E.; 
Brandhorst, K.; Bravaya, K. B.; Brown, S. T.; Casanova, D.; Chang, C.-M.; Chen, Y.; Chien, S. 
H.; Closser, K. D.; Crittenden, D. L.; Diedenhofen, M.; DiStasio, R. A.; Do, H.; Dutoi, A. D.; 
Edgar, R. G.; Fatehi, S.; Fusti-Molnar, L.; Ghysels, A.; Golubeva-Zadorozhnaya, A.; Gomes, J.; 
Hanson-Heine, M. W. D.; Harbach, P. H. P.; Hauser, A. W.; Hohenstein, E. G.; Holden, Z. C.; 
Jagau, T.-C.; Ji, H.; Kaduk, B.; Khistyaev, K.; Kim, J.; Kim, J.; King, R. A.; Klunzinger, P.; 
Kosenkov, D.; Kowalczyk, T.; Krauter, C. M.; Lao, K. U.; Laurent, A. D.; Lawler, K. V.; 
Levchenko, S. V.; Lin, C. Y.; Liu, F.; Livshits, E.; Lochan, R. C.; Luenser, A.; Manohar, P.; 
Manzer, S. F.; Mao, S.-P.; Mardirossian, N.; Marenich, A. V.; Maurer, S. A.; Mayhall, N. J.; 
Neuscamman, E.; Oana, C. M.; Olivares-Amaya, R.; O’Neill, D. P.; Parkhill, J. A.; Perrine, T. M.; 
Peverati, R.; Prociuk, A.; Rehn, D. R.; Rosta, E.; Russ, N. J.; Sharada, S. M.; Sharma, S.; 
Small, D. W.; Sodt, A. Molecular Physics 2015, 113, 184. 
 (211) Becke, A. D. The Journal of Chemical Physics 1993, 98, 5648. 
 (212) Lee, C.; Yang, W.; Parr, R. G. Physical Review B 1988, 37, 785. 
 (213) Hay, P. J.; Wadt, W. R. The Journal of Chemical Physics 1985, 82, 270. 
 (214) Hay, P. J.; Wadt, W. R. The Journal of Chemical Physics 1985, 82, 299. 
 (215) Wadt, W. R.; Hay, P. J. The Journal of Chemical Physics 1985, 82, 284. 
 (216) Chai, J.-D.; Head-Gordon, M. Physical Chemistry Chemical Physics 2008, 10, 
6615. 
 (217) Balabanov, N. B.; Peterson, K. A. The Journal of Chemical Physics 2005, 123, 
064107. 
 (218) Dunning, T. H. The Journal of Chemical Physics 1989, 90, 1007. 
 (219) Woon, D. E.; Dunning, T. H. The Journal of Chemical Physics 1993, 98, 1358. 
 (220) Zimmerman, P. Journal of Chemical Theory and Computation 2013, 9, 3043. 
 (221) Zimmerman, P. M. The Journal of Chemical Physics 2013, 138, 184102. 
 (222) Zimmerman, P. M. Journal of Computational Chemistry 2015, 36, 601. 
 (223) E. D. Glendening, J. K. B., A. E. Reed, J. E. Carpenter, J. A. Bohmann, C. M. 
Morales, and F. Weinhold  Theoretical Chemistry Institute, University of Wisconsin, Madison, 
WI, 2001, 2001. 
 (224) Fischer, M.; Stadlbauer, W. Journal of Heterocyclic Chemistry 1997, 34, 993. 
 (225) Markiewicz, J. T.; Wiest, O.; Helquist, P. Journal of Organic Chemistry 2010, 75, 
4887. 
 278 
 (226) Prakash, G. K. S.; Wang, F.; Shao, N.; Mathew, T.; Rasul, G.; Haiges, R.; 
Stewart, T.; Olah, G. A. Angewandte Chemie International Edition 2009, 48, 5358. 
 (227) Cesario, C.; Miller, M. J. J Org Chem 2009, 74, 5730. 
 (228) Sevier, C. S.; Kaiser, C. A. Biochimica et Biophysica Acta (BBA) - Molecular Cell 
Research 2008, 1783, 549. 
 (229) Frand, A. R.; Kaiser, C. A. Molecular cell 1999, 4, 469. 
 (230) Sevier, C. S.; Qu, H.; Heldman, N.; Gross, E.; Fass, D.; Kaiser, C. A. Cell, 129, 
333. 
 (231) Tu, B. P.; Weissman, J. S. J Cell Biol 2004, 164, 341. 
 (232) Princiotta, M. F.; Finzi, D.; Qian, S.-B.; Gibbs, J.; Schuchmann, S.; Buttgereit, F.; 
Bennink, J. R.; Yewdell, J. W. Immunity 2003, 18, 343. 
 (233) Rehder, D. S.; Borges, C. R. Biochemistry 2010, 49, 7748. 
 (234) Lee, Jun H.; Budanov, Andrei V.; Karin, M. Cell Metabolism, 18, 792. 
 (235) Saveljeva, S.; Cleary, P.; Mnich, K.; Ayo, A.; Pakos-Zebrucka, K.; Patterson, J. 
B.; Logue, S. E.; Samali, A. Oncotarget 2016. 
 (236) Garaeva, A. A.; Kovaleva, I. E.; Chumakov, P. M.; Evstafieva, A. G. Cell cycle 
(Georgetown, Tex.) 2016, 15, 64. 
 (237) Tomasovic, A.; Kurrle, N.; Surun, D.; Heidler, J.; Husnjak, K.; Poser, I.; 
Schnutgen, F.; Scheibe, S.; Seimetz, M.; Jaksch, P.; Hyman, A.; Weissmann, N.; von Melchner, 
H. J Biol Chem 2015, 290, 9738. 
 (238) Jin, S. H.; Yang, J. H.; Shin, B. Y.; Seo, K.; Shin, S. M.; Cho, I. J.; Ki, S. H. 
Toxicology and Applied Pharmacology 2013, 271, 95. 
 (239) Yang, J. H.; Kim, K. M.; Kim, M. G.; Seo, K. H.; Han, J. Y.; Ka, S. O.; Park, B. H.; 
Shin, S. M.; Ku, S. K.; Cho, I. J.; Ki, S. H. Free radical biology & medicine 2015, 78, 156. 
 (240) Ro, S. H.; Nam, M.; Jang, I.; Park, H. W.; Park, H.; Semple, I. A.; Kim, M.; Kim, J. 
S.; Park, H.; Einat, P.; Damari, G.; Golikov, M.; Feinstein, E.; Lee, J. H. Proc Natl Acad Sci U S 
A 2014, 111, 7849. 
 (241) DeNicola, G. M.; Karreth, F. A.; Humpton, T. J.; Gopinathan, A.; Wei, C.; Frese, 
K.; Mangal, D.; Yu, K. H.; Yeo, C. J.; Calhoun, E. S.; Scrimieri, F.; Winter, J. M.; Hruban, R. H.; 
Iacobuzio-Donahue, C.; Kern, S. E.; Blair, I. A.; Tuveson, D. A. Nature 2011, 475, 106. 
 (242) Kallenborn-Gerhardt, W.; Lu, R.; Syhr, K. M.; Heidler, J.; von Melchner, H.; 
Geisslinger, G.; Bangsow, T.; Schmidtko, A. Antioxid Redox Signal 2013, 19, 2013. 
 (243) Arrigo, A. P. Biological chemistry 1998, 379, 19. 
 (244) Preville, X.; Salvemini, F.; Giraud, S.; Chaufour, S.; Paul, C.; Stepien, G.; Ursini, 
M. V.; Arrigo, A. P. Experimental cell research 1999, 247, 61. 
 (245) Papp, E.; Nardai, G.; Soti, C.; Csermely, P. BioFactors (Oxford, England) 2003, 
17, 249. 
 (246) Baker, A.; Santos, B. D.; Powis, G. Biochem Biophys Res Commun 2000, 268, 
78. 
 (247) Zuo, Y.; Xiang, B.; Yang, J.; Sun, X.; Wang, Y.; Cang, H.; Yi, J. Cell Res 2009, 
19, 449. 
 (248) Rossig, L.; Fichtlscherer, B.; Breitschopf, K.; Haendeler, J.; Zeiher, A. M.; 
Mulsch, A.; Dimmeler, S. J Biol Chem 1999, 274, 6823. 
 (249) Mannick, J. B.; Hausladen, A.; Liu, L.; Hess, D. T.; Zeng, M.; Miao, Q. X.; Kane, 
L. S.; Gow, A. J.; Stamler, J. S. Science (New York, N.Y.) 1999, 284, 651. 
 (250) Torok, N. J.; Higuchi, H.; Bronk, S.; Gores, G. J. Cancer research 2002, 62, 
1648. 
 (251) Shalini, S.; Kumar, S. Molecular & Cellular Oncology 2015, 2, e1004956. 
 (252) Wang, Y. Y., J; and Yi, J Antioxidants & Redox Signaling 2012, 16, 8. 
 (253) Sobotta, M. C.; Liou, W.; Stöcker, S.; Talwar, D.; Oehler, M.; Ruppert, T.; Scharf, 
A. N. D.; Dick, T. P. Nat Chem Biol 2015, 11, 64. 
 279 
 (254) Gautier, V.; Le, H.-T.; Malki, A.; Messaoudi, N.; Caldas, T.; Kthiri, F.; Landoulsi, 
A.; Richarme, G. Journal of Molecular Biology 2012, 421, 662. 
 (255) Bonifati, V.; Rizzu, P.; van Baren, M. J.; Schaap, O.; Breedveld, G. J.; Krieger, 
E.; Dekker, M. C.; Squitieri, F.; Ibanez, P.; Joosse, M.; van Dongen, J. W.; Vanacore, N.; van 
Swieten, J. C.; Brice, A.; Meco, G.; van Duijn, C. M.; Oostra, B. A.; Heutink, P. Science (New 
York, N.Y.) 2003, 299, 256. 
 (256) Messaoudi, N.; Gautier, V.; Kthiri, F.; Lelandais, G.; Mihoub, M.; Joseleau-Petit, 
D.; Caldas, T.; Bohn, C.; Tolosa, L.; Rao, G.; Tao, K.; Landoulsi, A.; Bouloc, P.; Richarme, G. 
Journal of Bacteriology 2013, 195, 1167. 
 (257) Hwang, N. R.; Yim, S. H.; Kim, Y. M.; Jeong, J.; Song, E. J.; Lee, Y.; Lee, J. H.; 
Choi, S.; Lee, K. J. The Biochemical journal 2009, 423, 253. 
 (258) Humphrey, L. L.; Deffebach, M.; Pappas, M.; Baumann, C.; Artis, K.; Mitchell, J. 
P.; Zakher, B.; Fu, R.; Slatore, C. G. Annals of Internal Medicine 2013, 159, 411. 
 (259) Westwood, M. J., M; Grutters, J; Redekop, K; Armstrong, N; Lee, K; Gloy, V; 
Raatz, H; Misso, K ; Severens, J; and Kleijnen, J. Health Technology Assessment 2013, 17, 
268. 
 (260) Hulten, E.; Pickett, C.; Bittencourt, M. S.; Villines, T. C.; Petrillo, S.; Di Carli, M. 
F.; Blankstein, R. Journal of the American College of Cardiology 2013, 61, 880. 
 (261) Seigneurin, A.; Field, J. K.; Gachet, A.; Duffy, S. W. Annals of Oncology 2013. 
 (262) Lusic, H.; Grinstaff, M. W. Chemical reviews 2013, 113, 10.1021/cr200358s. 
 (263) Gambhir, S. S. Nat Rev Cancer 2002, 2, 683. 
 (264) Wood, K. A.; Hoskin, P. J.; Saunders, M. I. Clinical Oncology 2007, 19, 237. 
 (265) Pennant, M.; Takwoingi, Y.; Pennant, L.; Davenport, C.; Fry-Smith, A.; Eisinga, 
A.; Andronis, L.; Arvanitis, T.; Deeks, J.; Hyde, C. Health technology assessment (Winchester, 
England) 2010, 14, 1. 
 (266) AGENCY, I. A. E. Technical Reports Series 2008, 230. 
 (267) McQuade, P.; McCarthy, D. W.; Welch, M. J. In Positron Emission Tomography: 
Basic Sciences; Bailey, D. L., Townsend, D. W., Valk, P. E., Maisey, M. N., Eds.; Springer 
London: London, 2005, p 237. 
 (268) SM., Q. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008, 
52, 10. 
 (269) Freudenberg, L. S.; Schueler, A. O.; Beyer, T.; Antoch, G.; Kuhl, H.; Bornfeld, N.; 
Bockisch, A.; Egelhof, T. Survey of ophthalmology 2004, 49, 537. 
 (270) Buijsen, J.; van den Bogaard, J.; Janssen, M. H. M.; Bakers, F. C. H.; 
Engelsman, S.; Öllers, M.; Beets-Tan, R. G. H.; Nap, M.; Beets, G. L.; Lambin, P.; Lammering, 
G. Radiotherapy and Oncology 2011, 98, 270. 
 (271) Ross, T. L.; Wester, H. J. In Handbook of Nuclear Chemistry; Vértes, A., Nagy, 
S., Klencsár, Z., Lovas, R. G., Rösch, F., Eds.; Springer US: Boston, MA, 2011, p 2021. 
 (272) Riedi, P. C.; Lord, J. S. In Interstitial Intermetallic Alloys; Grandjean, F., Long, G. 
J., Buschow, K. H. J., Eds.; Springer Netherlands: Dordrecht, 1995, p 267. 
 (273) Saitô, H.; Ando, I.; Ramamoorthy, A. Progress in nuclear magnetic resonance 
spectroscopy 2010, 57, 181. 
 (274) Dowsett, D. Radiological Sciences Dictionary: Keywords, names and definitions; 
CRC Press 2009. 
 (275) Skovronsky, D. M.; Zhang, B.; Kung, M. P.; Kung, H. F.; Trojanowski, J. Q.; Lee, 
V. M. Proc Natl Acad Sci U S A 2000, 97, 7609. 
 (276) Sato, K.; Higuchi, M.; Iwata, N.; Saido, T. C.; Sasamoto, K. European Journal of 
Medicinal Chemistry 2004, 39, 573. 
 (277) Knight, J. C.; Edwards, P. G.; Paisey, S. J. RSC Advances 2011, 1, 1415. 
 (278) Mason, R. P.; Rodbumrung, W.; Antich, P. P. NMR in Biomedicine 1996, 9, 125. 
 280 
 (279) Jiang, Z. X.; Feng, Y.; Yu, Y. B. Chemical communications (Cambridge, England) 
2011, 47, 7233. 
 (280) Peng, H.; Blakey, I.; Dargaville, B.; Rasoul, F.; Rose, S.; Whittaker, A. K. 
Biomacromolecules 2009, 10, 374. 
 (281) Nakamura, T.; Matsushita, H.; Sugihara, F.; Yoshioka, Y.; Mizukami, S.; Kikuchi, 
K. Angewandte Chemie International Edition 2015, 54, 1007. 
 (282) Ahrens, E. T.; Flores, R.; Xu, H.; Morel, P. A. Nat Biotech 2005, 23, 983.  
